Yehuda Shoenfeld

Q: What Schools Are Affiliated With Yehuda Shoenfeld

Yehuda Shoenfeld is affiliated with the following schools: Weizmann Institute of Science, University of Perugia, Ariel University, Tel Aviv University, Hebrew University of Jerusalem, First Moscow State Medical University, University of Guadalajara, Ben-Gurion University of the Negev, Saint Petersburg State University

Yehuda Shoenfeld's AcademicInfluence.com Rankings

Yehuda Shoenfeld

Biology

#1045

World Rank

#1805

Historical Rank

Immunology

#16

World Rank

#19

Historical Rank

biology Degrees

Yehuda Shoenfeld

Philosophy

#1413

World Rank

#2582

Historical Rank

Logic

#200

World Rank

#438

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Yehuda Shoenfeld's Degrees

PhD Immunology Weizmann Institute of Science

Why Is Yehuda Shoenfeld Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Yehuda Shoenfeld is an Israeli physician and autoimmunity researcher. Biography Yehuda Shoenfeld works at Sheba Medical Center in Tel HaShomer and the Sackler Faculty of Medicine at Tel-Aviv University. He studied at the Hebrew University of Jerusalem. He is the incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases. Shoenfeld is the editor of two journals, Harefuah in Hebrew with English abstracts and Israel Medical Association Journal . He is co-editor-in-chief of Autoimmunity Reviews, and co-editor of the Journal of Autoimmunity, and member of the editorial board of the Clinical Reviews in Allergy & Immunology.

(See a Problem?)

Yehuda Shoenfeld's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) (2006) (4892)
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. (2002) (1813)
Effects of tobacco smoke on immunity, inflammation and autoimmunity. (2010) (821)
'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. (2011) (813)
Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. (2013) (744)
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines (2003) (743)
Pathogenesis and natural history of osteonecrosis. (2002) (731)
Vitamin D and autoimmunity: new aetiological and therapeutic considerations (2007) (619)
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (2010) (599)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (2009) (585)
Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. (2004) (567)
Anti-inflammatory and immunosuppressive drugs and reproduction (2006) (548)
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. (2010) (523)
EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) (511)
Obesity in autoimmune diseases: not a passive bystander. (2014) (504)
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. (1996) (483)
Hydroxychloroquine: From Malaria to Autoimmunity (2011) (471)
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies (2013) (471)
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases (2005) (445)
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. (1991) (423)
Convalescent plasma in Covid-19: Possible mechanisms of action (2020) (412)
Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. (2013) (412)
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus (2003) (410)
Catastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients (2001) (404)
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. (1983) (402)
The mosaic of autoimmunity. (1989) (390)
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. (1996) (389)
The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome (2013) (372)
HIV and autoimmunity. (2002) (364)
Mechanisms of Disease: atherosclerosis in autoimmune diseases (2006) (362)
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies (2009) (356)
Infections and autoimmunity--friends or foes? (2009) (352)
Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. (2002) (351)
Covid-19 and autoimmunity (2020) (341)
[The T cell receptor]. (1985) (333)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. (2004) (333)
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". (2009) (314)
The geoepidemiology of systemic lupus erythematosus. (2010) (307)
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients (2008) (306)
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? (2010) (306)
Gender and autoimmunity. (2007) (304)
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). (1992) (300)
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity (2003) (294)
Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. (2011) (293)
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease (2005) (293)
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. (1988) (286)
Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? (2000) (280)
Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. (1998) (278)
Vitamin D and autoimmune thyroid diseases (2011) (276)
Infections and SLE (2005) (272)
Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. (1999) (270)
Adjuvants and autoimmunity (2009) (264)
Matrix Metalloproteinase-9 and Autoimmune Diseases (2006) (264)
Idiotypic cross-reactions of monoclonal human lupus autoantibodies (1983) (261)
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) (2016) (259)
CD4+CD28− T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients (2004) (258)
A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. (2015) (254)
Vitamin D in Systemic and Organ-Specific Autoimmune Diseases (2013) (245)
The SARS-CoV-2 as an instrumental trigger of autoimmunity (2021) (243)
Vaccines and autoimmunity (2009) (241)
Defining and analyzing geoepidemiology and human autoimmunity. (2010) (240)
The microbiome in autoimmune diseases (2019) (239)
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination (2021) (238)
Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function (2007) (238)
Infection, vaccines and other environmental triggers of autoimmunity (2005) (236)
Colchicine treatment for recurrent pericarditis. A decade of experience. (1998) (234)
Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. (2006) (234)
The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. (1998) (232)
Serum antibodies in epilepsy and seizure-associated disorders (2005) (231)
Lupus nephritis: a critical review. (2012) (229)
Sex-based differences in autoimmune diseases. (2016) (229)
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome (2005) (225)
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies (2001) (224)
Safety of intravenous immunoglobulin (IVIG) therapy. (2007) (224)
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. (2013) (222)
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction (2018) (221)
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies (2019) (221)
Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. (1994) (220)
Erdheim-Chester Disease: a comprehensive review of the literature (2013) (212)
Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. (1998) (211)
Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. (1999) (208)
Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. (2007) (208)
Production of autoantibodies by human-human hybridomas. (1982) (208)
Citrullination and autoimmunity. (2015) (206)
A comprehensive review on adult onset Still's disease. (2018) (203)
Biologic therapy for autoimmune diseases: an update (2013) (202)
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. (2013) (201)
The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008. (2008) (200)
Infectious origin of the antiphospholipid syndrome (2005) (199)
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. (1994) (199)
ANTI-DNA ANTIBODY IDIOTYPES IN SYSTEMIC LUPUS ERYTHEMATOSUS (1984) (199)
Novel Biomarkers in Autoimmune Diseases (2007) (198)
Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. (2007) (197)
Prolactin and Autoimmunity (2018) (196)
The autoimmune bases of infertility and pregnancy loss. (2012) (195)
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning (2020) (194)
Autoimmune diseases and autoimmunity post-bone marrow transplantation (1998) (194)
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. (2008) (191)
Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. (2002) (188)
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes (1999) (188)
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. (2016) (186)
Hyperprolactinemia and autoimmune diseases. (2007) (185)
A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response (1999) (185)
Immunologic and genetic factors in autoimmune diseases. (1984) (183)
Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. (2004) (182)
Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. (1999) (179)
Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. (2006) (177)
Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. (2012) (177)
Geoepidemiology of autoimmune rheumatic diseases (2010) (177)
Intravenous immunoglobulin (2005) (174)
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. (2014) (172)
Systemic lupus erythematosus one disease or many? (2012) (170)
The Role of CD40–CD154 Interactions in Autoimmunity and the Benefit of Disrupting this Pathway (2004) (169)
Epstein–Barr Virus and Cytomegalovirus in Autoimmune Diseases (2007) (168)
State of the art: Reproduction and pregnancy in rheumatic diseases. (2015) (166)
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. (1984) (163)
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. (2006) (162)
Novel aspects of Sjögren’s syndrome in 2012 (2013) (160)
Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? (2004) (160)
Adoptive Transfer of β2-Glycoprotein I–Reactive Lymphocytes Enhances Early Atherosclerosis in LDL Receptor–Deficient Mice (2000) (159)
Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. (1998) (157)
Smoke and autoimmunity: The fire behind the disease. (2016) (156)
Ferritin in autoimmune diseases. (2007) (156)
Mycobacteria and autoimmunity. (1988) (155)
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy (2020) (154)
Idiotypic induction of autoimmunity: a new aspect of the idiotypic network (1994) (154)
Vaccines, adjuvants and autoimmunity (2015) (151)
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine (2020) (151)
Thymoma and autoimmunity (2011) (150)
Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations (2000) (150)
Sjögren's syndrome, the old and the new. (2012) (149)
Physical activity and autoimmune diseases: Get moving and manage the disease. (2017) (149)
Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves (1996) (148)
Neuropsychiatric lupus: a mosaic of clinical presentations (2015) (148)
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders (1998) (146)
Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. (1996) (146)
Antiphospholipid Syndrome Infectious Origin (2004) (145)
Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. (2000) (145)
The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease (2009) (145)
The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. (2008) (143)
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications (2015) (143)
Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. (1998) (143)
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression (2010) (141)
Tobacco smoking and autoimmune rheumatic diseases (2007) (141)
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease (2017) (140)
What causes alopecia areata? (2013) (140)
Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications. (2007) (139)
What is the contents of the magic draft IVIg? (2008) (139)
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. (2011) (139)
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". (2006) (139)
Precocious intima-media thickening in patients with primary Sjögren's syndrome. (2005) (138)
Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. (1985) (138)
The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008. (2008) (137)
Viral infection can induce the production of autoantibodies (2007) (137)
Geo-epidemiology and autoimmunity. (2010) (136)
Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. (1993) (136)
Antiphospholipid syndrome (2018) (135)
Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis (2009) (135)
Validated methods for assessment of subclinical atherosclerosis in rheumatology (2012) (135)
Serum autoantibodies in patients with primary sclerosing cholangitis. (2000) (134)
Diagnostic criteria in autoimmune diseases (2008) (133)
Vaccine-induced autoimmunity. (1996) (133)
Fibromyalgia and cytokines. (2014) (131)
Atherosclerosis as an infectious, inflammatory and autoimmune disease (2001) (131)
Treatment of pregnant patients with antiphospholipid syndrome (2003) (131)
Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. (2012) (130)
The role of gender and organ specific autoimmunity. (2012) (130)
Tyrosinase as an autoantigen in patients with vitiligo (1996) (129)
Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. (2011) (128)
Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. (1981) (126)
The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008. (2008) (126)
Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. (2015) (125)
Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation (2009) (124)
Cancer and autoimmune diseases. (2017) (124)
Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis. (2018) (124)
Transverse myelitis and vaccines: a multi-analysis (2009) (124)
Intravenous immunoglobulin and the kidney--a two-edged sword. (2004) (123)
Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity. (2017) (123)
Human papillomavirus vaccine and systemic lupus erythematosus (2013) (121)
Silicone implants and lymphoma: The role of inflammation. (2015) (121)
Features associated with epilepsy in the antiphospholipid syndrome. (2004) (121)
Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer (2003) (120)
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report (2003) (120)
Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. (2006) (120)
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. (1997) (120)
Evaluation of the BioPlex™ 2200 ANA Screen: Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive Autoantibodies (2005) (119)
Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. (2010) (117)
Vascular Endothelial Growth Factor (VEGF) in Autoimmune Diseases (2007) (116)
Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review. (2014) (116)
TNF-α, rheumatoid arthritis, and heart failure: a rheumatological dilemma (2005) (115)
Protective Molecules–C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein A1 (Apo A1), and Their Autoantibodies: Prevalence and Clinical Significance in Autoimmunity (2005) (113)
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum (2013) (113)
Hepatitis B Virus (HBV) and Autoimmune Disease (2008) (112)
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) – An update (2017) (112)
On the molecular determinants of the SARS-CoV-2 attack (2020) (112)
Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. (2002) (111)
A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases (2009) (111)
Molecular mimicry and auto-immunity (2007) (111)
Cannabinoids and autoimmune diseases: A systematic review. (2016) (111)
The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity (2007) (110)
Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. (2007) (110)
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. (1984) (109)
Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. (1986) (109)
SARS-CoV-2, the autoimmune virus (2020) (109)
Environment and lupus-related diseases (2012) (108)
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? (2000) (108)
Osteonecrosis in patients with SLE (2003) (108)
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unm (2017) (107)
The significance of natural autoantibodies. (1988) (107)
Assessment of Subclinical Vascular Disease Associated with Ankylosing Spondylitis (2011) (107)
Autoimmunity following Hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (ASIA): analysis of 93 cases (2012) (107)
In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations – a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases * (2002) (106)
Anti‐Vitamin D, Vitamin D in SLE (2007) (105)
Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. (2006) (104)
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. (2001) (104)
Gaucher's disease: a disease with chronic stimulation of the immune system. (1982) (104)
NK cells in autoimmunity: a two-edg'd weapon of the immune system. (2008) (104)
Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects on the mosaic of autoimmunity (2005) (103)
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases (2014) (103)
Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination (2012) (103)
Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: Two faces of the same coin (2011) (103)
Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? (2005) (103)
Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies (1997) (103)
Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus. (2002) (102)
Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. (2010) (102)
The role of vitamin D in regulating immune responses. (2010) (102)
Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants (2013) (101)
Microbiota at the crossroads of autoimmunity. (2016) (101)
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies (2003) (101)
Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. (2004) (101)
Adverse Effects of Intravenous Immunoglobulin Therapy in 56 Patients with Autoimmune Diseases (2001) (100)
Accelerated Atherosclerosis in Rheumatoid Arthritis (2005) (100)
Prophylaxis of the antiphospholipid syndrome: a consensus report (2003) (99)
The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry (2018) (99)
Autoantibody explosion in antiphospholipid syndrome. (2008) (99)
Intravenous immunoglobulin therapy of antiphospholipid syndrome. (2000) (98)
Infectome: A platform to trace infectious triggers of autoimmunity (2012) (98)
No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. (1996) (98)
The infectious etiology of vasculitis (2009) (97)
Atopy and Asthma in Migrants (2005) (97)
The dual association between lymphoma and autoimmunity. (2001) (97)
Chronic fatigue syndrome with autoantibodies--the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. (2008) (96)
The Association Between Anti‐Thyroid Antibodies and Pregnancy Loss (2001) (96)
Early Atherosclerosis in Rheumatoid Arthritis: Effects of Smoking on Thickness of the Carotid Artery Intima Media (2005) (96)
Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. (2005) (96)
Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. (2001) (95)
SLE and infections (2003) (95)
Intravenous immunoglobulin treatment of lupus nephritis. (2000) (95)
Autoantibodies and Prediction of Reproductive Failure (2006) (95)
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. (2010) (94)
Infectious antibodies in systemic lupus erythematosus patients (2009) (94)
Serologic and Clinical Response to Treatment of Systemic Vasculitis and Associated Autoimmune Disease with Intravenous Immunoglobulin (1999) (94)
To smell the immune system: olfaction, autoimmunity and brain involvement. (2006) (94)
Autoimmunity in the Elderly: Insights from Basic Science and Clinics - A Mini-Review (2017) (93)
Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. (2004) (92)
Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. (2006) (92)
Ageing and autoantibodies. (1988) (92)
The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies (2004) (91)
HLA-DRB1 the notorious gene in the mosaic of autoimmunity (2017) (91)
Systemic antiphospholipid syndrome (2003) (90)
Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies (2020) (90)
Autoimmunity: From Bench to Bedside (2013) (89)
Animal Models of Systemic Lupus Erythematosus (1994) (89)
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. (2008) (89)
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. (1987) (89)
Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature (2009) (89)
CNS dysfunction in the antiphospholipid syndrome (2003) (89)
Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. (1996) (88)
Vitamin D endocrine system and the immune response in rheumatic diseases. (2011) (88)
Toll-like Receptors and their Role in the Development of Autoimmune Diseases (2004) (88)
Exposure to Epstein–Barr Virus Infection Is Associated with Mild Systemic Lupus Erythematosus Disease (2009) (88)
Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis (2003) (87)
The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. (2003) (87)
The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (2012) (87)
The Effect of Intravenous γ-Globulin on the Induction of Experimental Antiphospholipid Syndrome (1993) (87)
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study (2007) (86)
Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. (2006) (86)
Vitamin D and thyroid disease: to D or not to D? (2014) (86)
Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature. (2011) (86)
Infection and Autoimmunity (1987) (86)
Autoimmune aspects of cytokine and anticytokine therapies. (2003) (85)
Antiinflammatory and immunomodulatory properties of statins (2002) (85)
Are we at a stage to predict autoimmune rheumatic diseases? (2007) (85)
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions (2011) (85)
International Multicenter Evaluation of Autoantibodies to Ribosomal P Proteins (2006) (85)
xAzathioprine therapy for patients with systemic lupus erythematosus (2001) (84)
Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. (1999) (84)
Heat intolerance in former heatstroke patients. (1979) (84)
Intravenous immunoglobulin therapy and systemic lupus erythematosus (2005) (84)
Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome) (2006) (84)
Vitamin D: a new anti‐infective agent? (2014) (84)
Systemic Thromboembolism in Inflammatory Bowel Disease: Mechanisms and Clinical Applications (2005) (84)
Brief Report: Immune Factors in Autism: A Critical Review (2002) (84)
Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. (1994) (84)
Predicting and Preventing Autoimmunity, Myth or Reality? (2006) (84)
The catastrophic antiphospholipid syndrome--Asherson's syndrome. (2003) (83)
TLR2 Is One of the Endothelial Receptors for β2-Glycoprotein I (2010) (83)
The long pentraxin 3 and its role in autoimmunity. (2009) (83)
Smoking and Immunity: an Additional Player in the Mosaic of Autoimmunity (1997) (83)
Role of infectious agents in systemic rheumatic diseases. (2008) (83)
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis (2007) (83)
Juvenile idiopathic arthritis. (2006) (83)
Review: intravenous immunoglobulin therapy and thromboembolic complications (2005) (83)
Serpins, Immunity and Autoimmunity: Old Molecules, New Functions (2013) (83)
Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients (2007) (82)
Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. (2004) (82)
IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients (2005) (82)
Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention. (2015) (82)
Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays. (2019) (82)
Autoantibodies against Protective Molecules—C1q, C‐Reactive Protein, Serum Amyloid P, Mannose‐Binding Lectin, and Apolipoprotein A1 (2007) (82)
Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE (1990) (82)
Anticardiolipin Antibodies in Infections are Heterogenous in Their Dependency on β 2-Glycoprotein I: Analysis of Anticardiolipin Antibodies in Leprosy (1994) (82)
High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. (2005) (82)
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations (2011) (82)
The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. (2009) (81)
Infection and vasculitis (2008) (81)
Atherosclerosis in Autoimmune Rheumatic Diseases—Mechanisms and Clinical Findings (2009) (80)
Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. (2008) (80)
The Clinical Significance of 25OH-Vitamin D Status in Celiac Disease (2012) (80)
Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression). (2008) (80)
Autoantibody production by patients infected with Leishmania. (1989) (80)
Atherosclerosis and antiphospholipid syndrome (2003) (80)
Early onset of autoimmunity in MRL/++ mice following immunization with β2 glycoprotein I (1995) (80)
Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. (2011) (80)
Ten cases of systemic lupus erythematosus related to hepatitis B vaccine (2009) (80)
Defining an Antigenic Epitope on Platelet Factor 4 Associated With Heparin-Induced Thrombocytopenia (1998) (80)
Clinical and Molecular Evidence for Association of SLE with parvovirus B19 (2010) (79)
Successful treatment of early secondary myelofibrosis in SLE with IVIG (1997) (79)
The role of anti‐idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice (1989) (79)
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 (2003) (79)
Target Recognition of β2-Glycoprotein I (β2GPI)-Dependent Anticardiolipin Antibodies: Evidence for Involvement of the Fourth Domain of β2GPI in Antibody Binding (1998) (78)
Inflammation and accelerated atherosclerosis: basic mechanisms. (2005) (78)
Oxidized LDL/β2-glycoprotein I complexes: new aspects in atherosclerosis (2005) (78)
Antiphospholipid syndrome: pathogenic mechanisms. (2003) (78)
Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. (2011) (78)
Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. (2012) (78)
Hyperactivity in a mouse model of the antiphospholipid syndrome (2001) (77)
Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. (2005) (77)
Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature. (1998) (77)
Benign familial leukopenia and neutropenia in different ethnic groups (1988) (77)
Antiphospholipid antibodies in acute coronary syndrome (2003) (77)
Neuropsychiatric features of systemic lupus erythematosus. (2005) (77)
Prevalence of hepatitis C serum antibody in autoimmune diseases. (2009) (77)
The Possible Role of Prolactin In Autoimmunity (1991) (76)
Vaccination and systemic lupus erythematosus: the bidirectional dilemmas (2001) (76)
Mycobacterium Tuberculosis, Autoimmunity, and Vitamin D (2010) (76)
A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. (1999) (76)
Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. (1992) (76)
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. (2019) (75)
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: Insights from an analysis of 500 cases. (2019) (75)
Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside (2009) (75)
Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin. (1995) (75)
Asthma as a Paradigm for Autoimmune Disease (2003) (74)
IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist (2014) (74)
sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia (2014) (74)
Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. (2008) (74)
The sense of smell in systemic lupus erythematosus. (2009) (74)
Vaccination as an additional player in the mosaic of autoimmunity. (2000) (74)
ASIA syndrome and endocrine autoimmune disorders. (2020) (74)
Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: the olfactory and immune system interrelationship. (2009) (74)
Enhancement of Atherosclerosis in Beta-2-Glycoprotein I-Immunized Apolipoprotein E-Deficient Mice (1999) (73)
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. (2014) (73)
Usefulness of colchicine in preventing recurrences of pericarditis. (1994) (73)
Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies (2002) (73)
Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases (2005) (73)
B cell targeted therapy in autoimmunity. (2007) (73)
Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. (1995) (73)
Immunization with anti‐neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration (1995) (73)
Marked Improvement of Severe Cardiac Dysfunction After One Course of Intravenous Immunoglobulin in a Patient with Systemic Lupus Erythematosus (1999) (72)
Probiotics: If It Does Not Help It Does Not Do Any Harm. Really? (2019) (72)
CD 4 CD 28 T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients (2004) (72)
Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome. (2014) (72)
The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. (1994) (72)
BAFF, a New Target for Intravenous Immunoglobulin in Autoimmunity and Cancer (2007) (72)
Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. (2020) (72)
An antibody profile of systemic lupus erythematosus detected by antigen microarray (2010) (72)
Atherosclerosis-related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis (1999) (72)
Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease (2011) (71)
The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. (2007) (71)
Autoantibodies in Nonautoimmune Individuals during Infections (2007) (71)
A medical nutriment has supportive value in the treatment of colorectal cancer (2003) (71)
Infections and Autoimmunity: A Panorama (2008) (71)
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm (2020) (71)
Antiphospholipid syndrome induced by HIV (2001) (71)
Infections and vaccines in the etiology of antiphospholipid syndrome (2012) (70)
Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. (2012) (70)
The Role of Infections in the Immunopathogensis of Systemic Sclerosis–Evidence from Serological Studies (2009) (70)
Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. (2009) (70)
Leukocytosis in non hematological malignancies—A possible tumor-associated marker (2004) (69)
Age and sex difference in response to short exposure to extreme dry heat. (1978) (69)
Vitamin D and autoimmunity (2016) (69)
Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. (2010) (69)
Autoimmune Thyroid Disease and Autoimmune Rheumatic Disorders (2009) (69)
Facing the enigma of immunomodulatory effects of intravenous immunoglobulin (2005) (69)
Antiprothrombin Antibodies are Associated with Pregnancy Loss in Patients with the Antiphospholipid Syndrome (2003) (69)
Vimentin as antigenic target in autoimmunity: A comprehensive review. (2018) (69)
The Multiple Autoimmune Syndromes. A Clue for the Autoimmune Tautology (2012) (69)
Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. (1987) (69)
Cancer in autoimmune diseases. (1988) (69)
Functional impairment of the arterial wall in primary Sjögren's syndrome: Combined action of immunologic and inflammatory factors (2010) (69)
Diagonal Ear Lobe Crease and Coronary Risk Factors (1980) (69)
Autoantibody profile in the sera of women with hyperprolactinemia. (1995) (68)
The role of anti‐endothelial cell antibodies in Kawasaki disease –in vitro and in vivo studies (2002) (68)
Scientific evidence of the therapeutic effects of dead sea treatments: a systematic review. (2012) (68)
The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture (2003) (68)
Transverse Myelitis in Patients with Antiphospholipid Antibodies – The Importance of Early Diagnosis and Treatment (2002) (68)
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome (2005) (68)
Atherosclerosis and the antiphospholipid syndrome: A link unravelled? (1998) (67)
Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned (2020) (67)
Bacterial triggers and autoimmune rheumatic diseases. (2008) (67)
Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. (2000) (67)
Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. (2000) (67)
A novel automated indirect immunofluorescence autoantibody evaluation (2012) (67)
The role of stress in the mosaic of autoimmunity: An overlooked association. (2018) (67)
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity (2013) (66)
The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis (1997) (66)
The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. (2005) (66)
Predicting post-vaccination autoimmunity: who might be at risk? (2015) (66)
Coronary Artery Disease but Not Coronary Calcification Is Associated with Elevated Levels of Cardiolipin, Beta-2-Glycoprotein-I, and Oxidized LDL Antibodies (2001) (66)
Vaccination may be associated with autoimmune diseases. (2004) (65)
Sex gender and autoimmunity. (2012) (65)
An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients. (2003) (65)
Intravenous immunoglobulin therapy for autoimmune diseases (2009) (65)
Autoimmune aspects of primary pulmonary hypertension. (1995) (65)
Skin Score Decrease in Systemic Sclerosis Patients Treated with Intravenous Immunoglobulin – A Preliminary Report (2000) (65)
Histidine-Rich Glycoprotein Modulation of Immune/Autoimmune, Vascular, and Coagulation Systems (2008) (65)
Fermented Wheat Germ Extract (Avemar) in the Treatment of Cancer and Autoimmune Diseases (2005) (65)
Association of α-actinin–binding anti–double-stranded DNA antibodies with lupus nephritis (2006) (65)
Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome (2003) (64)
The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment. (1995) (64)
Neurological manifestations of antiphospholipid syndrome (2010) (64)
Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation. (2020) (64)
A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. (1987) (64)
Fibrosis regression induced by intravenous gammaglobulin treatment (2003) (64)
Breastfeeding and autoimmunity: Programing health from the beginning (2018) (64)
Coffee and autoimmunity: More than a mere hot beverage! (2017) (64)
Infectious Serologies and Autoantibodies in Inflammatory Bowel Disease (2009) (64)
Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. (1999) (64)
Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. (1992) (64)
Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells (1995) (64)
Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity (2006) (64)
Anti-DNA antibodies (1994) (63)
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Thyroid Autoimmunity (2017) (63)
The Decade of Autoimmunity (1999) (63)
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16. (2006) (63)
Malignancies in Autoimmune Rheumatic Diseases – A Mini-Review (2010) (63)
Common ECG changes in athletes. (1976) (63)
The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice. (2002) (63)
Successful Treatment of Systemic Lupus Erythematosus Cerebritis with Intravenous Immunoglobulin (1999) (63)
Vitamin D insufficiency in a large MCTD population. (2011) (63)
The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis (2005) (62)
Gamma-globulin inhibits tumor spread in mice. (1999) (62)
Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus (2007) (62)
Anti‐infectious Antibodies and Autoimmune‐associated Autoantibodies in Patients with Type I Diabetes Mellitus and their Close Family Members (2009) (62)
Azathioprine therapy for patients with systemic lupus erythematosus. (2001) (62)
In Vitro Effect of Anticardiolipin Autoantibodies Upon Total and Pulsatile Placental hCG Secretion During Early Pregnancy (1993) (61)
Do infections facilitate the emergence of systemic sclerosis? (2011) (61)
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. (2002) (61)
The Effect of Aspirin on Recurrent Fetal Loss in Experimental Antiphospholipid Syndrome (1993) (61)
TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. (2005) (61)
Sjögren's syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). (2014) (61)
Bcg and autoimmunity: another two-edged sword. (2001) (61)
Autoantibodies Profile in the Sera of Patients with Sjogren]s Syndrome: The ANA Evaluation—A Homogeneous, Multiplexed System (2004) (60)
Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. (1998) (60)
The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. (2009) (60)
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review) (2020) (60)
Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. (1998) (60)
Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines (2014) (60)
Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. (1995) (60)
A need for standardization of the anti-endothelial-cell antibody test. (1995) (60)
In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration. (1999) (60)
Vitiligo autoantibodies are effective against melanoma (1993) (60)
Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty. (1999) (59)
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. (1995) (59)
Long-term complications of past glucocorticoid use. (2013) (59)
Response of Vasculitic Peripheral Neuropathy to Intravenous Immunoglobulin (2005) (59)
Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases. (2001) (59)
Autoantibody Panel Screening in Recurrent Miscarriages (2004) (59)
The antiphospholipid syndrome as a neurological disease. (2010) (59)
Antiphospholipid syndrome (2018) (59)
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity (2013) (58)
Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS) (2013) (58)
Immunomodulatory Effects of Intravenous Immunoglobulins as a Treatment for Autoimmune Diseases, Cancer, and Recurrent Pregnancy Loss (2005) (58)
Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells. (2000) (58)
Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? (2003) (58)
Geographical Differences in Autoantibodies and Anti-infectious Agents Antibodies Among Healthy Adults (2011) (58)
Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice. (1990) (58)
Autoantibodies associated with atherosclerosis. (2000) (58)
Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins. (1999) (57)
Celiac disease and autoimmunity. (1996) (57)
Natural autoantibodies in the serum of healthy women--a five-year follow-up. (1989) (57)
Autoantibody-mediated atherosclerosis. (2002) (57)
The Importance of the Pathogenic 16/6 Idiotype in the Induction of SLE in Naive Mice (1990) (57)
Cardiac manifestations in antiphospholipid syndrome. (2007) (57)
Autoimmunity in atherosclerosis: lessons from experimental models (2000) (57)
Helicobacter pylori serology in autoimmune diseases – fact or fiction? (2013) (56)
A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo. (2004) (56)
Prolactin and Autoimmunity (2012) (56)
The mechanisms behind helminth's immunomodulation in autoimmunity. (2015) (56)
Chronic Infections and Atherosclerosis (2007) (56)
Infection and vaccination in chronic fatigue syndrome: Myth or reality? (2007) (56)
Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)--animal models as a proof of concept. (2013) (56)
Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden. (2012) (56)
Long-Term Therapy with Intravenous Immunoglobulin is Beneficial in Patients with Autoimmune Diseases (2012) (56)
Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. (2012) (56)
Increased endothelial cell expression of a3β1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome (1999) (56)
Antibody-specific behavioral effects: Intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice (2014) (56)
Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. (1996) (56)
Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale? (2009) (55)
Effects of exposure to Finnish sauna. (1976) (54)
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients (2018) (54)
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus (2010) (54)
Aortic stenosis associated with gastrointestinal bleeding. A survey of 612 patients. (1980) (54)
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients (2018) (54)
Immunomodulation for treatment and prevention of atherosclerosis. (2002) (54)
New Therapeutic Strategies for Systemic Sclerosis—a Critical Analysis of the Literature (2005) (54)
Postural Orthostatic Tachycardia Syndrome (POTS) – A novel member of the autoimmune family (2016) (54)
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. (2020) (54)
Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis. (2008) (54)
Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases. (2018) (54)
Early Atherosclerosis and Autoantibodies to Heat‐Shock Proteins and Oxidized LDL in Systemic Sclerosis (2007) (54)
2021 DORIS definition of remission in SLE: final recommendations from an international task force (2021) (53)
Clinical Thrombotic Manifestations in SLE Patients With and Without Antiphospholipid Antibodies: A 5-year Follow-up (2007) (53)
Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19 (2020) (53)
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. (1998) (53)
Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: Additional evidence for the kaleidoscope of autoimmunity (1997) (53)
The mosaic of autoimmunity: the role of environmental factors. (2009) (53)
Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature (2009) (53)
The presence of antiphospholipid antibodies in acute myocardial infarction (1995) (53)
Infection, Vaccination, and Autoantibodies in Chronic Fatigue Syndrome, Cause or Coincidence? (2009) (53)
High-dose intravenous immunoglobulins for lupus nephritis — a salvage immunomodulation (2001) (53)
Autoimmunity and pregnancy. (1985) (53)
2020 international consensus on ANCA testing beyond systemic vasculitis. (2020) (53)
Diagnosis and management of catastrophic antiphospholipid syndrome (2017) (52)
To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. (2007) (52)
The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. (2005) (52)
Effects of Biologics on Vascular Function and Atherosclerosis Associated with Rheumatoid Arthritis (2009) (52)
The genetic regulation of the induction of experimental SLE. (1990) (52)
Immunomodulation of experimental autoimmune diseases via oral tolerance. (2000) (52)
Mycoplasma-pneumoniae-Induced Thrombotic Thrombocytopenic Purpura (2000) (52)
Infections May Have a Protective Role in the Etiopathogenesis of Celiac Disease (2009) (52)
Autoantibodies to tyrosinase (1997) (52)
Human monoclonal anti‐DNA antibodies react as lymphocytotoxic antibodies (1985) (52)
Atherosclerosis in systemic lupus erythematosus (2010) (52)
Dichotomic effects of IFN‐γ on the development of systemic lupus erythematosus‐like syndrome in MRL‐lpr / lpr mice (2000) (52)
Nicotine and autoimmunity: The lotus' flower in tobacco (2017) (51)
Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review. (2012) (51)
Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. (1999) (51)
Perspectives on vaccine induced thrombotic thrombocytopenia (2021) (51)
Anti‐idiotype immunomodulation of experimental anti‐phospholipid syndrome via effect on Th1/Th2 expression (1999) (51)
Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases. (2011) (51)
Are autoantibodies present in patients with subacute and chronic urticaria? (2001) (51)
Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis. (2000) (51)
Hyperferritinemia in autoimmunity. (2008) (51)
Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis (2003) (51)
The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA syndrome. (2011) (51)
Susac syndrome: clinical characteristics, clinical classification, and long-term prognosis (2016) (51)
Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin. (1993) (51)
IVIG for Autoimmune, Fibrosis, and Malignant Conditions: Our Experience with 200 Patients (2004) (50)
β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity? (2012) (50)
Association between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis. (2002) (50)
The detection of pleural effusion using a parametric EIT technique (2009) (50)
Early recognition of acutely deteriorating patients in non-intensive care units: assessment of an innovative monitoring technology. (2012) (50)
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil (2017) (50)
Pemphigus and infectious agents. (2008) (50)
HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies. (2011) (50)
Smell and Autoimmunity: A Comprehensive Review (2013) (50)
Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis (2010) (49)
The autoimmune characteristics of progressive or sudden sensorineural hearing loss (2006) (49)
Ferritin – from iron, through inflammation and autoimmunity, to COVID-19 (2021) (49)
Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases. (2008) (49)
OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. (2007) (49)
Dietary factors in rheumatic autoimmune diseases: a recipe for therapy? (2017) (49)
Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease (2015) (49)
Prevalence of Celiac Disease in Latin America: A Systematic Review and Meta-Regression (2015) (49)
The role of the human anti-DNA idiotype 16/6 in autoimmunity. (1989) (49)
Infectious Serologies and Autoantibodies in Wegener's Granulomatosis and Other Vasculitides (2009) (49)
Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies (2007) (49)
Familial multiple myeloma. A review of thirty-seven families. (1982) (48)
Pseudotumor cerebri in systemic lupus erythematosus. (1995) (48)
The Pathogenesis of Neural Injury in Animal Models of the Antiphospholipid Syndrome (2010) (48)
ReviewSilicone Gel Breast Implants and Connective Tissue Disease—A Comprehensive Review (2003) (48)
Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. (1999) (48)
Statins and autoimmune diseases. (2004) (48)
Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. (2013) (48)
Intravenous Immunoglobulin and Cytokines (2007) (48)
Protective autoimmunity in cancer (review). (2007) (48)
Autoimmunity and heart diseases: pathogenesis and diagnostic criteria (2009) (48)
Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies ( autoimmunity / autoantibodies / systemic lupus erythematosus / lupus anticoagulant ) (48)
Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do. (2016) (48)
European Attempts to Set Guidelines for Improving Diagnostics of Autoimmune Rheumatic Disorders (2006) (47)
Harnessing Autoimmunity (Vitiligo) to Treat Melanoma (2007) (47)
IL-10/TGF-β-Treated Dendritic Cells, Pulsed with Insulin, Specifically Reduce the Response to Insulin of CD4+ Effector/Memory T Cells from Type 1 Diabetic Individuals (2010) (47)
Parasitic infection and autoimmunity (2009) (47)
Amputation of digits or limbs in patients with antiphospholipid syndrome. (2008) (47)
Oxidized low‐density lipoprotein (Ox‐LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS) (1997) (47)
Molecular mimicry between host and pathogen: examples from parasites and implication. (1999) (47)
Aspirin modulates interleukin-3 production: additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome. (1995) (47)
Adjuvants- and vaccines-induced autoimmunity: animal models (2017) (47)
Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS) (2001) (47)
Autoantibodies in neoplasia an unresolved enigma (1990) (47)
Vitamin D and systemic lupus erythematosus - The hype and the hope. (2017) (47)
Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome (2008) (47)
Silicone and scleroderma revisited (2012) (46)
Preferential secretion of a common anti-DNA idiotype (16/6 Id) and anti-polynucleotide antibodies by normal mononuclear cells following stimulation with Klebsiella pneumoniae. (1986) (46)
Common infections, idiotypic dysregulation, autoantibody spread and induction of autoimmune diseases. (1996) (46)
Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumor T and B cell lines. (2002) (46)
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. (2010) (46)
Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. (1995) (46)
Molecular mimicry in systemic lupus erythematosus (2009) (46)
HBV vaccine and dermatomyositis: is there an association? (2008) (46)
Vitamin D and autoimmune thyroid diseases: facts and unresolved questions (2015) (46)
The role of dietary sodium in autoimmune diseases: The salty truth. (2018) (46)
Novel therapeutic compound tuftsin–phosphorylcholine attenuates collagen‐induced arthritis (2016) (46)
Antiphospholipid syndrome (APS): where does it come from? (2007) (46)
Neuropsychiatric lupus and infectious triggers (2008) (46)
Note of Republication: A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires (2018) (46)
Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases? (2006) (46)
The putative role of cytokines in the induction of primary anti‐phospholipid syndrome in mice (1992) (45)
Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety (2020) (45)
Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unraveled. (2003) (45)
Antigens and antibodies in malignant melanoma. (1994) (45)
Aspirin‐Interleukin‐3 Interrelationships in Patients With Anti‐Phospholipid Syndrome (1996) (45)
Intravenous gamma globulin inhibits the production of matrix metalloproteinase‐9 in macrophages (2002) (45)
Autoimmune diseases other than lupus share common anti-DNA idiotypes. (1988) (45)
Natural autoantibodies in sera of patients with Gaucher's disease (1995) (45)
Silicone and autoimmunity (2011) (45)
Pregnancy Loss and Endometriosis: Pathogenic Role of Anti‐Laminin‐1 Autoantibodies (2005) (45)
From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide. (2016) (44)
The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. (1999) (44)
Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases (2009) (44)
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. (1999) (44)
Increased Prevalence of Autoantibodies in Celiac Disease (1998) (44)
Cannabinoids for the treatment of rheumatic diseases — where do we stand? (2018) (44)
Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus? (2007) (44)
ANTI-DNA ANTIBODY IDIOTYPES IN SLE (1984) (44)
The systemic nature of the antiphospholipid syndrome (2004) (44)
Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. (2006) (44)
Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients (2005) (44)
Vitamin D and rheumatoid arthritis: an ongoing mystery (2017) (43)
The Clinical Significance of Anti-Beta-1 Adrenergic Receptor Autoantibodies in Cardiac Disease (2013) (43)
Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk? (2015) (43)
Allergic Disease and Autoimmune Effectors Pathways (2002) (43)
Autoantibodies associated with reproductive failure (2004) (43)
Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE (2010) (43)
Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature (2018) (43)
Glucocorticoids and the cardiovascular system: state of the art. (2010) (43)
IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients (2011) (43)
Public health awareness of autoimmune diseases after the death of a celebrity (2017) (43)
Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus (2009) (43)
Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages (2007) (42)
Antiphospholipid syndrome dilemmas still to be solved: 2008 status (2007) (42)
Sensitization to ibuprofen in systemic lupus erythematosus. (1980) (42)
Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies. (2008) (42)
Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus. (2006) (42)
The Role of Innate and Adaptive Immunity to Oxidized Low‐Density Lipoprotein in the Development of Atherosclerosis (2005) (42)
Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and b‐cell proliferations? (1984) (42)
Infections and Wegener's granulomatosis--a cause and effect relationship? (1997) (42)
The thrombophilic network of autoantibodies in celiac disease (2013) (42)
Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome. (1998) (42)
Autoantibodies in male homosexuals and HIV infection. (1991) (41)
The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. (2006) (41)
Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis (2013) (41)
The Clinical and Diagnostic Significance of Anti-myosin Autoantibodies in Cardiac Disease (2013) (41)
Explosion of autoimmune diseases and the mosaic of old and novel factors (2011) (41)
The Diagnostic and Clinical Significance of Anti-Muscarinic Receptor Autoantibodies (2012) (41)
Infertility in women with systemic autoimmune diseases. (2019) (41)
Anti-troponin autoantibodies and the cardiovascular system (2010) (41)
Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies (2001) (41)
Autoimmune Hemolytic Anaemia in the Antiphospholipid Syndrome (2006) (40)
Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the ‘autoimmune (auto-inflammatory) syndrome induced by adjuvants’ (ASIA) (2014) (40)
Mosaic of anti-endothelial antibodies (1995) (40)
Detection of anti-histone activity in sera of patients with monoclonal gammopathies. (1987) (40)
Intraocular inflammation in autoimmune diseases. (2004) (40)
Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? (2022) (40)
Gluten Sensitivity in Multiple Sclerosis (2009) (40)
Anti-idiotypes to Oxidized LDL Antibodies in Intravenous Immunoglobulin Preparations--Possible Immunomodulation of Atherosclerosis (2003) (40)
Thrombocytopenic conditions—autoimmunity and hypercoagulability: Commonalities and differences in ITP, TTP, HIT, and APS (2005) (40)
Autoantibodies in the sera of patients with lymphoma. (1992) (40)
Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. (2020) (40)
Sexual dimorphism in COVID-19: potential clinical and public health implications (2022) (40)
Autoantibodies as predictors of pregnancy complications. (2008) (40)
Imbalance in B cell and T Follicular Helper Cell Subsets in Pulmonary Sarcoidosis (2020) (40)
Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotype. (1991) (39)
The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. (2008) (39)
Small-fiber neuropathy definition, diagnosis, and treatment (2019) (39)
Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle (2013) (39)
Pericarditis following permanent pacemaker insertion. (2004) (39)
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity (2005) (39)
The origin and significance of anti-DNA antibodies. (1987) (39)
Increased Prevalence of Anti-Third Generation Cyclic Citrullinated Peptide Antibodies in Patients With Rheumatoid Arthritis and CREST Syndrome (2007) (39)
Immunology, Autoimmunity, and Autoantibodies in Parkinson’s Disease (2012) (39)
Dermatomyositis and polymyositis associated with the antiphospholipid syndrome—a novel overlap syndrome (2000) (39)
Autoantibodies, autoimmunity and cancer (review). (1998) (39)
Artherosclerosis as an infectious, inflammatory and autoimmune disease. (2001) (39)
Individual olfactory perception reveals meaningful nonolfactory genetic information (2015) (39)
Pemphigus following hepatitis B vaccination-coincidence or causality? (2005) (39)
Adverse effects of gluten ingestion and advantages of gluten withdrawal in nonceliac autoimmune disease (2017) (39)
Safety issues and concerns of new immunomodulators in rheumatology (2015) (38)
Anti-Phospholipid Antibodies And Infertility (2007) (38)
Antifibrosis: To Reverse the Irreversible (2010) (38)
Reshaping the mosaic of autoimmunity. (2006) (38)
Insights into atherosclerosis therapy in antiphospholipid syndrome. (2007) (38)
Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis (1996) (38)
Prolactin and autoimmunity: The hormone as an inflammatory cytokine. (2019) (38)
Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies. (1994) (38)
Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis (2000) (38)
The ASIA syndrome: basic concepts (2017) (38)
Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. (1991) (38)
Severe ASIA syndrome associated with lymph node, thoracic, and pulmonary silicone infiltration following breast implant rupture: experience with four cases (2015) (38)
Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice. (2015) (38)
1 – AUTOIMMUNITY AND AUTOIMMUNE DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (2004) (38)
Atherosclerosis and autoimmunity (2001) (38)
Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine. (2015) (37)
Behçet's disease‬ and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study‬. (2017) (37)
Inhibitor(s) of natural anti‐cardiolipin autoantibodies (1993) (37)
Can Lupus Flares be Associated with Tuberculosis Infection? (2010) (37)
Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic? (1993) (37)
Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells. (2001) (37)
COLD-INDUCED PROFUSE SWEATING ON BACK AND CHEST A New Genetic Entity? (1978) (37)
Use of intravenous immunoglobulin in livedo vasculitis. (2000) (37)
Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. (2006) (37)
Vaccination and allergy (2004) (37)
Essential pathogenic role of endogenous IL‐18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL‐18‐binding protein: Fc construct (2003) (37)
Ferritin and prolactin levels in multiple sclerosis. (2011) (37)
Anti-tyrosinase antibodies in malignant melanoma (1996) (37)
Interleukin-3 and pregnancy loss in antiphospholipid syndrome. (1998) (37)
Common infectious agents prevalence in antiphospholipid syndrome (2009) (37)
The kaleidoscope of autoimmunity. (1993) (37)
Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome (2011) (37)
Infections, vaccines and autoimmunity (2009) (37)
Pathogenicity of human anti‐platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti‐PF4/heparin and induction of thrombocytopenia by heparin (1997) (37)
The viral-autoimmunity relationship. (1995) (36)
Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome (2012) (36)
New approaches in the diagnosis of sepsis. (2001) (36)
The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome. (1996) (36)
Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form (2021) (36)
Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies (2021) (36)
Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients (2013) (36)
HPV and systemic lupus erythematosus: a mosaic of potential crossreactions (2017) (36)
The significance of T suppressor cells in the development of autoimmunity. (1989) (36)
Suppression of experimental systemic lupus erythematosus (SLE) with specific anti‐idiotypic antibody–saporin conjugate (1994) (36)
Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. (2008) (36)
Fatal peripheral neurolymphomatosis after remission of histiocytic lymphoma (1983) (36)
Efficacy of intravenous immunoglobulin (IVIG) affinity‐purified anti‐desmoglein anti‐idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris (2010) (36)
Guillain-Barré syndrome following hepatitis B vaccination. (2004) (36)
A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members. (1986) (36)
Neurological Dysfunction Associated with Antiphospholipid Syndrome: Histopathological Brain Findings of Thrombotic Changes in a Mouse Model (2004) (36)
Post-influenza vaccination vasculitides: a possible new entity. (2009) (36)
Immunogenetic Predictors of Severe COVID-19 (2021) (35)
Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis (2009) (35)
Dietary polyunsaturated fatty acids decrease anti-dsDNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus (1998) (35)
Systemic polyarteritis nodosa following hepatitis B vaccination. (2008) (35)
Cancer and autoimmunity (2002) (35)
b2GP-I in the anti phospholipid (Hughes') syndrome—from a cofactor to an autoantigen — from induction to prevention of antiphospholipid syndrome (1998) (35)
Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease. (2015) (35)
Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome. (1999) (35)
Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases. (2008) (35)
Anti-Endothelial Cell Antibodies in Systemic Sclerosis (1999) (35)
Autoimmune Dilated Cardiomyopathy (2008) (35)
The Reduction of Serum B‐Lymphocyte Activating Factor levels following Quinacrine Add‐On Therapy in Systemic Lupus Erythematosus (2006) (35)
IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus (2004) (35)
Myelin‐ and microbe‐specific antibodies in guillain‐barré syndrome (2005) (35)
Novel pebbles in the mosaic of autoimmunity (2013) (35)
Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis (2007) (35)
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? (2020) (34)
The beta-2-glycoprotein I and antiphospholipid antibodies. (1992) (34)
Vitamin D, autoimmunity and recurrent pregnancy loss: More than an association (2018) (34)
A common anti-DNA antibody idiotype and anti-phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. (1989) (34)
Plasma Homocysteine Levels, The Prevalence of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Macrovascular Disorders in Systemic Sclerosis: Risk Factors for Accelerated Macrovascular Damage? (2009) (34)
European Working Party on Systemic Lupus Erythematosus: a 15-year report. (2006) (34)
Heat-Shock Proteins in Autoimmunity (2013) (34)
Is narcolepsy a classical autoimmune disease? (2015) (34)
Autoantibodies, Autoimmunity and Cancer (2000) (34)
Induction of SLE-like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying the 166 ID (1988) (34)
Diet and lupus (2001) (34)
DNA antibody idiotypes: a review of their genetic, clinical, and immunopathologic features. (1987) (34)
Classical Examples of the Concept of the ASIA Syndrome (2020) (34)
Further Experience with Intravenous Immunoglobulin in Women with Recurrent Miscarriage and a Poor Prognosis (2001) (34)
Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. (2004) (33)
Parasitic infection and autoimmunity. (1991) (33)
Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases (1992) (33)
Is PET/CT essential in the diagnosis and follow-up of temporal arteritis? (2017) (33)
DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. (1999) (33)
Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future (2015) (33)
The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade (2012) (33)
Studies of Sick Building Syndrome. IV. Mycotoxicosis (2002) (33)
Pathogenic natural anti‐cardiolipin antibodies: the experience from monoclonal gammopathy (1994) (33)
Olfaction, psychiatric disorders and autoimmunity: Is there a common genetic association? (2009) (33)
Influenza vaccine and autoimmunity. (2009) (33)
Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination? (2019) (33)
Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis? (2006) (33)
Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation (1998) (33)
Sarcoidosis and Autoimmunity: From Genetic Background to Environmental Factors. (2016) (33)
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment (2003) (33)
Titers of antibody to common pathogens: relation to food-based interventions in rural Kenyan schoolchildren. (2003) (33)
Anti-endothelial cell antibodies in patients with coronary atherosclerosis. (2000) (33)
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality? (2016) (32)
EASI—The European Autoimmunity Standardisation Initiative (2007) (32)
Anticardiolipin and anti-beta-2-glycoprotein I antibodies (2005) (32)
Is atherosclerosis accelerated in systemic sclerosis? Novel insights (2014) (32)
The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease. (2007) (32)
Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes. (2002) (32)
Health effects of cigarette smoking. (1998) (32)
Insights into the autoimmune aspect of premature ovarian insufficiency. (2019) (32)
Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis. (1990) (32)
Medical cannabis: Another piece in the mosaic of autoimmunity? (2017) (32)
Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy (2005) (32)
Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF/ICSI treatment: A prospective cohort study. (2017) (32)
Long term safety of IVIg therapy in multiple sclerosis: 10 years experience (2006) (32)
When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) (2012) (32)
Olfaction--a window to the mind. (2009) (32)
Eppur Si Muove: vitamin D is essential in preventing and modulating SLE (2016) (31)
Effect of Long-Acting Thromboxane Receptor Antagonist (BMS 180,291) on Experimental Antiphospholipid Syndrome (1994) (31)
Chronic infections and autoimmunity. (1991) (31)
therapeutical considerations Vitamin D and autoimmunity: new etiological and (2007) (31)
Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. (2000) (31)
Vaccination infection and autoimmunity: myth and reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland. (2007) (31)
Accelerated atherosclerosis in rheumatoid arthritis. (2007) (31)
Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model (2003) (31)
Tracing environmental markers of autoimmunity: introducing the infectome (2013) (31)
Lessons from the "Euro-Lupus Cohort". (2002) (31)
Antiphospholipid Antibody-Mediated Reproductive Failure in Antiphospholipid Syndrome (2010) (31)
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity (2022) (31)
Milestones in the Antiphospholipid Syndrome (2002) (31)
Antiphospholipid antibodies: a critique of their heterogeneity and hegemony. (1994) (31)
Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculosis antibody TB/68 (16/6 Id+). (1991) (31)
The association of Gaucher's disease and dysproteinemias. (1980) (31)
Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I. (2003) (31)
Psychological stress and type 1 diabetes mellitus: what is the link? (2018) (30)
From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries. (2014) (30)
Autoantibodies and common idiotypes in men and women with sperm antibodies. (1988) (30)
Lupus and Cardiovascular Disease: The Facts (2006) (30)
Transcriptomic analysis of COVID-19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection (2020) (30)
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations (2020) (30)
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series (2014) (30)
Antiphosphatidylserine Antibodies Affect Rat Yolk Sacs in Culture: a Mechanism for Fetal Loss in Antiphospholipid Syndrome (2004) (30)
Anti-DNA and Antiphospholipid Antibodies in IVIG Preparations: In Vivo Study in Naive Mice (2004) (30)
PARKINSON’S DISEASE, AUTOIMMUNITY, AND OLFACTION (2009) (30)
Transverse myelitis associated with chronic hepatitis C. (2003) (30)
Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. (1995) (30)
Intravenous immunoglobulin and recurrent pregnancy loss (2005) (30)
The autonomic aspects of the post-COVID19 syndrome (2022) (30)
Biologicals (2012) (30)
Lessons from experimental APS models (1998) (30)
Sequence Uniqueness as a Molecular Signature of HIV-1-Derived B-Cell Epitopes (2009) (30)
The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome (2003) (30)
Anti-endothelial cell antibodies in the sera of hyperprolactinemic women (1998) (30)
Inter-Pathogen Peptide Sharing and the Original Antigenic Sin: Solving a Paradox (2018) (29)
Elevated cardiac troponins: the ultimate marker for myocardial necrosis, but not without a differential diagnosis. (2009) (29)
Gastrointestinal-associated autoantibodies in different autoimmune diseases. (2012) (29)
The effect of cyclosporin A on early and late stages of experimental lupus. (1992) (29)
IgG subclasses of human autoantibodies. (1997) (29)
Antiphospholipid syndrome in pregnancy--animal models and clinical implications. (1998) (29)
Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. (2003) (29)
Animal models of antiphospholipid syndrome. (1998) (29)
Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. (1995) (29)
Massive Proteinuria as a Main Manifestation of Primary Antiphospholipid Syndrome (1998) (29)
AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease (2001) (29)
Human monoclonal antibodies derived from lymph nodes of a patient with breast carcinoma react with MuMTV polypeptides (1987) (29)
A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus. (1987) (29)
Detection of Anti-Phospholipid and Anti-DNA Antibodies and their Idiotypes in Newborns of Mothers with Anti-Phospholipid Syndrome and SLE (1993) (29)
IVIg to prevent tumor metastases (Review). (2002) (29)
Infectomics and autoinfectomics: a tool to study infectious-induced autoimmunity (2015) (29)
Systemic lupus erythematosus and cancer: associated or not? (2002) (29)
Shifts in autoimmune diseases: the kaleidoscope of autoimmunity. (1991) (29)
The effect of standardised submaximal work load on intraocular pressure. (1978) (29)
Multireactive pattern of serum autoantibodies in asymptomatic individuals with immunoglobulin A deficiency (1995) (29)
The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. (2005) (29)
β2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels (1999) (29)
Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure (2017) (29)
Osteogenesis imperfecta. Review of the literature with presentation of 29 cases. (1975) (29)
High-Dose Intravenous γ-Globulins for Heparin-Induced Thrombocytopenia: A Prompt Response (1998) (29)
C-Reactive protein and its implications in systemic lupus erythematosus. (2007) (29)
Guillain-Barré as an autoimmune disease. (1996) (29)
Immunity, autoimmunity and inflammatory bowel disease. (2014) (28)
The mosaic of autoimmunity. A classical case of inhalation of a polyclonal activating factor in a genetically and hormonally susceptible patient leading to multiple autoimmune diseases. (2001) (28)
On chronic fatigue syndrome and nosological categories (2018) (28)
Influence of fusion cell ratio and cell plating density on production of human-human hybridomas secreting anti-DNA autoantibodies from patients with systemic lupus erythematosus. (1984) (28)
Anti-cardiolipin and anti-β2-glycoprotein I (β2GP-I) antibody assays as screening for anti-phospholipid syndrome (2003) (28)
Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS) (2014) (28)
Low levels of calcium or vitamin D - which is more important in systemic lupus erythematosus patients? An extensive data analysis. (2016) (28)
Diversity and pattern of inheritance of autoantibodies in families with multiple cases of systemic lupus erythematosus. (1992) (28)
Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the “Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants” (2014) (28)
The Homogeneous Multiplexed System-a New Method for Autoantibody Profile in Systemic Lupus Erythematosus (2005) (28)
Precocious Atherosclerosis in Rheumatoid Arthritis (2007) (28)
Cross‐Reactive Epitopes on β2‐Glycoprotein‐I and Saccharomyces cerevisiae in Patients with the Antiphospholipid Syndrome (2007) (28)
Human papilloma virus and lupus: the virus, the vaccine and the disease (2017) (28)
Lethal immunoglobulins: Autoantibodies and sudden cardiac death. (2019) (28)
A new player in the antiphospholipid syndrome : the β2 glycoprotein I cofactor (1992) (28)
Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment. (2001) (28)
Heat stress: comparison of short exposure to severe dry and wet heat in saunas. (1976) (28)
Abnormal olfactory function demonstrated by manganese‐enhanced MRI in mice with experimental neuropsychiatric lupus (2010) (28)
Severe Blastocystis hominis in an elderly man. (1996) (28)
Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases (Review). (1997) (28)
Anti-histone antibodies in SLE and other autoimmune diseases. (1989) (28)
Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome. (2000) (28)
Sweat Studies in Hyperhidrosis palmaris and plantaris (1976) (28)
Antiphospholipid Syndrome and Cancer (2007) (28)
The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases (2015) (28)
Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. (1996) (27)
Some like it hot: The emerging role of spicy food (capsaicin) in autoimmune diseases. (2016) (27)
Induction of Tolerance to Experimental Anti‐Phospholipid Syndrome (APS) by Syngeneic Bone Marrow Cell Transplantation (1995) (27)
Correlating low-similarity peptide sequences and HIV B-cell epitopes. (2008) (27)
Cardiac valvulopathy in the antiphospholipid syndrome (2002) (27)
Autoantibodies to histones and their subfractions in chronic liver diseases. (1989) (27)
Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain. (2000) (27)
Systemic lupus erythematosus and thymoma--a double-edged sword. (1995) (27)
Effect of Avemar--a fermented wheat germ extract--on rheumatoid arthritis. Preliminary data. (2006) (27)
Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort. (2013) (27)
Monoclonal gammopathy in patients with chronic and acute myeloid leukemia (1984) (27)
Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding? (2019) (27)
Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome. (2001) (27)
Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin (1999) (27)
A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis (2015) (27)
TNF αDNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome (2003) (27)
Plasma cell dyscrasia. Analysis of 423 patients. (1979) (27)
16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus (2013) (27)
Chella David: a lifetime contribution in translational immunology. (2011) (27)
Autoantibodies to oxidized low-density lipoprotein in coronary artery disease. (2001) (27)
Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases. (2006) (27)
Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature (2015) (27)
The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans (2006) (27)
Antinuclear and related autoantibodies in sera of healthy subjects with IgA deficiency. (1989) (27)
Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer‐associated antigens by anti‐idiotypic antibodies (1988) (26)
Novel therapies for thyroid autoimmune diseases: An update. (2019) (26)
The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome. (1993) (26)
Autoantibody Level Modification in Adult Patients with Idiopathic Thrombocytopenic Purpura following Intravenous Immunoglobulin Treatment (2000) (26)
Levels of lupus autoantibodies in pregnant SLE patients: correlations with disease activity and pregnancy outcome. (1996) (26)
Surgery in patients with circulating lupus anticoagulant. (1981) (26)
Idiotype specific T-cell lines inducing experimental systemic lupus erythematosus in mice. (1991) (26)
Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives. (1988) (26)
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires (2018) (26)
Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA. (1998) (26)
Looking Into the Eyes of Patients with Antiphospholipid Syndrome (2007) (26)
Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins (2002) (26)
Autoantibodies to Cardiolipin and Beta-2-Glycoprotein-I in Coronary Artery Disease Patients with and without Hypertension (2002) (26)
Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome (2006) (26)
Human Papillomavirus Epitope Mimicry and Autoimmunity: The Molecular Truth of Peptide Sharing (2019) (26)
Primary Sjögren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. (1995) (26)
Long-term inflammatory conditions following silicone exposure: the expanding spectrum of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). (2014) (26)
Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies (2017) (26)
Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule. (2002) (26)
Ibuprofen may induce meningitis in (NZB X NZW)F1 mice. (1985) (26)
IVIG in autoimmunity and cancer – efficacy versus safety (2002) (26)
Prolactin’s role in the pathogenesis of the antiphospholipid syndrome (2010) (26)
A Possible Mechanism of Autoimmune‐Mediated infertility in Women with Endometriosis (2011) (25)
The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis (2017) (25)
Primary leiomyosarcoma of the pulmonary artery. (1981) (25)
Autoantibodies, Polymorphisms in the Serotonin Pathway, and Human Leukocyte Antigen Class II Alleles in Chronic Fatigue Syndrome (2009) (25)
Rheumatologic features of hematologic disorders. (1999) (25)
Vitamin D and Autoimmune Diseases (2017) (25)
Evidence of impaired sense of smell in hereditary angioedema (2011) (25)
Autoimmunity in atherosclerosis (2000) (25)
The relationship of antiphospholipid antibodies to infections--do they bind to infecting agents or may they even be induced by them? (2000) (25)
International Consensus on ANCA Testing in Eosinophilic Granulomatosis with Polyangiitis. (2020) (25)
The environment and antiphospholipid syndrome (2006) (25)
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis (2015) (25)
The role of inflammatory cytokines in the pathogenesis of systemic lupus erythematosus-related atherosclerosis: a novel target for treatment? (2006) (25)
Impaired sense of smell and altered olfactory system in RAG-1−∕− immunodeficient mice (2015) (25)
Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis (2001) (25)
Prevalence of Antiphospholipid and Antioxidized Low‐Density Lipoprotein Antibodies in Rheumatoid Arthritis (2005) (25)
Induction of Experimental Primary and Secondary Antiphospholipid Syndromes in Naive Mice (1992) (25)
Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. (1996) (24)
Inhibition of diabetes in NOD mice by idiotypic induction of SLE. (1999) (24)
A latitudinal gradient study of common anti-infectious agent antibody prevalence in Italy and Colombia. (2008) (24)
Hyperstimulation of Adaptive Immunity as the Common Pathway for Silicone Breast Implants, Autoimmunity, and Lymphoma of the Breast. (2019) (24)
Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris (2005) (24)
Effects of treatment strategy on endothelial function. (2010) (24)
Melanoma-associated hypopigmentation: where are the antibodies? (1996) (24)
Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity (1997) (24)
Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus (1998) (24)
The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic. (2017) (24)
The mechanism of benign hereditary neutropenia. (1982) (24)
Vaccines, viruses, and voodoo. (2002) (24)
The emerging concept of pathogenic natural autoantibodies. (1997) (24)
Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS (2007) (24)
Autoantibodies in leprosy sera (2005) (24)
Immunization of Naïve Mice with Mouse Laminin‐1 Affected Pregnancy Outcome in a Mouse Model (2003) (24)
Catastrophic Antiphospholipid Syndrome (2007) (24)
Magnesium Fortification of Drinking Water Suppresses Atherogenesis in Male LDL-Receptor-Deficient Mice (1999) (24)
The importance of glucocorticoid receptors in systemic lupus erythaematosus. A systematic review. (2015) (24)
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures (2017) (24)
Genetics and autoantibodies (2013) (24)
Changes in Blood Pressure in the Lying and Sitting Positions in Normotensive, Borderline and Hypertensive Subjects (1983) (24)
Vaccination and Autoimmunity (2004) (24)
APS—More Systemic Disease than SLE (2007) (23)
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus. (2020) (23)
Autoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease. (1989) (23)
Autoimmune Rheumatic Diseases (2014) (23)
Induction and treatment of the antiphospholipid syndrome – lessons from animal models (2001) (23)
When uncommon and common coalesce: adult onset Still’s disease associated with breast augmentation as part of autoimmune syndrome induced by adjuvants (ASIA) (2016) (23)
AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS (2007) (23)
Intravenous immunoglobulin and fibrosis (2005) (23)
Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism (1994) (23)
Leukopenia and low incidence of myocardial infarction. (1981) (23)
Induction of experimental systemic lupus erythematosus in mice by immunization with a monoclonal anti-La autoantibody. (1990) (23)
Anti-phospholipid syndrome: from patient's bedside to experimental animal models and back to the patient's bedside. (1998) (23)
Analysis of different glycosylation states in IgG subclasses. (1996) (23)
Stem cells transplantation–a cure for autoimmune diseases (1998) (23)
Pseudotumour cerebri in SLE (1995) (23)
Salazopyrin-induced eosinophilic pneumonia. (1980) (23)
[Physical activity, physical fitness and health]. (1977) (23)
Systemic lupus erythematosus and the SLE galaxy. (2010) (23)
Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients (2018) (23)
Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice (2017) (23)
Pathogenic significance and diagnostic value of lupus autoantibodies. (1993) (23)
Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic events. (1999) (23)
Antinuclear antibodies: Is the indirect immunofluorescence still the gold standard or should be replaced by solid phase assays? (2018) (23)
The role of malignancies in patients with catastrophic anti-phospholipid (Asherson’s) syndrome (2007) (23)
Livedo Reticularis as a Criterion for Antiphospholipid Syndrome (2007) (23)
Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4+ T cell response to β2GPI (2011) (23)
Using Continuous Motion Monitoring Technology to Determine Patient’s Risk for Development of Pressure Ulcers (2011) (22)
Maximal backpack load for long distance hiking. (1977) (22)
The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies. (1989) (22)
The mosaic of autoimmunity : (the factors associated with autoimmune disease ) (1989) (22)
Fermented Wheat Germ Extract (Avemar) Inhibits Adjuvant Arthritis (2007) (22)
Suppression of Atherogenesis in Female Low-Density Lipoprotein Receptor Knockout Mice following Magnesium Fortification of Drinking Water: The Importance of Diet (2000) (22)
Autoantibody Screen in Inflammatory Myopathies High Prevalence of Antibodies to Gliadin (2009) (22)
β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome. (2011) (22)
Immune Tolerance Induction with Multiepitope Peptide Derived from Citrullinated Autoantigens Attenuates Arthritis Manifestations in Adjuvant Arthritis Rats (2015) (22)
Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome (2005) (22)
The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions (1998) (22)
Neurological and Neuroendocrine‐Cytokine Inter‐relationship in the Antiphospholipid Syndrome (2002) (22)
Antitreponemal Antibodies Leading to Autoantibody Production and Protection from Atherosclerosis in Kitavans from Papua New Guinea (2009) (22)
Outcome of patients having dermatomyositis admitted to the intensive care unit (2007) (22)
A possible role for IVIg in the treatment of soft tissue sarcoma: a clinical case and an experimental model. (2002) (22)
Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding. (1998) (22)
Antinuclear antibody profile in UCD line 200 chickens: a model for progressive systemic sclerosis. (1993) (22)
Review: Anti-Endothelial Cell Antibodies: a Need for Standardization (1994) (22)
Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions. (2005) (22)
Allergy and autoimmunity: parallels and dissimilarity: the yin and yang of immunopathology. (2009) (21)
Impaired binding capacity of asialyl and agalactosyl IgG to Fc gamma receptors. (1995) (21)
Debate on vaccines and autoimmunity: Do not attack the author, yet discuss it methodologically. (2017) (21)
Traditional cardiovascular risk factors in primary Sjögren's syndrome--role of dyslipidaemia. (2006) (21)
Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. (1998) (21)
A better definition of the anti-DFS70 antibody screening by IIF methods. (2018) (21)
Antinuclear autoantibodies in uveitis. (1989) (21)
The prediction of coronary atherosclerosis employing artificial neural networks (2000) (21)
Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival (2019) (21)
Vaccination in patients with chronic or autoimmune rheumatic diseases: the ego, the id and the superego. (2012) (21)
Exacerbations of autoimmune diseases during pregnancy and postpartum. (2019) (21)
Common lupus anti-DNA antibody idiotypes in chronic liver diseases. (1987) (21)
Anti-Rnp antibodies in chronic liver diseases. (1987) (21)
Anti-Ro(SSA) antibodies in patients with rheumatoid arthritis--a possible marker for gold induced side effects. (1994) (21)
Smoking and obesity in systemic lupus erythematosus: a cross‐sectional study (2017) (21)
Eppur Si Muove: ferritin is essential in modulating inflammation (2018) (21)
Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo). (1996) (21)
Autoantibodies to brain and polynucleotides in patients with schizophrenia: A puzzle (1992) (21)
Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background (2011) (21)
Epitope Predictions Indicate the Presence of Two Distinct Types of Epitope-Antibody-Reactivities Determined by Epitope Profiling of Intravenous Immunoglobulins (2013) (21)
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies (2018) (21)
The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice (2011) (21)
Familial leukopenia among Yemenite Jews. (1979) (21)
Asymptomatic (benign) monoclonal gammopathy--a study of 100 patients. (1977) (21)
Effect of Azathioprine on the Anticoagulant Activity of Warfarin (2000) (21)
Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms (2014) (21)
Autoimmunity and schizophrenia: an epiphenomenon or an etiology? (1993) (21)
The effect of anti-tuberculosis treatment on levels of anti-phospholipid and anti-neutrophil cytoplasmatic antibodies in patients with active tuberculosis (2013) (21)
Idiotypes in medicine : autoimmunity, infection and cancer (1997) (21)
The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis (2007) (20)
Antiphosphatidylserine antibodies and reproductive failure (2004) (20)
Pleural effusion--presenting sign in multiple myeloma. (1978) (20)
Effects of aging on the induction of experimental systemic lupus erythematosus (SLE) in mice (1991) (20)
Detection of Anti-Phospholipid and Anti-DNA Antibodies and their Idiotypes in Newborns of Mothers with Anti-Phospholipid Syndrome and Sle (1993) (20)
Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis. (1987) (20)
A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values. (2019) (20)
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. (2006) (20)
High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response. (1998) (20)
Autoimmunity: From Bench to Bedside [Internet] (2013) (20)
From animal models to human genetics: research on the induction and pathogenicity of autoantibodies. (2005) (20)
The Effects of IgG Purified from Women with SLE and Associated Pregnancy Loss on Rat Embryos in Culture (2002) (20)
The outcome of bacterial infection in subjects with benign familial leukopenia (BFL). (1985) (20)
Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water (2007) (20)
Systemic lupus erythematosus and parvovirus B-19 (2003) (20)
Antibody clustering helps refine lupus prognosis. (2009) (20)
Antioxidants and smoking in autoimmune disease--opposing sides of the seesaw? (2008) (20)
Hepatitis B: infection, vaccination and autoimmunity. (2008) (20)
The good, the bad and the ugly of vaccination. (2000) (20)
Peripheral Vascular Occlusions Leading to Gangrene and Amputations in Antiphospholipid Antibody Positive Patients (2007) (20)
The link between schizophrenia and hypothyroidism: a population-based study (2018) (20)
The new H1N1 and HPV vaccines and old fears (2010) (20)
Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model. (2001) (20)
Air Travel, Circadian Rhythms/Hormones, and Autoimmunity (2017) (20)
Vitamin D and thyroid autoimmune diseases: the known and the obscure (2015) (20)
Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases. (2020) (19)
Walking. A method for rapid improvement of physical fitness. (1980) (19)
Liver cystic echinococcosis and human host immune and autoimmune follow-up: A review (2017) (19)
Antiphospholipid Antibodies and Infections-Drugs (2002) (19)
Toward molecular targeting with specific intravenous immunoglobulin preparation (2005) (19)
Anti-nuclear antibodies associated with schistosomiasis and anti-schistosomal antibodies associated with SLE. (1994) (19)
Lupus erythematosus tumidus induced by sex reassignment surgery. (2007) (19)
[The anaerobic capacity]. (1979) (19)
BCG immunotherapy – from pathophysiology to clinical practice (2006) (19)
From autoantibody research to standardized diagnostic assays in the management of human diseases – report of the 12th Dresden Symposium on Autoantibodies (2016) (19)
New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation (1997) (19)
Antiphospholipid syndrome: insights from animal models (2000) (19)
Infectious Serologies and Autoantibodies in Hepatitis C and Autoimmune Disease-Associated Mixed Cryoglobulinemia (2012) (19)
The Antiphospholipid (Hughes') Syndrome: An Entity to Be Expanded (1999) (19)
Aids and Autoimmunity : For Debate (1989) (19)
Anti-idiotypes and their application under autoimmune, neoplastic, and infectious conditions. (1994) (19)
FMF Is Associated With a Wide Spectrum of MHC Class I- and Allied SpA Disorders but Not With Classical MHC Class II-Associated Autoimmune Disease: Insights From a Large Cohort Study (2019) (19)
Multiple autoimmune disease in a patient with hyperprolactinemia. (2005) (19)
Induction of Autoimmunity A Role for the Idiotypic Network a (1997) (19)
Prevention of tumor spread by matrix metalloproteinase-9 inhibition: old drugs, new concept. (2002) (19)
ITP following vaccination. (2020) (18)
Multiple autoimmune diseases in a young woman: tuberculosis and splenectomy as possible triggering factors? Another example of the "mosaic" of autoimmunity. (2008) (18)
Introduction autoantibodies—the smoke and the fire (2005) (18)
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Sjögren's Syndrome. (2016) (18)
B cell depletion in autoimmune rheumatic diseases. (2005) (18)
Close association between valvular heart disease and central nervous system manifestations in antiphospholipid syndrome (2005) (18)
Laboratory diagnosis of antiphospholipid syndromes. (1995) (18)
Interleukin-3 immunoassay in systemic lupus erythematosus patients: preliminary data. (1993) (18)
Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosy (2005) (18)
Novel approaches to therapy for systemic lupus erythematosus. (2000) (18)
Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions (2017) (18)
Immunomodulation of murine experimental SLE-like disease by interferon-γ (1998) (18)
Stenosis in Antiphospholipid Syndrome: A New Finding with Clinical Implications (2006) (18)
Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network. (1993) (18)
Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome. (1993) (18)
Exercise and heat orthostatism and the effect of heat acclimation and physical fitness. (1977) (18)
Superior vena cava syndrome – changing etiology in the third millennium (2012) (18)
Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess (2018) (18)
Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice (2013) (18)
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I (2015) (18)
Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement. (1987) (18)
Cellular and humoral immune responses to heat shock protein-65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice (2000) (18)
From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael Sela. (2014) (18)
Novel approaches to therapy for SLE (2003) (18)
Recurrent spontaneous abortions in antiphospholipid syndrome: natural killer cells - an additional mechanism in a multi factorial process. (2007) (18)
Monitoring the apoptotic process induced by oxidized low-density lipoprotein in Jurkat T-lymphoblast and U937 monocytic human cell lines (2007) (18)
Efficacy and Safety of Intravenous Immunoglobulin in Patients with Metastatic Melanoma (2007) (18)
IgA in Sjögren's syndrome. (1994) (18)
Age related distribution of serum immunoglobulin concentration in 1003 healthy children and adults. (1980) (18)
Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays. (2009) (18)
Microbiome and autoimmune diseases: cause and effect relationship. (2019) (18)
Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry (2017) (18)
Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis. (2004) (17)
Anti-DFS70 autoantibodies in undifferentiated connective tissue diseases subjects: what’s on the horizon? (2018) (17)
Antinuclear autoantibodies in chronic liver diseases. (1989) (17)
Elevated homocysteine levels in patients with Raynaud's syndrome. (1999) (17)
Autoimmunity: Will worms cure rheumatoid arthritis? (2013) (17)
Pulmonary alveolar proteinosis associated with fanconi's anemia. (1979) (17)
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features (2017) (17)
Infections: a double-edge sword in autoimmunity. (2018) (17)
Accreditation in autoimmune diagnostic laboratories. A position paper of the European Autoimmunity Standardisation Initiative (EASI). (2017) (17)
Antibodies against acute phase proteins and their functions in the pathogenesis of disease: a collective profile of 25 different antibodies. (2011) (17)
Infectious Agents in the Pathogenesis of Primary Biliary Cirrhosis (2011) (17)
Prolactin, bromocriptine and autoimmune diseases. (1996) (17)
Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I. (1997) (17)
Autoimmune dysautonomia in women with silicone breast implants. (2021) (17)
Anti‐platelet and Anti‐DNA IgM in waldenström macroglobulinemia and ITP (1987) (17)
Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: comment on the article by Farragher et al. (2009) (17)
Everything is Autoimmune Until Proven Otherwise (2013) (17)
[The effect of blocking TNF-alpha in patients with cancer-related cachexia and anorexia]. (2010) (17)
Do some antiphospholipid antibodies target endothelial cells? (1996) (17)
Comparative safety of mRNA COVID‐19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database (2021) (17)
Undifferentiated Connective‐Tissue Diseases (2015) (17)
High dose intravenous immunoglobulins: a new step in the treatment of systemic lupus erythematosus. (2000) (17)
The story of the 16/6 idiotype and systemic lupus erythematosus. (2008) (17)
A human monoclonal anti-DNA antibody derived from a patient with polymyositis having the common lupus 16/6 idiotype. (1988) (17)
Adjuvants and lymphoma risk as part of the ASIA spectrum (2015) (17)
Serum immunoglobulin levels in patients with active pulmonary tuberculosis and patients with Klebsiella infection. (1987) (17)
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in naïve mice. (2014) (17)
Induction of thyroid autoantibodies in naive mice by idiotypic manipulation. (1996) (17)
Molecular mimicry between SARS‐CoV‐2 and the female reproductive system (2021) (17)
Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9‐year retrospective study (2018) (17)
Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome: what is its role? (2001) (17)
Readability of Wikipedia Pages on Autoimmune Disorders: Systematic Quantitative Assessment (2017) (17)
Sialic acid-IVIg targeting CD22. (2010) (17)
Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients. (2019) (17)
Post-COVID syndrome: the aftershock of SARS-CoV-2 (2021) (17)
Infections, idiotypes and SLE (1995) (17)
Vaccination for Atherosclerosis (2010) (17)
Hepatitis B vaccination and undifferentiated connective tissue disease: another brick in the wall of the autoimmune/inflammatory syndrome induced by adjuvants (Asia). (2013) (17)
Effects of adjuvants for human use in systemic lupus erythematosus (SLE)‐prone (New Zealand black/New Zealand white) F1 mice (2014) (17)
Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine. (2016) (17)
Obesity: an additional piece in the mosaic of autoimmunity. (2014) (17)
Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination. (2021) (17)
MMP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology (2006) (17)
Bisphenol A: A notorious player in the mosaic of autoimmunity (2018) (16)
Detection of antimitochondrial antibodies: characterization by enzyme immunoassay and immunoblotting. (1989) (16)
Frontiers of SLE: review of the 5th International Congress of Systemic Lupus Erythematosus, Cancun, Mexico, April 20-25, 1998. (1999) (16)
Stroke among Rheumatoid Arthritis Patients: Does Age Matter? A Real-Life Study (2017) (16)
Central nervous system involvement in systemic lupus erythematosus: an imaging challenge. (2013) (16)
WITHDRAWN: Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil. (2016) (16)
Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis. (2007) (16)
Autoimmunity and novel therapies in immune-mediated thrombocytopenia. (2013) (16)
Measurement of electrical skin impedance of dermal-visceral zones as a diagnostic tool for inner organ pathologies: a blinded preliminary evaluation of a new technique. (2005) (16)
Characteristics of antineuronal antibodies in systemic lupus erythematosus patients with and without central nervous system involvement: the role of mycobacterial cross-reacting antigens. (1990) (16)
Infection and primary biliary cirrhosis. (2009) (16)
The occurrence of thromboembolic events following airplane flights--'the economy class syndrome'. (1995) (16)
Natural killer cells and autoimmunity (1989) (16)
Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis (2014) (16)
Animal models for antiphospholipid syndrome in pregnancy. (1997) (16)
1st International Conference on Cutaneous Lupus Erythematosus Düsseldorf, Germany, September 1-5, 2004. (2005) (16)
Hypophosphatemia as diagnostic aid in sepsis. (1982) (16)
Helminth-Based Product and the Microbiome of Mice with Lupus (2019) (16)
Photocopy machines and occupational antiphospholipid syndrome. (2008) (16)
Vitamins and systemic lupus erythematosus: to D or not to D (2013) (16)
An unusually complicated case of primary Sjögren's syndrome: development of transient "lupus-type" autoantibodies following silicone implant rejection. (2004) (16)
Abul Abbas: an epitome of scholarship. (2013) (16)
Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice (2017) (16)
Antiphospholipid Antibodies Bind ATP: A putative Mechanism for the Pathogenesis of Neuronal Dysfunction (2005) (16)
The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases (2007) (16)
The effect of Intravenous Immunoglobulin (IVIG) on \textit{ex vivo} activation of human leukocytes. (2017) (16)
The effect of the immunomodulator agent AS101 on interleukin‐2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti‐DNA antibody (1990) (16)
The utility of PET/CT in large vessel vasculitis (2020) (16)
Colchicine-induced rhabdomyolysis (2007) (16)
Antibodies to the cytoplasm, cell membrane and nuclear membrane of malignant neoplasms in pooled normal human polyspecific immunoglobulin G. (1999) (15)
Inflammatory bowel disease: adverse effect of isotretinoin. (2009) (15)
Ciprofloxacin Affects Pregnancy Loss in CBA/JxDBA/2J Mice Possibly via Elevation of Interleukin‐3 and Granulocyte Macrophage‐Colony Stimulating Factor Production (2000) (15)
[The digital doctor]. (2015) (15)
Review: Hepatitis C virus, autoimmunity and rheumatic disease (1997) (15)
Anti-phospholipid antibodies. (2014) (15)
Association between dairy intake and the risk of contracting type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis with subgroup analysis of men versus women (2019) (15)
Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis (1991) (15)
From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link? (2005) (15)
In utero exposure to Azathioprine in autoimmune disease. Where do we stand? (2020) (15)
The complement system and systemic sclerosis (1993) (15)
Natural (antiphospholipid-PDH,-DNA) autoantibodies and their physiologic serum inhibitors. (1995) (15)
A comparison of autoantibodies and common DNA antibody idiotypes in SLE patients and their spouses. (1988) (15)
Intravenous immunoglobulin and guillain-barré syndrome (2005) (15)
Multi-center evaluation of autoantibodies to the major ribosomal P C22 epitope (2012) (15)
Induction of SLE-like Disease in Naive Mice with a Monoclonal Anti-DNA Antibody Derived from a Patient with Polymyositis Carrying the 16/6 ID (1989) (15)
Multiple Autoantibodies Associated with Autoimmune Reproductive Failure (2003) (15)
New therapeutic avenues in autoimmunity. (1996) (15)
Intravenous immunoglobulin (IVIG) in the vanguard therapy of Systemic Sclerosis. (2019) (15)
Polymyalgia rheumatica and temporal arteritis in a married couple. (1984) (15)
Immunomodulation of various autoimmune diseases by intravenous immunoglobulin. (1999) (15)
Diagnosing Diseases by Measurement of Electrical Skin Impedance (2007) (15)
Vaccines in the 21st century: the genetic response and the innocent bystander. (2005) (15)
Advances in our understanding of immunization and vaccines for patients with systemic lupus erythematosus (2017) (15)
Hypercalcaemia-Induced Psychopathology in Malignant Diseases (1979) (15)
Role of IL-3 in the Antiphospholipid Syndrome (1994) (15)
Acclimatization to heat. (1965) (15)
How is my patient doing? Evaluating hospitalized patients using continuous vital signs monitoring. (2009) (15)
Clinical Evidence for Utilizing Cannabinoids in the Elderly. (2017) (15)
Intravenous immunoglobulin and atherosclerosis (2005) (15)
A mouse model for heparin-induced thrombocytopenia. (1999) (14)
Squamous cell carcinoma associated with sarcoidosis in the lung. (1978) (14)
Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events. (2005) (14)
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease (2021) (14)
Pyomyositis or "injectiositis"--Staphylococcus aureus multiple abscesses following intramuscular injections. (2003) (14)
BCG immunisation and the `Trojan Horse' phenomenon of vaccination (2003) (14)
Agammaglobulinemia, plasma cell dyscrasia, and amyloidosis in a 12-year-old child. (1977) (14)
Antiphospholipid syndrome and the idiotypic network (1995) (14)
Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results. (2004) (14)
Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits. (2017) (14)
Heat-shock proteins: Inflammatory versus regulatory attributes (2008) (14)
Autoantibodies in cancer patients: are they tumor related or age related? (1990) (14)
The hyperferritinemic syndromes and CD163: a marker of macrophage activation. (2014) (14)
[Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. (2001) (14)
The detection of antithyroglobulin activity in human serum monoclonal immunoglobulins (monoclonal gammopathies) (1993) (14)
Chronic Infections and Atherosclerosis (2009) (14)
Anti-neuronal antibodies in antiphospholipid syndrome with central nervous system involvement: the difference from systemic lupus erythematosus (1995) (14)
Restricted specificity of anti-ribosomal P antibodies to SLE patients in Israel. (2006) (14)
Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis. (2016) (14)
A Combination of IgG and IgM Autoantibodies in Chronic Cold Agglutinin Disease: Immunologic Studies and Response to Splenectomy (1985) (14)
Clinical characteristics of ruptured chordae tendineae in hospitalized patients: Primary tear versus infective endocarditis (1998) (14)
Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? (2009) (14)
The relationship between body temperature and intraocular pressure. (1981) (14)
Low levels of heat shock proteins-60 and -65 autoantibodies in Sjögren's syndrome. (2005) (14)
Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west. (2017) (14)
NEUTROPENIA INDUCED BY HYPERCAROTENAEMIA (1982) (14)
Anti-laminin-1 Autoantibodies, Pregnancy Loss and Endometriosis (2004) (14)
Rheumatoid arthritis and thyroid dysfunction: A cross-sectional study and a review of the literature. (2018) (14)
Screening tests for inflammatory activity: applications in rheumatology (2009) (14)
Distribution of Two Common Idiotypes of Anticardiolipin Antibodies in Sera of Patients with Primary Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Monoclonal Gammopathies (1992) (14)
Linseed oil suppresses the anti-beta-2-glycoprotein-I in experimental antiphospholipid syndrome. (2000) (14)
Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. (2003) (14)
Interleukin-3-like activity levels in pregnant women: possible modulation by progesterone. (1992) (14)
Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. (1999) (14)
Autoimmune multiorgan involvement in elderly men is it SLE? (1994) (14)
Anti‐citrullinated‐protein‐antibody‐specific intravenous immunoglobulin attenuates collagen‐induced arthritis in mice (2015) (14)
From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity (2020) (14)
Efficacy of Different Types of Therapy for COVID-19: A Comprehensive Review (2021) (14)
Premature coronary disease in systemic lupus. (2004) (13)
The Dead Sea is alive. (1996) (13)
Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen (1995) (13)
Are Anti-DFS70 Autoantibodies Protective? (2019) (13)
Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss. (2007) (13)
Description and forecast of summer climate in physiologically significant terms (1978) (13)
Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG) (2006) (13)
Serum monoclonal antibodies derived from patients with multiple myeloma react with mycobacterial phosphoinositides and nuclear antigens. (1989) (13)
Lupus and leprosy: beyond the coincidence (2015) (13)
Immunomodulation of Experimental APS: Lessons from Murine Models (1996) (13)
Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic (2021) (13)
The Contribution of Experimental Models to our Understanding of Etiology, Pathogenesis and Novel Therapies in the Antiphospholipid Syndrome (2000) (13)
Atopy and Asthma in Migrants: The Function of Parasites (2015) (13)
Anti-β 2 -Glycoprotein I Autoantibodies and Atherosclerosis (2002) (13)
The Influence of Different Cultivating Conditions on Polymorphonuclear Leukocyte Apoptotic Processes In vitro, I: The Morphological Characteristics of PMN Spontaneous Apoptosis (2003) (13)
Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations (2001) (13)
High proportions of dementia among SLE patients: A big data analysis (2018) (13)
Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome (2002) (13)
Human lupus monoclonal autoantibodies bind to Raji cells. (1985) (13)
Determination of autoantibodies in patients with familial Mediterranean fever and their first degree relatives. (1991) (13)
Reactivity of peripheral blood lymphocytes to oxidized low‐density lipoprotein: A Novel system to estimate atherosclerosis employing the cellscan (1999) (13)
[Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity]. (2011) (13)
Melanoma and immunotherapy bridge 2015 (2016) (13)
The significance of antibodies to DNA in the primary antiphospholipid syndrome. (1994) (13)
Hantavirus seropositivity in Israeli patients with renal failure. (1998) (13)
Hypersensitivity to Mycophenolate Mofetil in Systemic Lupus Erythematosus: Diagnostic Measures and Successful Desensitization (2005) (13)
The opposite effect of human leukocyte antigen genotypes in sarcoidosis and tuberculosis: a narrative review of the literature (2020) (13)
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry". (2022) (13)
Systemic lupus erythematosus and lymphoma. A family study. (1983) (13)
Novel Insights Into Associations of Antibodies Against Cardiolipin and beta2-glycoprotein I with Clinical Features of Antiphospholipid Syndrome (2007) (13)
Identification of Histidine‐Rich Glycoprotein, a Potential Autoantigen, in Human and Rat Brain Preparations (2007) (13)
Cytokine levels in various intravenous immunoglobulin (IVIg) preparations. (2001) (13)
Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue (1991) (13)
The use of hybridomas to analyse autoimmunity. (1984) (13)
Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases. (2014) (13)
EASI – European Autoimmunity Standardisation Initiative: facing the challenges of diagnostics in autoimmunity (2017) (13)
A study of antipolynucleotide antibodies, anti-Klebsiella (K30) antibodies and anti-DNA antibody idiotypes in ankylosing spondylitis. (1987) (13)
Microbiome, autoimmunity, allergy, and helminth infection: The importance of the pregnancy period (2017) (13)
Absence of anti-idiotypic antibodies in IVIG preparations to autoantibodies of rare autoimmune diseases. (1995) (12)
The role of the idiotypic network in the induction of experimental systemic lupus erythematosus (1989) (12)
[Antimitochondrial antibodies and primary biliary cirrhosis]. (1993) (12)
Predictive value of anti-citrullinated peptide antibodies: a real life experience (2014) (12)
Vitamin D deficiency in an Italian cohort of infertile women (2017) (12)
Thrombocytopenia from acetaminophen. (1980) (12)
Heat‐Shock Protein 65 Autoantibodies Are Differently Associated with Early Atherosclerosis in Rheumatoid Arthritis and in Healthy Subjects (2007) (12)
Recent advances and current state of immunotherapy in systemic lupus erythematosus (2016) (12)
Effects of salt loading during exercise in a hot dry climate. (1986) (12)
Antiphospholipid syndrome: a consensus for treatment? (2003) (12)
Effect of physical effort on the white blood cells in benign familial leukopenia. (1981) (12)
Check point inhibitors and autoimmunity: Why endocrinopathies and who is prone to? (2020) (12)
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases. (2019) (12)
Tuftsin–phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model (2018) (12)
Mortality among Patients with Giant Cell Arteritis: A Large-scale Population-based Cohort Study (2019) (12)
Successful intravenous immunoglobulin therapy for resistant inflammatory pseudotumor of the orbit. (2005) (12)
The detection of anti-Ro/SS-A and anti-La/SS-B activity of human serum monoclonal immunoglobulins (monoclonal gammopathies). (1992) (12)
Advances in therapy of autoimmune diseases. (1988) (12)
The hyperferritinemic syndrome. (2014) (12)
Detection of Antibodies to Gangliosides and Glycolipids in Various Intravenous Immunoglobulin (IVIg) Preparations (2000) (12)
Challenges for the Autoimmunologist (2010) (12)
Rheumatology in the Middle East in 2017: clinical challenges and research (2017) (12)
Cognitive impairment in antiphospholipid syndrome: evidence from animal models (2012) (12)
The autoimmune side of rheumatic fever. (2014) (12)
An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice (2017) (12)
Systemic sclerosis. Introduction. (2011) (12)
Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis (2018) (12)
Parotitis as the presenting symptom of Wegener's granulomatosis: case report and meta-analysis. (2013) (12)
Quality and best practice in medical laboratories: specific requests for autoimmunity testing (2020) (12)
Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus. (1986) (12)
The pathogenic 16/6 idiotype in patients with silica associated systemic lupus erythematosus (SLE) and uranium miners with increased risk for development of SLE. (1998) (12)
Good prognosis for hospitalized SLE patients with non-related disease. (2014) (12)
Mortality of patients with systemic lupus erythematosus admitted to the intensive care unit - A retrospective single-center study. (2018) (12)
Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases (2013) (12)
Optimal back-pack load for short distance hiking. (1978) (12)
Complement profile in primary biliary cirrhosis (1992) (12)
The production of human monoclonal anti-MMTV antibodies by in vitro immunization with anti-idiotypic antibodies. (1991) (11)
Induction of SLE-like Disease in Naive Mice with a Monoclonal Anti-DNA Antibody Derived from a Patient with Polymyositis Carrying the 16/6 ID (1989) (11)
Central nervous system (CNS) involvement in SLE (1998) (11)
Video Q&A: what is ASIA? An interview with Yehuda Shoenfeld (2013) (11)
A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor. (1992) (11)
Patients With Vasculitides Admitted to the Intensive Care Unit: Implications From a Single-Center Retrospective Study (2019) (11)
Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome. (2019) (11)
Churg-Strauss Syndrome: Singulair or Silicone (or both?). (2016) (11)
Medical, Genomic, and Evolutionary Aspects of the Peptide Sharing between Pathogens, Primates, and Humans (2020) (11)
Idiotypes and autoimmunity. (1990) (11)
Response to: ‘Detection of antinuclear antibodies: added-value of solid phase assay?’ by Bossuyt and Fieuws (2013) (11)
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015. (2015) (11)
Treating prolactinoma can prevent autoimmune diseases. (2015) (11)
Intelligent nutrition: health-promoting mechanisms of probiotics. (2003) (11)
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity (2022) (11)
Anti‐DNA idiotype‐ and anti‐idiotype‐specific T cell responses in patients with systemic lupus erythematosus and their first‐degree relatives (1990) (11)
Systemic Lupus Erythematosus 2014 (2014) (11)
Sex and Gender Differences in Autoimmune Diseases (2012) (11)
Hepatitis C virus, autoimmunity and rheumatic disease. (1997) (11)
ORIGINAL ARTICLE: Anti‐Elastin Antibodies and Elastin Turnover in Normal Pregnancy and Recurrent Pregnancy Loss (2009) (11)
In vitro T-cell functions specific to an anti-DNA idiotype and serological markers in patients with systemic lupus erythematosus (SLE) (1988) (11)
Acute varicella infection heralding Wilsonian crisis. (1994) (11)
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome. (1994) (11)
CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis (2016) (11)
Peptide immunotherapy in autoimmune diseases. (2000) (11)
Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome (2003) (11)
ELISA measurement of antibody titer to purified protein derivative and mycobacteria-derived phosphoglycolipids: tool for diagnosing active pulmonary tuberculosis. (1987) (11)
Immunosuppression and immunomodulation of experimental models of systemic lupus erythematosus and antiphospholipid syndrome. (1996) (11)
The spectrum between antiphospholipid syndrome and systemic lupus erythematosus (2014) (11)
Autoimmune diseases and pregnancy. (2019) (11)
Chapter 13 – Paraneoplastic Syndromes (2000) (11)
Survival without surgical repair of acute rupture of the right ventricular free wall (1999) (11)
Is there a cure for systemic lupus erythematosus? (2013) (11)
The Idiotypic Network in Antinuclear-Antibody-Associated Diseases (2000) (10)
Behavioral changes in systemic lupus erythematosus are of an autoimmune nature (2007) (10)
From Pauling's abzyme concept to the new era of hydrolytic anti-DNA autoantibodies: a link to rational vaccine design? - A review (2011) (10)
[Morbidity and mortality in systemic lupus erythematosus]. (2001) (10)
A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies (2015) (10)
Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality? (2005) (10)
Sweat studies in hyperhidrosis palmaris and plantaris. A survey of 60 patients before and after cervical sympathectomy. (1976) (10)
Environmental factors may modulate antiphospholipid antibody production in family members of patients with systemic lupus erythematosus. (1999) (10)
Life-threatening hypophosphatemia in a patient with acute myelogenous leukemia. (1980) (10)
The rheumatologic complications of hematologic disorders. (1983) (10)
Aluminum excytotoxicity and neuroautotoimmunity: the role of the brain expression of CD32+ (FcγRIIa), ICAM-1+ and CD3ξ in aging. (2013) (10)
Isotretinoin-induced adult onset Still's disease. (2000) (10)
New Clinical Phenotype of the Post-Covid Syndrome: Fibromyalgia and Joint Hypermobility Condition (2022) (10)
Attenuation of Colon Carcinoma Tumor Spread by Intravenous Immunoglobulin (2007) (10)
[Depression and the immune system]. (1999) (10)
Catastrophic antiphospholipid syndrome: an orchestra with several musicians. (2014) (10)
Experimental and induced animal models of systemic lupus erythematosus and Sjögren's syndrome. (1989) (10)
Probiotic Supplementation with Lactobacillus casei (Actimel) Induces a Th1 Response in an Animal Model of Antiphospholipid Syndrome (2007) (10)
Anti-laminin-1 autoantibodies, pregnancy loss and endometriosis. (2004) (10)
Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis. (1992) (10)
Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm. (2008) (10)
Physiological and pathological implications of laminins: From the gene to the protein (2007) (10)
Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant. (2012) (10)
The diverse pathogenic potential of anti-DNA antibodies from various sources to induce experimental systemic lupus erythematosus. (1996) (10)
The use of ELISA for the measurement of autoantibodies to nuclear antigens: comparison with other methodologies. (1988) (10)
Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome. (2003) (10)
The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders (2018) (10)
Treatment of hematologic disorders other than immune thrombocytopenic purpura with intravenous immunoglobulin (IVIg) - report of seven cases and review of the literature. (2000) (10)
Rhupus; unusual presentations (2015) (10)
Innovations in Autoimmunity in the Last Decade (1999) (10)
Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications (2015) (10)
Association between vaccination and Guillain-Barré syndrome. (2013) (10)
Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study (2019) (10)
Pulmonary Eosinophilia (2008) (10)
Estimating pulmonary congestion in elderly patients using bio-impedance technique: correlation with clinical examination and X-ray results. (2009) (10)
Improved accuracy in DFS pattern interpretation using a novel HEp-2 ELITE system (2019) (10)
Neuropsychiatric SLE: from animal model to human (2017) (10)
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLE. (1998) (10)
Autoantibodies--diagnostic, pathogenic and prognostic relevance. (1997) (10)
Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg). (2009) (10)
Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents (1997) (10)
[Ischemic hepatitis in congestive heart failure after an episode of hypotension]. (1997) (9)
The effects of incubation temperature and coating procedure on the measurement of antibodies to cardiolipin. (1991) (9)
Carbamazepine (Tegretol)-induced thrombocytopenia. (1982) (9)
Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: Is TNF alpha the link? (2017) (9)
Antinuclear Autoantibodies in Healthy Nonpregnant and Pregnant Women and Their Offspring (1991) (9)
Refractory leg infection as an inducer of the catastrophic antiphospholipid syndrome. (2004) (9)
Facts and challenges for the autoimmunologist. Lessons from the second Colombian autoimmune symposium. (2012) (9)
Anti-Idiotypic Agonistic Antibodies: Candidates for the Role of Universal Remedy (2020) (9)
Chapter 36 – Parasitic Infection and Autoimmunity (1991) (9)
Primary biliary cirrhosis and autoimmune rheumatic diseases: prediction and prevention. (1992) (9)
Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides (2006) (9)
The significance of experimental models of systemic lupus erythematosus and antiphospholipid syndrome induced by idiotypic manipulation. (1994) (9)
BLyS/BAFF: a potential target in the treatment of active systemic lupus erythematosus. (2004) (9)
Cholinergic Urticaria A Seasonal Disease (1981) (9)
Characterization of a Murine Anti-laminin-1 Monoclonal Antibody (AK8) Produced by Immunization with Mouse-derived Laminin-1 (2005) (9)
Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome (2017) (9)
[Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)]. (2005) (9)
Dysregulation of G protein-coupled receptors of the autonomic nervous system, adrenergic and muscarinic acetylcholine receptors, in patients with autoimmune dysautonomic-related disorders (2020) (9)
WHAT REALLY HAPPENS TO FECUNDITY IN AUTOIMMUNE DISEASES? (1994) (9)
Antibiotic therapy in autoimmune disorders (2014) (9)
Immune network and autoimmunity. (1996) (9)
Anti-GalNAcβ: a novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model. (2012) (9)
The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis. (2018) (9)
Mindfulness-based group therapy for systemic lupus erythematosus: A first exploration of a promising mind-body intervention. (2017) (9)
HPV vaccines and autoimmune diseases (2012) (9)
Prolactin: Another Important Player in the Mosaic of Autoimmunity. (2016) (9)
Anterior ST‐elevation myocardial infarction induced by rituximab infusion: A case report and review of the literature (2017) (9)
Letter to the editor – HPV vaccine and autoimmunity Incidence of new‐onset autoimmune disease in girls and women with pre‐existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study (2017) (9)
Identification of anti-Sm and anti-RNP autoantibodies by immunoblotting and immunoassay. (1988) (9)
Aggressive plasma cell myeloma. (1982) (9)
Cutting-Edge Issues in Organ-Specific Autoimmunity (2011) (9)
Cryoglobulinemia in chronic liver diseases. (1980) (9)
The medical and scientific aspects of spa therapy. (1996) (9)
Laminin-1 (LM-111) in preeclampsia and systemic lupus erythematosus (2013) (9)
Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody. (2006) (9)
Functional properties of antiendothelial cell antibodies (1998) (9)
5th International symposium on IVIG: IVIG in the third millenium, 25-27 September 2003, Interlaken, Switzerland. (2003) (9)
Immunomodulation of experimental antiphospholipid syndrome. (1998) (9)
Is autoimmunology a discipline of its own? A big data-based bibliometric and scientometric analyses (2017) (9)
Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease. (2002) (9)
A Novel System to Diagnose Cutaneous Adverse Drug Reactions Employing the Cellscan—Comparison with Histamine Releasing Test and Inf-γ Releasing Test (2005) (8)
Treatment of systemic lupus erythematosus and antiphospholipid syndrome: from experimental models to patients' bedside. (1996) (8)
A Picture is Worth a Thousand Words: Art and Medicine. (2017) (8)
Anti-phospholipid autoantibodies--do they have a pathogenic role in infertility? (1998) (8)
Autoimmunity: when the immune system becomes the self-ish giant. (2011) (8)
Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment. (2002) (8)
Introduction: Infection and Autoimmunity (2004) (8)
Systemic lupus erythematosus: treatment. (2009) (8)
The therapeutic potential of targeting anti-Ribosomal-P antibody in treating SLE patients with depression (2007) (8)
Autoantibodies, idiotypes, anti-idiotypes and autoimmunity. (1986) (8)
Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey (2020) (8)
Immunomodulation in human and experimental arthritis: including vitamin D, helminths and heat-shock proteins (2014) (8)
Mycophenolate mofetil in animal models of autoimmune disease (2005) (8)
Antinuclear autoantibodies in sera of healthy pregnant women and their offspring. (1988) (8)
Natural hidden autoantibodies. (2007) (8)
NATURAL AUTOANTIBODIES, HERALDING, PROTECTING AND INDUCING AUTOIMMUNITY (2007) (8)
Renal failure and low molecular weight heparins. A dangerous liaison? The case of retroperitoneal hematoma. (2005) (8)
Human anti-DNA idiotype (16/6 idiotype): pathogenic role in autoimmunity. (1990) (8)
Mechanisms of thrombosis in the antiphospholipid syndrome (2003) (8)
Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis (2019) (8)
The induction of experimental vascular diseases by immunization with pathogenic autoantibodies. (2000) (8)
Sudden death and physical exertion. (1981) (8)
[Colchicine as therapy for recurrent pericarditis]. (1997) (8)
Comparison of clinical and laboratory parameters for systemic lupus erythematosus activity in Israelis versus Europeans. (1996) (8)
Manipulation of autoimmune diseases with T-suppressor cells: lessons from experimental SLE and EAE. (1993) (8)
Cognitive Dysfunction and Antiphospholipid Antibodies (2012) (8)
Binding of monoclonal anti-DNA and anti-TB glycolipids to brain tissue. (1989) (8)
Strategies and treatment alternatives in the management of Erdheim–Chester disease (2013) (8)
Sweating in the 'anhidrotic type' of congenital ectodermal dysplasia. (1975) (8)
COVID-19 as an infectome paradigm of autoimmunity (2021) (8)
The Smell in COVID-19 Infection: Diagnostic Opportunities. (2020) (8)
Choroid Plexus Connexin 43 Expression and Gap Junction Flexibility Are Associated with Clinical Features of Acute EAE (2009) (8)
Adjuvants and Autoimmunity: Why Do We Develop Autoantibodies, Autoimmune Diseases and Lymphomas. (2017) (8)
Disease specificity of antibodies to poly (ADP-ribose); their relationships to anti-DNA antibodies and to disease activity in lupus. (1990) (8)
Graves' disease presenting as right heart failure. (2006) (8)
Anti-DNA idiotypes: their pathogenic role in autoimmunity. (1992) (8)
[Treatment of autoimmune diseases]. (1987) (8)
10th International Congress on Antiphospholipid Antibodies--summary. (2003) (8)
New laboratory criteria of the autoimmune inflammation in pulmonary sarcoidosis and tuberculosis. (2021) (8)
Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis. (2005) (8)
[Hyperhomocysteinemia--a risk factor or vascular disease?]. (1999) (8)
D-penicillamine-induced autoantibodies in a mouse model. (1995) (7)
[Fibrosarcoma after silicone breast augmentation: is there a connection?]. (1998) (7)
The mosaic of autoimmunity - A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual. (2021) (7)
HPV vaccines and lupus: current approaches towards preventing adverse immune cross-reactivity (2018) (7)
Carotid artery intima–media thickness, heat shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis (2008) (7)
Prevalence of rubella serum antibody in autoimmune diseases. (2012) (7)
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? (2015) (7)
Decrease in 14‐3‐3&eegr; protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib (2019) (7)
A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist’s office (2017) (7)
Sjogren's syndrome in Israel: Primary versus secondary disease (1994) (7)
Oxidatively altered IgG with increased immunoreactivity to β2-glycoprotein I and its peptide clusters influence human coronary artery endothelial cells (2015) (7)
Induction of Goodpasture antibodies to noncollagenous domain (NC1) of type IV collagen in mice by idiotypic manipulation. (1995) (7)
Adoptive Transfer of b 2 -Glycoprotein I–Reactive Lymphocytes Enhances Early Atherosclerosis in LDL Receptor–Deficient Mice (2000) (7)
The olfactory function is impaired in patients with idiopathic inflammatory myopathies (2014) (7)
Plaque morphea with neurological involvement—an extraordinary uncommon presentation (2015) (7)
Idiotypic network dysregulation (2000) (7)
Autoantibodies against Autonomic Nerve Receptors in Adolescent Japanese Girls after Immunization with Human Papillomavirus Vaccine (2019) (7)
Association between giant cell arteritis and thyroid dysfunction in a “real life” population (2017) (7)
Rehabilitation of patients with NCA (neurocirculatory asthenia) through a short term training program. (1978) (7)
Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma). (1996) (7)
Major surgery in leukemic patients. (1982) (7)
The Utility of 18FDG-PET/CT in Diagnosing Fever of Unknown Origin: The Experience of a Large Tertiary Medical Center (2021) (7)
The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies (1986) (7)
Corneal Confocal Microscopy in the Diagnosis of Small Fiber Neuropathy: Faster, Easier, and More Efficient Than Skin Biopsy? (2021) (7)
Oculomotor nerve paresis-presenting sign of acute myeloblastic leukemia in a patient with polycythemia vera. (1980) (7)
The Efficacy of Intravenous Immunoglobulin in Guillain-Barré Syndrome: The Experience of a Tertiary Medical Center. (2018) (7)
The Mosaic of Systemic Lupus Erythematosus: Highlights of the Third International Conference on SLE 13-15 April 1992 (1992) (7)
Antiphospholipid Syndrome: From the Laboratory Bench to the Patients' Bedside (1995) (7)
Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. (1996) (7)
Anti-neutrophil cytoplasmic antibody-enriched IgG induces adhesion of human T lymphocytes to extracellular matrix proteins. (1997) (7)
Erdheim-Chester disease: an orphan condition seeking treatment. (2012) (7)
The Heart Matters: Contribution of Genetic Factors in Recurrent Pericarditis. (2019) (7)
Association of subclinical atherosclerosis and leukopenia in systemic autoimmune diseases: comment on the article by Huang et al. (2010) (7)
Anti-Glomerular Basement Membrane Antibody Diagnostics in a Large Cohort Tertiary Center: Should We Trust Serological Findings? (2017) (7)
From proteomics to molecular epidemiology: relevance of autoantibodies. (2003) (7)
Vitamin D: a panacea for autoimmune diseases? (2015) (7)
Serological markers in inflammatory bowel disease: the pros and cons (2002) (7)
Depressed PHA transformation and acute leukemia in macroglobulinemia (1979) (7)
"Leukopenia: idiopathic or drug-induced"--how to differentiate? (1982) (7)
Anti-DNA idiotypes: from induction of disease to novel therapeutical approaches. (2005) (7)
Autoimmune/Inflammatory Syndrome Induced by Adjuvant Associated with a Metal Implant in the Mouth; Explantation Was Followed by Recovery. (2020) (7)
Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anticardiolipin antibodies of patients with primary antiphospholipid syndrome. (1991) (7)
The infectious etiology of the antiphospholipid syndrome (APS). (2004) (7)
Manipulation of anti-DNA idiotypes: a possible treatment approach to autoimmune diseases. (1992) (7)
Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus. (2005) (7)
The Future of Autoimmunity (2012) (7)
The kaleidoscope of autoimmunity - From genes to microbiome. (2019) (7)
The general practice guide to autoimmune diseases (2012) (7)
2nd conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005. (2006) (7)
Does duodenal ulcer lead to an early diagnosis of gastric cancer? (1987) (7)
Cholinergic urticaria. A seasonal disease. (1981) (6)
Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases (1990) (6)
Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature (2019) (6)
Hybridomas from unimmunized individuals. (1986) (6)
Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana’s healthy population (2020) (6)
SLE and Cancer (2000) (6)
Idiotypic network, pathogenic autoantibodies and autoimmunity (1995) (6)
Inflammatory and immune aspects of atherosclerosis. (1999) (6)
The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value (2015) (6)
Fecundity in autoimmune diseases. (1995) (6)
Intravenous immune globulins (IVIg) treatment for organizing pneumonia in a selective IgG immune deficiency state (2014) (6)
SP0190 2019 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SJöGREN”S SYNDROME WITH TOPICAL AND SYSTEMIC THERAPIES (2019) (6)
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases (2017) (6)
Pearls in autoimmunity (2011) (6)
A new experimental model for Wegener's granulomatosis. (1995) (6)
An analysis of autoimmunity through studies of DNA antibody idiotypes. (1988) (6)
Silicone Breast Implants as Predisposing Factor for Non-Hodgkin’s Lymphoma: An Additional Facet of Auto-Inflammatory Syndrome Induced by Adjuvant (2014) (6)
Idiotypes and Anti-Idiotypic Antibodies (1996) (6)
Experimental Systemic Lupus Erythematosus: Role of the Idiotypic Network (1994) (6)
Detection of Cellular Activity in Autoimmune Disorders by the Cellscan System (1999) (6)
The diversity of autoantibodies to P-ribosomal: the infectious-autoimmunity plot (2007) (6)
Effect of tumor necrosis factor α inhibition on CD28 surface expression on CD4+ T cells (2006) (6)
The Smoking Cancer—Autoimmunity Connection (2000) (6)
AIDS and autoimmunity. (1989) (6)
IntroductionInfection and Autoimmunity (2004) (6)
Human monoclonal antibodies derived from pleural effusion lymphocytes of a patient with breast carcinoma react with human breast cancer-associated antigens and mouse mammary tumor virus polypeptides. (1987) (6)
Thromboembolic phenomena in patients with hereditary factor XI deficiency. (1998) (6)
Allergic purpura following intravenous administration of iron dextran. (1979) (6)
High levels of a common anti-DNA idiotype (16/6), a genetic marker for SLE. (1986) (6)
1.P.10 Hyperimmunization of chow-fed ApoE deficient mice with homologous oxidized low density lipoprotein suppresses early atherogenesis (1997) (6)
Hemophagocytic syndrome with hyperferritinemia: a stormy immunological response. (2013) (6)
Functional Heterogeneity of Pathogenic Anti-Endothelial Cell Antibodies (2001) (6)
Pharmacologic management of neuropsychiatric lupus (2016) (6)
Prediction of Antiphospholipid syndrome using Annexin A5 competition assay in patients with SLE (2016) (6)
Tuftsin phosphorylcholine—a novel compound harnessing helminths to fight autoimmunity (2018) (6)
Circulating anticoagulant and serological tests for syphilis. (1980) (6)
Idiotypic induction of autoimmunity: do we need an autoantigen? (1994) (6)
beta 2-glycoprotein I in human and murine atherosclerosis. (2001) (6)
Increased presence of common systemic lupus erythematosus (SLE) anti-DNA idiotypes (16/6 Id, 32/15 Id) is induced by procainamide (1987) (6)
Use of intravenous immunoglobulin in idiopathic membranous nephropathy. (1999) (6)
The frequency of a common anti-DNA antibody idiotype (16/6) in different populations of patients with systemic lupus erythematosus. (1991) (6)
Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity. (2004) (6)
Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro. (2016) (6)
Pregnancy-induced leukocytosis in Yemenite Jews. (1983) (6)
Autoimmune / in fl ammatory syndrome induced by adjuvants (2010) (6)
Hypercalcemia in Hodgkin's disease. (1980) (6)
[Neurologic complications of primary Sjogren's syndrome]. (1991) (6)
European Forum on Antiphospholipid Antibodies: research in progress (2009) (6)
The expanding world of autoimmunity. (2002) (6)
Rheumatoid Arthritis and Cancer (2000) (6)
Generalized pruritus in metastatic adenocarcinoma of the stomach. (1977) (6)
Full skin thickness burns caused by contact with the pavement in a heat-stroke victim. (1989) (5)
Toxoplasmosis and systemic lupus erythematosus. Comparative serological studies. (1991) (5)
[Extreme bilirubinemia in hepatitis A associated with G6PD-deficiency]. (1990) (5)
Asherson's syndrome of the catastrophic antiphospholipid antibodies. (2008) (5)
Revisiting old ghosts: prenatal viral exposure and schizophrenia. (2005) (5)
Hidden autoantibodies (2000) (5)
Pathogenic natural autoantibodies. (1993) (5)
Small Fiber Neuropathy in Sarcoidosis (2021) (5)
Immunomodulation of RA Patients' PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens (2017) (5)
Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination. (2008) (5)
[Autoimmune mechanisms in cardiovascular diseases]. (2009) (5)
A malignancy work-up in patients with cancer-associated (paraneoplastic) autoimmune diseases: pemphigus and myasthenic syndromes as cases in point (review). (1999) (5)
Acupuncture therapy for rheumatoid arthritis (2004) (5)
The genetics of autoimmunity: the familial tendency of systemic lupus erythematosus. (1989) (5)
Lack of Antilipoprotein Lipase Antibodies in Takayasu's Arteritis (2009) (5)
Autoimmunity and cancer - Beneficial relationships. (1997) (5)
Homogeneous populations of macrophages from histiocytic lymphoma patients as a source for macrophage subpopulations which differ in immunoregulatory properties (1982) (5)
38 - SLE and Infections (2004) (5)
Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis (2020) (5)
The Dark Side of Beauty: About Breast Implants and Lymphoma. (2017) (5)
Age, weight and heart rate at rest as predictors of aerobic fitness. (1981) (5)
Autoimmune diseases: multiple factors involved in the etiology. (1988) (5)
Acute onset of psoriatic spondyloarthritis as a new manifestation of post-streptococcal reactive arthritis: a case series (2019) (5)
Anti-Prothrombin Antibodies in Thrombosis and Atherosclerosis (2001) (5)
[IVIG therapy in sepsis]. (2001) (5)
Induction of experimental systemic lupus erythematosus in mice. (1988) (5)
Narcolepsy--genes, infections and vaccines: the clues for a new autoimmune disease. (2014) (5)
SAT0687 Silicone breast implants and the risk of autoimmune diseases: real world analysis (2018) (5)
Intracellular fluorescence polarization measurements by the Cellscan system: detection of cellular activity in autoimmune disorders. (1997) (5)
Clinical experience with biologic treatment in resistant eosinophilic fasciitis (2021) (5)
Hippocrates' Oath is challenged. (2009) (5)
Comparative clinical study of cefonicid, chloramphenicol, and penicillin in community-acquired pneumonia. (1998) (5)
A multidimensional autoantibody analysis specifying systemic lupus erythematosus patients with neuropsychiatric symptomatology. (1992) (5)
Vaccines and Optic Neuritis: Consequence or Coincidence? (2021) (5)
Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting (2014) (5)
The Antiphospholipid Syndrome: History, Definition, Classification, and Differential Diagnosis (2018) (5)
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis. (2019) (5)
[Intravenous immunoglobulins treatment of patients with Graves' ophthalmopathy]. (2001) (5)
Preface. The autoimmunologist and the congresses of autoimmunity. (2009) (5)
Prevalence of Toxoplasma antibodies among patients with various autoimmune diseases (2010) (5)
Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development (2020) (5)
Autoimmune Concept of Schizophrenia: Historical Roots and Current Facets. (2021) (5)
[Satisfaction among patients of a homeopathic clinic]. (1996) (5)
[Central nervous system involvement in antiphospholipid syndrome]. (2001) (5)
Sjögren's Syndrome Associated With Thrombotic Thrombocytopenic Purpura: A Case-Based Review (2020) (5)
Importance of intestinal microenvironment in development of arthritis. A systematic review (2015) (5)
Mycophenolate mofetil in animal models of autoimmune disease (2005) (5)
The relationship between autoantibodies targeting GPCRs and the renin-angiotensin system associates with COVID-19 severity (2021) (5)
Immunoglobulin changes in SLE. (1977) (5)
Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members (1994) (5)
Catalytic antibodies: generation, nature, and possible role as chemical warfare scavengers. (1996) (5)
Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-β2-glycoprotein-I autoantibodies (2008) (5)
Autoimmunity at a glance (2002) (5)
The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis (2022) (5)
The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti- β2GPI Abs induced by common bacteria (2001) (5)
Myositis and Vaccines (2015) (5)
Therapy with biologic agents in SLE (2004) (5)
Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis. (2015) (5)
Coincidence of granulomatosis and polyangiitis with atypical clinical manifestation and antiphospholipid syndrome (2013) (5)
Antinuclear autoantibodies in sera of patients with IgA nephropathy. (1990) (5)
Exploring the pathways of inflammation and coagulopathy in COVID-19: A narrative tour into a viral rabbit hole (2021) (5)
PATHOGENIC MECHANISMS AND CLINICAL RELEVANCE OF AUTOANTIBODIES (2007) (5)
The Effect of Exercise on Neurogenesis in the Brain. (2022) (5)
British medical journals play politics. (2009) (5)
Controversies in rheumatism and autoimmunity. (2012) (5)
Immune Mediated Myopathy following Long-Term Statin Therapy. (2015) (4)
[Atherosclerosis as an immune process]. (1995) (4)
Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice (2020) (4)
Immunomodulation of Murine Chronic DSS-Induced Colitis by Tuftsin–Phosphorylcholine (2019) (4)
Recovery heart rate after sub-maximal work. (1976) (4)
Thyroid disease and vitamin D deficiency (2010) (4)
ANTI-RIBOSOMAL P ANTIBODIES (2007) (4)
Are Anti-Phospholipid Syndrome and Systemic Lupus Erythematosus Two Different Diseases? A 10-Year Late Remake. (2019) (4)
The complement system and primary biliary cirrhosis. (1992) (4)
Erratum to: A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist’s office (2017) (4)
Pyruvate dehydrogenase as an antigen to detect antimitochondrial antibodies. (1990) (4)
Current knowledge regarding Asherson’s syndrome (2009) (4)
Malignancies and autoimmune rheumatic diseases. (2001) (4)
Heterogeneity of anti-β2-glycoprotein I antibodies (2005) (4)
Association between Takayasu arteritis and ischemic heart disease: a cohort study (2019) (4)
Primary biliary cirrhosis is a multisystem disorder. (1991) (4)
Autoimmune Tautology in a Complex Case of Polyautoimmunity: Systemic Sclerosis, Autoimmune Liver Involvement, Antiphospholipid Syndrome and Hashimoto's Thyroiditis. (2017) (4)
[Smell: integrating neurodegeneration and autoimmunity - a personal view]. (2009) (4)
Olfactory dysfunction and autoimmunity: pathogenesis and new insights. (2017) (4)
Primary Ovarian Insufficiency Nationwide Incidence Rate and Etiology Among Israeli Adolescents. (2020) (4)
The Importance of the Study of Monoclonal Antibodies (1987) (4)
Tolerogenic citrullinated peptide for arthritis (2015) (4)
Aerobic work capacity in sedentary men and active athletes in Israel. (1977) (4)
Gm allotype system and autoimmune diseases (1989) (4)
Cognitive Impairment, Sleep Disturbance, and Depression in Women with Silicone Breast Implants: Association with Autoantibodies against Autonomic Nervous System Receptors (2022) (4)
Primary pulmonary hypertension: a facet of diffuse angiopathic process? (1982) (4)
Genetics and Origin of Antiphospholipid Syndrome (2015) (4)
Hyaline membrane disease in the cape coloured. (1979) (4)
Immunoregulation of autoimmune diseases. (1990) (4)
Placental type isoferritins in chronic liver diseases. (1987) (4)
Response to health in the Occupied Palestinian Territory (2011) (4)
Immunization with vaccines and Sjögren's syndrome (2014) (4)
Autoantibodies for Cardiac Channels and Sudden Cardiac Death and its Relationship to Autoimmune Disorders (2018) (4)
Cannabidiol Treatment in a Murine Model of Systemic Lupus Erythematosus Accelerates Proteinuria Development. (2018) (4)
Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins (2001) (4)
[Prevalence of pterygium in Israel]. (1978) (4)
Molecular Mimicry: Lessons from Experimental Models of Systemic Lupus Erythematosus and Antiphospholipid Syndrome (2000) (4)
Scabies-associated angioimmunoblastic lymphadenopathy. (1986) (4)
Heart, rheumatism and autoimmunity: Milan, Italy. February 5-7, 2004. (2004) (4)
Primary biliary cirrhosis: increasing problem, approaching solution. (1992) (4)
Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater? (2018) (4)
[HLA and autoimmune diseases]. (1987) (4)
Silicone Breast Illness as a Classical Example of Autoimmune/Inflammatory Syndrome Induced by Adjuvant (ASIA). (2022) (4)
Treating inflammatory bowel disease: from helminths to ova. (2014) (4)
Eppur si muove (Galileo Galilei 1564-1642): the idiotypic dysregulation of autoantibodies as part of the etiology of SLE (2000) (4)
Gluten-free diet can ameliorate the symptoms of non-celiac autoimmune diseases. (2021) (4)
Autoimmunity: concepts and diagnosis at the cutting edge. Proceedings of the Fourth International Congress on Autoimmunity supported by the American Autoimmune Related Diseases Association and the Associazione Patologie Autoimmuni Internazionale. November 3-7, 2004. Budapest, Hungary. (2005) (4)
Erratum: Antiphospholipid syndrome (Nature reviews. Disease primers (2018) 4 (17103)) (2018) (4)
Idiotypic Induction of Autoimmune Diseases: A New Aspect of Infection and Autoimmunity (1994) (4)
Ageing, autoantigen specific-Ts cells, involution of the thymus, autoimmunity and autoimmune diseases. (1991) (4)
Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice. (2002) (4)
Pathogenic anti-DNA idiotype (16/6 Id) in systemic lupus erythematosus (2004) (4)
'Autoantibody dominance' pattern following idiotypic manipulation of naive mice by immunization with anti-U1RNP antibodies. (1997) (4)
Novel approaches to therapy for systemic lupus erythematosus: update 2005 (2005) (4)
The mosaic of autoimmunity – Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens (2022) (4)
[Breast silicone implant and autoimmunity--coincidence or cause and effect relationship?]. (1998) (4)
Frontiers in SLE: Review of the 5th International Congress of systemic Lupus Erythematosus. (1999) (4)
An idiopathic thrombocytopenic purpura with polyneuropathy (2017) (4)
Lack of Association between Anti-Phospholipid Antibodies (APLA) and Attention Deficit/Hyperactivity Disorder (ADHD) in Children (2003) (4)
[Lupus-like disease due to minocycline]. (2002) (4)
Atherosclerosis: Evidence for the Role of Autoimmunity (2001) (4)
Aspirin for prevention of myocardial infarction. A double-edged sword. (1997) (4)
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023. (2023) (4)
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience. (2021) (4)
[Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis]. (2003) (4)
Vaccines and Autoimmunity: Shoenfeld/Vaccines and Autoimmunity (2015) (4)
[Fibrotic diseases]. (2002) (4)
Tumor-Associated Disialylated Glycosphingolipid Antigen-Revealing Antibodies Found in Melanoma Patients' Immunoglobulin Repertoire Suggest a Two-Direction Regulation Mechanism Between Immune B Cells and the Tumor (2019) (4)
Autoimmunity in the Brain (2007) (4)
Immunointerventions in experimental model for antiphospholipid syndrome. (1996) (4)
Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spouses. (1996) (4)
Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS. (2000) (4)
The Lancet against Israel. (2013) (4)
[The role of ultraviolet light, and sun and fluorescent light, in the pathogenesis of systemic lupus erythematosus]. (1998) (4)
Primary biliary cirrhosis--association or overlap with other autoimmune diseases. (1997) (4)
Retracted: Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro. (2017) (4)
The mosaic of schizophrenia: has the time arrived to monitor the illness with biomarkers? (2008) (4)
New experimental autoimmune models. (1989) (4)
Surgery in patients with hepatitis. (1981) (4)
Coma with triphasic wave pattern in EEG as a complication of temporal arteritis (1992) (4)
Orthostatic hypotension in amputees and subjects with spinal cord injuries. (1978) (4)
Lipids and Immunity (2001) (4)
Idiotypes and Anti-Idiotypes (2014) (4)
P0574 AUTOIMMUNE THYROID DISEASE AND AUTOIMMUNE RHEUMATIC DISORDERS (2009) (4)
THE EFFECT OF SALT LOADING DIET ON THE INTRAOCULAR PRESSURE (1982) (4)
Borderline positive antineutrophil cytoplasmic antibodies (ANCA)-PR3/MPO detection in a large cohort tertiary center: lessons learnt from a real-life experience (2018) (4)
[THE ENVIRONMENT AND AUTOIMMUNE DISEASES]. (2015) (4)
Gender influences SLE-immune cells, genetics, experimental models and lupus patients. (2010) (4)
Application of a Static Fluorescence-based Cytometer (the CellScan) in Basic Cytometric Studies, Clinical Pharmacology, Oncology and Clinical Immunology (2005) (4)
INTRAVENOUS IMMUNOGLOBULIN ( IVIg ) AS AN INHIBITOR OF TUMOUR GROWTH : FROM AUTOIMMUNITY TO CANCER (2003) (4)
Infections and Autoimmune Diseases: An Interplay of Pathogenic and Protective Links (2015) (4)
Crohn's disease-specific anti-CUZD1 pancreatic antibodies are absent in ruminants with paratuberculosis. (2015) (4)
Application of a Static Fluorescence-Based Cytometer: The Cellscan in Clinical Immunology (2006) (3)
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins. (2013) (3)
Nucleosomes, DNA and SLE: where is the starting point? (1996) (3)
Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients (2003) (3)
Recurrent Pericarditis: Is Immunotherapy the Answer? (2018) (3)
Salazopyrine-induced tachycardia. (1980) (3)
[CA 15-3--a tumor marker in breast cancer]. (1993) (3)
Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. (2022) (3)
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children’s Outcome (2021) (3)
Helminth-Related Tuftsin-Phosphorylcholine Compound and its Interplay with Autoimmune Diseases. (2019) (3)
Systematic Review and Meta-Analysis of Case-Control Studies from 7,000 COVID-19 Pneumonia Patients Suggests a Beneficial Impact of Tocilizumab with Benefit Most Evident in Non-Corticosteroid Exposed Subjects. (2020) (3)
Identification and characterization of antimitochondrial autoantibodies in sera of patients with monoclonal gammopathies. (1995) (3)
[Playing with fire...]. (1996) (3)
The Putative Adverse Effects of Bisphenol A on Autoimmune Diseases. (2021) (3)
Annular, semicircular lipoatrophy of the thighs associated with incomplete "CREST" syndrome: Raynaud's, telangiectasias, and esophageal dysmotility. (2003) (3)
Refractory disease in autoimmune diseases. (2011) (3)
Casual blood pressure: its relationship to several cardiovascular risk factors in middle-aged men. (1984) (3)
Galactorrhea Following Silicone Breast Implant Placement (2019) (3)
[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases]. (2015) (3)
Algorithm for antinuclear antibodies in subjects with clinical suspicion of autoimmune diseases. (2019) (3)
Obesity in Autoimmune Diseases (2019) (3)
Aspirin-induced aplastic anaemia. (1979) (3)
Helminths and autoimmunity: the good, the bad and the ugly. (2015) (3)
Antiphospholipid antibody testing – slow progress? (2012) (3)
The mirabilis period of autoimmunity. (2012) (3)
[Hyperviscosity syndrome in plasma cell dyscrasia]. (1979) (3)
Transient mixed cryoglobulinemia associated with typhoid hepatitis. (1980) (3)
HLA Antigens in Genetic Neutropenia of Yemenite Jews (1979) (3)
Naturally-occurring tumor-reactive autoantibodies: a monoclonal antibody from normal mice reacts with tumor cells and with DNA. (1988) (3)
Natural Autoantibodies—Homeostasis, Autoimmunity, and Therapeutic Potential (2014) (3)
[Phenomena associated with sympathectomy following hyperhidrosis]. (1976) (3)
The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus. (1996) (3)
The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches, 1st edition. (2017) (3)
[CA 125 in diagnosis and prognosis of epithelial ovarian cancer]. (1994) (3)
The relationship between the lupus anticoagulant, anticardiolipin antibodies and antiphospholipid antibodies. (1992) (3)
Etanercept-Induced Pneumonitis: Severe Complication of Tumor Necrosis Factor-Alpha Blocker Treatment. (2015) (3)
Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome (2021) (3)
Serum glucose and lactic acid concentrations during prolonged and strenuous exercise in man. (1977) (3)
Leucocytoclastic vasculitis after coronary bypass artery grafting (1996) (3)
The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens (2022) (3)
Cannabis and Autoimmunity - The Neurologic Perspective: A Brief Review (2016) (3)
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy (2020) (3)
Review : Modulation of experimental systemic lupus erythematosus with linomide (1996) (3)
Antigens Recognized by Sera from Patients with Visceral Leishmaniasis (1989) (3)
[The autoimmunologist: a profession being created]. (2009) (3)
Aspirin, interleukin-3 and the antiphospholipid syndrome. (1996) (3)
Intravenous immunoglobulin (2005) (3)
Introduction–Idiotypes and Anti-Idiotypes (1997) (3)
Autoimmune hepatitis: a part of the antiphospholipid syndrome? (2005) (3)
Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases (2015) (3)
Warfarin treatment during pregnancy in patients with prosthetic mitral valves. (1981) (3)
[Post-infectious clinical-immunological syndrome and its place in clinical practice]. (2009) (3)
Antibodies Against Acute Phase Proteins (2014) (3)
[Activation of B-lymphocytes]. (1976) (3)
[Cachexia, malignancy and tumor necrosis factor alpha (TNF-alpha)]. (2007) (3)
Association Between Autoantibodies and Neuropsychiatric Manifestations of Autoimmune Disease: Comment on the Article by Lauvsnes et al (2015) (3)
Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies. (1997) (3)
Intravenouse immunoglobuline in dysautonomia. (2022) (3)
Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome (2022) (3)
“APS pregnancy – The offspring” (2020) (3)
Familial studies on the occurrence of natural autoantibodies. (1989) (3)
[Recurrent gastrointestinal bleeding associated with aortic stenosis]. (1978) (2)
Natural autoimmunity in physiology and pathology 1st Moscow International Conference Moscow, Russia, September 15–17, 2005 (2006) (2)
The analyses of common idiotypes of human monoclonal anti-DNA autoantibodies in SLE and related conditions (1986) (2)
[Infectious agents and atherosclerosis]. (1998) (2)
Novel antiphospholipid antibodies in autoimmune bullous diseases. (2014) (2)
Vitamin D and the Immune System. (2017) (2)
The Influence of Different Cultivating Conditions on Polymorphonuclear Leukocyte Apoptotic Process In Vitro, II: Ultrastructural Characteristics of PMN Populations Incubated with Proteinase 3 Anti-neutrophil Autoantibodies (2005) (2)
The games go on: British Medical Journals play politics, again. (2012) (2)
Progestogens and Autoimmunity (2021) (2)
AB0459 IMMUNOGLOBULINS COMBINED WITH STANDARD THERAPIES FOR THE PREVENTION OF RELAPSES IN REFRACTORY OBSTETRICAL ANTIPHOSPHOLIPID SYNDROME: A SERIES OF 103 CASES (2019) (2)
Positive Anti-GABAB Receptor Antibodies in a Patient with Hashimoto’s Thyroiditis and Bipolar Affective Disorder (2021) (2)
[Post-infection clinico-immunologic syndrome: fundamentals of etiopathogenesis and immunogenodiagnostic strategy]. (2009) (2)
Anti-cardiolipin antibody from a patient with antiphospholipid syndrome ( APS ) recognizes only an epitope expressed by cardio-lipin / 2-glycoprotein-I ( 2 GPI ) complex and induces APS (2006) (2)
Clinical application of static fluorescence‐based cytometry, Cellscan, in cutaneous adverse drug reaction (2011) (2)
[Neonatal lupus erythematosus--cardiac manifestations and atrio-ventricular conduction block]. (2007) (2)
[Recurrent avascular bone necrosis in systemic lupus]. (1989) (2)
Radioimmunodetection of tumors with monoclonal antiplacental ferritin antibody: preliminary results. (1989) (2)
Hepatitis B Vaccination and Autoimmunity (2015) (2)
[Relapse of sarcoidosis after alternative medical treatment]. (1999) (2)
[Silicone implants for breast augmentation and autoimmune disease]. (1993) (2)
Current treatment strategies for management of antiphospholipid syndrome (2014) (2)
A Focus on Anti-Tyrosinase Antibodies in Melanoma and Vitiligo (1999) (2)
Anticitrullinated Protein Antibodies Induce Inflammatory Gene Expression Profile in Peripheral Blood Cells from CCP–positive Patients with RA (2018) (2)
[A hundred years of medical research in Israel]. (2013) (2)
THU0304 Adherence To Hydroxychloroquine as Assessed by Measurements of Drug and Metabolite Blood Levels in An International Prospective Study of Sle Patients in Flare (2016) (2)
Smell and Autoimmunity—State of the Art (2019) (2)
[The murine mammary tumor virus (MuMTV) and the association with breast cancer]. (1985) (2)
Vaccination, atherosclerosis and systemic lupus erythematosus (2009) (2)
[Septic arthritis in an HIV-positive hemophiliac]. (1996) (2)
Anti-ribosomal P antibody in schizophrenia. (2011) (2)
[Medicine and intercessory prayer]. (2002) (2)
10 – IDIOTYPES AND ANTI-IDIOTYPES (2007) (2)
Lipid Replacement Therapy: Is it a New Approach in Patients with Chronic Fatigue Syndrome? (2014) (2)
Erratum to Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages (2008) (2)
Morphological platelet anomalies in thrombotic thrombocytopenic purpura. (1982) (2)
[Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants]. (1998) (2)
Bovine Milk Proteins as a Trigger for Autoimmune Diseases: Myth or Reality? (2020) (2)
1.P.110 Induction of early atherosclerosis in LDL-receptor deficient mice immunized with beta 2 glycoprotein I (1997) (2)
The Role of Plastics in the Spectrum of Autoimmune Disease—Bisphenol A (2019) (2)
Molecular mimicry: lessons from an experimental model of antiphospholipid syndrome in naive mice. (2000) (2)
Cancer and Autoimmune Diseases (2019) (2)
Chapter 12 Molecular and immunological evidence for SARS-CoV-2 being the autoimmune virus (2023) (2)
Air flights and venous thromboembolism--a preventable condition. (2002) (2)
Neurologic Manifestations of Autoimmune Diseases (2012) (2)
[Multiple sclerosis and anti-phospholipid syndrome--one or two diseases?]. (2004) (2)
Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus (2020) (2)
Diabolical, haunting terror--here and now. (2002) (2)
[Cerebral infarction in Crohn's disease]. (1995) (2)
Microangiopathic antiphospholipid antibody-associated syndromes: a tribute to Ronald Asherson. (2008) (2)
Cytokines in Autoimmunity (1999) (2)
The microbiome of the lung. (2013) (2)
Depressed PHA transformation and acute leukemia in macroglobulinemia. (1979) (2)
Systemic lupus erythematosus associated with mixed cryoglobulinaemia and circulating anticoagulant. (1978) (2)
The Role of Intravenous Immunoglobulins in the Management of Acute Complex Autoimmune Conditions (2011) (2)
Human papillomavirus vaccine safety in systemic lupus erythematosus patients (2020) (2)
7th International Immunoglobulin Conference: Immunomodulation (2014) (2)
12 – Anti-DNA Antibodies: Is DNA the Self Antigen or a Shelf Antigen, or are all Autoimmune Diseases Immunogen Driven? (1997) (2)
Effect of tumor necrosis factor alpha inhibition on CD28 surface expression on CD4+ T cells. (2006) (2)
[The clinical significance of IgA deficiency]. (1988) (2)
Chorea: rare expression of neuropsychiatric manifestation of systemic lupus erythematosus. (1989) (2)
Idiotypic induction of autoimmunity. (1998) (2)
A6.13 Effects of anti-tnf therapy on circulating oxLDL-BETA2GPI complex levels in arthritis (2015) (2)
How to outfox mother nature--autoimmunity: moving from shadows to sunshine. (2000) (2)
The pathogenic role of circulating Hashimoto's Thyroiditis‐derived TPO‐positive IgG on fetal loss in naïve mice (2020) (2)
[The association of infecting agents and autoimmune diseases]. (1987) (2)
The beneficial effects of statins in autoimmune disease therapy. (2007) (2)
Apoptosis and its association with autoimmunity (1995) (2)
The significance of HLA studies in human-human hybridomas. (1988) (2)
Prevalence of anti-DFS 70 antibodies in patients with and without systemic autoimmune rheumatic diseases (2018) (2)
Magnesium fortification of water. A possible step forward in preventive medicine? (1997) (2)
Autoantibodies in angioneurotic edema (1998) (2)
Hyperstimulation of the immune system as a cause of autoimmune diseases (2020) (2)
[Ocular manifestations in the antiphospholipid syndrome]. (1999) (2)
The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stress (2010) (2)
Antimyocardial Autoantibodies (AMCA) (2014) (2)
[Physiologic pigmentation of the gingiva]. (1976) (2)
C-reactive protein in traditional melanesians on Kitava (2020) (2)
Innate immunity, inflammation and atherogenesis (2003) (2)
Short term effect of high dose insulin on thymic morphology of ICR female mice (1997) (2)
Tattoo as a Possible Trigger for Autoimmune Syndrome Induced by Adjuvants (2021) (2)
The tellurium‐based immunomodulator, AS101 ameliorates adjuvant‐induced arthritis in rats (2020) (2)
Book Review: Hughes Syndrome: Antiphospholipid Syndrome (2001) (2)
In response to comment on “Autoimmune post‑COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?” by Jara LJ et al (2022) (2)
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19 (2022) (2)
Sjögren’s Syndrome Associated with Chikungunya Infection: A Case Report (2021) (2)
[Is it possible to predict and prevent primary biliary cirrhosis?]. (1999) (2)
34 - Parsitic Infection and Autoimmunity (2004) (2)
Omental cake in a male. (2003) (2)
Alternative therapies in rheumatic diseases—pros and cons (2001) (2)
Drug-Induced Autoimmunity (2019) (2)
Atherosclerosis (2002) (2)
Anti-Idiotypic Therapy in Autoimmunity (2000) (2)
Fatal peripheral neurolymphomatosis (1984) (2)
Primary biliary cirrhosis: Lymphocyte subsets and function in a time frame (1989) (2)
Authors' Reply: Human Papilloma Virus Vaccine and Primary Ovarian Failure (2014) (2)
Cannabis sativa as a Potential Treatment for Systemic Sclerosis. (2019) (2)
Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome (2022) (2)
Cardiac arrest following HPV Vaccination (2019) (2)
Bisphenol A as a Factor in the Mosaic of Autoimmunity. (2021) (2)
[Mosaic of Autoimmunity- the Novel Factors of Autoimmune Diseases Revisited]. (2020) (2)
Introduction: Autoimmunity as an Additional ‘Risk Factor’ for Atherosclerosis (2001) (2)
Introduction: The Immune System, the Autoimmune State and Autoimmune Disease (2000) (2)
Changes in the T‐wave of the electrocardiograph in urticaria (1974) (2)
The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome (2023) (2)
[Why viral (SARS, Ebola and AIDS) epidemics now?]. (2003) (2)
[Schizophrenia--an autoimmune disease?]. (1997) (2)
High frequency of vitamin D insufficiency in polymyalgia rheumatica and giant cell arteritis: preliminary results. (2021) (2)
Successful treatment with recombinant alpha 2 beta interferon for refractory idiopathic thrombocytopenic purpura. (1992) (2)
From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of (2007) (2)
Can laboratory evaluation differentiate between coronavirus disease-2019, influenza, and respiratory syncytial virus infections? A retrospective cohort study (2021) (2)
Primary biliary cirrhosis (1998) (2)
[Chronic stimulation of the immune system in sarcoidosis and monoclonal gammopathy of undetermined significance]. (2009) (2)
Elevated titers of anti-ribosomal-P antibodies in systemic lupus erythematosus (2005) (2)
Cutting edge issues in allergy and clinical immunology. (2007) (2)
Superantigens and experimental SLE induced by idiotypic dysregulation. (1996) (2)
Efficacy and survival of golimumab with and without methotrexate in patients with psoriatic arthritis: A retrospective study from daily clinical practice. (2018) (2)
[Fading into extinction?]. (2002) (2)
Absence of predictive parameters for CNS involvement in adult non-lymphocytic leukaemia at time of diagnosis. (2009) (2)
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground? (2022) (2)
Anti-DFS70 among HIV-positive individuals - A prospective study. (2018) (2)
Evaluation of Assisted Reproductive Technologies outcomes in women with antithyroid autoantibodies (2021) (2)
Role of Adjuvants in Infection and Autoimmunity (2015) (2)
Severe in an elderly man (1996) (2)
[Sauna and its influence on the human body]. (1977) (2)
7th International Immunoglobulin Conference: Immunomodulation (2014) (2)
The biology of symptom-based disorders - Time to act. (2022) (2)
15 - Parvovirus B19 Infection and its Association to Autoimmune Disease (2004) (2)
Catalytic antibodies. Structure and possible applications. (1995) (2)
Serum Alpha Fetal Protein in a Three Year Old Child with Hepatoma 1 (1976) (2)
[Use of English in French scientific publications]. (1994) (2)
Infections and autoimmunity -new insights into an age-old reciprocity. (2018) (2)
Infection and Autoimmunity, 2nd edition (2004) (2)
Animal Models of Vasculitides (2008) (2)
BMC medicine editorial board members on open access publishing (2014) (1)
Inappropriate anti-diuretic hormone (ADH) secretion in a patient with extensive fibrothorax. (1980) (1)
Systemic Involvement in the Antiphospholipid Syndrome (2002) (1)
The effect of exposure to heat on intraocular pressure (1979) (1)
Corrigendum to 'The role of dietary sodium in autoimmune diseases: The salty truth' [AUTREV 17-11 (2018) 1069-1073]. (2019) (1)
[Sex hormones and autoimmune diseases]. (1987) (1)
Intravenous Immunoglobulin for Inflammatory Myositis (2020) (1)
Anti-PTX3: are they real? (2008) (1)
Aneurysms in primary antiphospholipid syndrome: a case-based review (2021) (1)
Vitamin D and Immune System Function in Patients with COVID-19. (2022) (1)
Original Article Gastrointestinal-associated autoantibodies in different autoimmune diseases (2012) (1)
Cytokines, antibodies to cytokines and autoimmunity. (1998) (1)
Chapter 27 – Antiribosomal P Antibodies (2014) (1)
Antiphospholipid Antibodies in Human and Murine Atherosclerosis (2002) (1)
Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease (2014) (1)
Sjögren syndrome associated with protein-losing enteropathy: case-based review (2020) (1)
Aerobic work capacity in high school students in Israel. (1977) (1)
Magnesium fortifecation of drinking water suppresses atherogenesis in male LDL-receptor knockout mice (1999) (1)
Cholera vaccines: not live. (2011) (1)
Retracted: Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro. (2017) (1)
Authors’ reply: Human papillomavirus vaccine and primary ovarian failure (2014) (1)
[The family of metalloproteinases and their immunomodulatory significance]. (2002) (1)
PR3-ANCA vasculitis as manifestation of ASIA syndrome following aesthetic breast augmentation: a new kid on the block? (2022) (1)
[Dermatological manifestations in the antiphospholipid syndrome]. (2005) (1)
[The department of internal medicine--returned to its formal glory]. (2001) (1)
The story of the murine antiendothelial monoclonal antibody BGM (2000) (1)
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity (2023) (1)
Aerobic work capacity in high school students in the "Kibutz" (communal settlement) in Israel. (1978) (1)
Can Gender Reassignment Surgery Modulate the Risk of Development of Autoimmune Diseases? (2022) (1)
Immunological Issues in Y2K (2000) (1)
[Partnership in Healthcare - The patient, the caregiver and the bridge between them]. (2020) (1)
No correlation between anti-prothrombin antibodies and pregnancy loss in experimental model (2000) (1)
The Smell in COVID-19 Infection: Diagnostic Opportunities. (2020) (1)
Autoimmunity and the endocrine system: Adrenal, Graves' disease, immune checkpoint. (2020) (1)
Cancer Therapy with Anti-Idiotypic Antibodies (1997) (1)
[Has schizophrenia an immunologic basis]. (1991) (1)
4P-1093 Endothelial dysfunction in young rheumatoid arthritis patients with low disease activity (2003) (1)
Erratum to “Intravenous immunoglobulin-indications and mechanisms in cardiovascular diseases” [Journal of Autoimmunity Reviews 7(6) (2008) 445-452] (2010) (1)
Sjögren’s Syndrome and Environmental Factors (2016) (1)
The forefront of autoimmunity. (2018) (1)
Breastfeeding in the systemic lupus erythematosus patient (2019) (1)
Immunomodulation of Experimental Antiphospholipid Syndrome: Lessons from Murine Models (1999) (1)
The risks behind the widespread use of siliconized syringes in the healthcare practice (2021) (1)
Basic principles and new diagnostic tools (2007) (1)
COVID‐19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age‐associated B cells (2022) (1)
The coexistence of familial Mediterranean fever (FMF) in systemic lupus erythematosus (SLE) patients – A cross sectional study (2021) (1)
Rituximab in SLE (2012) (1)
Modifiable contributing factors to COVID-19: A comprehensive review (2022) (1)
Fourth autoimmunity meeting--Noel Rose day. 25 January 1990, Tel-Hashomer, Israel. Proceedings. (1990) (1)
Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease (2021) (1)
[Autoimmune diseases in pregnancy]. (1986) (1)
[Autoimmune or autoinflammatory syndromes induced by adjuvants]. (2012) (1)
Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants (1998) (1)
Relapsing polychondritis associated with heart block. (2021) (1)
Immune tolerance as a strategy for treatment of atherosclerosis (2005) (1)
Immunoglobulin secretion of mononuclear cells induced by various mitogens. (1988) (1)
Early Recognition Of Acutely Deteriorating Patients In Non- Intensive Care Unit Setting: Assessment Of An Innovative Monitoring Technology (2011) (1)
[Bone marrow transplantation for severe autoimmune diseases--treatment of choice or a treatment of no choice?]. (1998) (1)
[COVID-19 - 2019]. (2020) (1)
Human Monoclonal Antibodies Directed Against HuMTV Antigens from Human Breast Cancer Cells (1986) (1)
Dysautonomia Following Tetanus, Diphtheria, and Pertussis Vaccine (Tdap): The First Case of Extreme Cachexia Caused by Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA Syndrome) in a Human. (2021) (1)
Guillain-Barré and Other Immune-Mediated Neuropathies (2008) (1)
[Clinical significance of antibodies to Ro (SSA) and La (SSB)]. (1988) (1)
Entering a great period in autoimmunity (2006) (1)
Psychological Stress and the Kaleidoscope of Autoimmune Diseases (2019) (1)
Autoimmune Autonomic Dysfunction Syndromes: Potential Involvement and Pathophysiology Related to Complex Regional Pain Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Silicone Breast Implant–Related Symptoms and Post-COVID Syndrome (2022) (1)
Pneumococcal Vaccines and Autoimmune Phenomena (2015) (1)
[Autoantibodies to cytoskeleton in autoimmune disease]. (1984) (1)
Pulmonary Hypertension in a Patient with Marian’s Syndrome (1981) (1)
[Prolactin and bromocriptine in rheumatic and autoimmune diseases]. (1993) (1)
Is GVHD a model of PBC? Characterization of autoantibodies in GVHD (1998) (1)
Anti-Inflammatory Therapeutic Approaches (2012) (1)
Introduction to the special issue on the 9th International Congress on Autoimmunity (2014) (1)
Neuropsychiatric manifestations of systemic lupus erythematosus — A primary disease manifestation (2009) (1)
Idiotypic induction of autoimmunity: a new classification of autoimmune diseases. (1994) (1)
Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels (2004) (1)
[Libman-Sacks endocarditis--a jubilee year]. (1997) (1)
[Hybridomas: a potent new biotechnology; the production and the use of monoclonal antibodies]. (1982) (1)
Novel applications of basic research (2007) (1)
COVID-19 as part of the hyperferritinemic syndromes: is there a role for iron depletion therapy? (2020) (1)
Acknowledgment to reviewers (2013) (1)
Pathogenic anti-endothelial cell antibodies: classification to anti-microvascular EC and anti-macrovascular EC antibodies. (2000) (1)
Preface (2009) (1)
Is cancer an autoimmune process dependent on anti-apoptotic autoantibodies? (2000) (1)
ON THE PATHOGENESIS OF PSYCHIC DISORDERS IN HASHIMOTO'S THYROIDITIS (2018) (1)
Autoimmune diseases and treatment: Organ-specific and systemic disorders. Foreword (2005) (1)
Editorial: Reshaping the Mosaic of Autoimmunity (2006) (1)
All Magic Comes with a Price: A Case of Henoch-Schönlein Purpura Post-influenza Vaccination. (2020) (1)
Finger Gangrene in an SLE Patient (1995) (1)
[The erythrocyte sedimentation rate in modern medicine]. (1991) (1)
[The mosaic of pemphigus]. (2001) (1)
Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms (2014) (1)
Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the ‘autoimmune (auto-inflammatory) syndrome induced by adjuvants’ (ASIA) (2014) (1)
Whither Autoimmunity: The Lessons of Anti-CCP and B cell Depletion (2008) (1)
What is the Origin of Antiphospholipid Antibodies (2012) (1)
Antiphospholipid Syndrome and Antibodies (2014) (1)
Measles, Mumps, and Rubella Vaccine: A Triad to Autoimmunity (2015) (1)
"Broken heart syndrome" (Takotsubo cardiomyopathy). (2011) (1)
Comment on: Dietary yeast reduce inflammation in central nerve system via microflora (2015) (1)
Editorial for “Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form” (2023) (1)
Small Fiber Neuropathy in Pulmonary Sarcoidosis and Tuberculosis: Clinical and Histological Correlates (2020) (1)
Interrelation of auto-immune process, endocrine disorders and depression (2020) (1)
Bone pains in chronic myelomonocytic leukaemia, treated by cytosine arabinoside. (1978) (1)
Antiphospholipid Antibodies and Their Relationship With Infections, Vaccines, and Drugs (2017) (1)
Antibody targeting of phosphatidylserine for detection and immunotherapy of cancer (2018) (1)
Immunologist's Little Dirty Secret Finger: A Case Report of Polyautoimmunity Following an Accidental Self-injection of Complete Freund's Adjuvant. (2020) (1)
Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. (2022) (1)
Alpha-fetoprotein assay. Significance and clinical applications. (1975) (1)
SP0150 “Asia” – Autoimmune (Auto-inflammatory) Syndromes Induced by Adjuvants (2016) (1)
[Medicine in the digital era: the future is already here]. (2013) (1)
AB0287 Decrease in 14–3–3eta protein levels is correlated with improvement of clinical disease activity in tofacitinib treated early rheumatoid arthritis patients (2018) (1)
Autoantibodies: Third Edition (2013) (1)
Antiphospholipid Syndrome as a Neurological Disease (2010) (1)
[Kaleidoscopic autoimmunity]. (1998) (1)
Prof. Shoenfeld refers to Dr. Helen Petousis-Harris’ attack on Dr. Manuel Martinez-Lavin’s article. Clin Rheumatol 2016; 35: 833–834 (2016) (1)
Idiotypes of Anti-DNA Antibodies (1997) (1)
Ageing and autoimmunity: lessons learnt from the presence of autoantibodies in patients with malignant conditions (1991) (1)
[Fulminant hepatic failure due to hepatitis A]. (1989) (1)
Systemic Sclerosis Sine Scleroderma After Silicone Breast Implants. (2020) (1)
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium. (2023) (1)
Corrigendum to “The mosaic of autoimmunity - A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual” [Autoimmunity Reviews, Volume 20 (2021) 102945] (2022) (1)
Vitamin B12 and primary antiphospholipid syndrome (2021) (1)
INTRAVENOUS IMMUNOGLOBULIN ( IVIg ) IN AUTOIMMUNE DISEASES – EXPANDING INDICATIONS AND INCREASING SPECIFICITY (2003) (1)
Severe anemia diagnosed on computed tomography. (2006) (1)
[Basic research during residency in Israel: is change needed?]. (2013) (1)
Infection , Tumors and Autoimmunity (2013) (1)
The mosaic of SLE-II: highlights of the fourth international conference on systemic lupus erythematosus—March 1995 (1995) (1)
[Congenital ectodermal dysplasia]. (1976) (1)
'ASIA'- Autoimmune (Auto-inflammatory) syndromes induced by adjuvants (2014) (1)
New treatment avenues: oral tolerance--mechanisms and applicability to human diseases. (1999) (1)
Speaker Abstracts (SP01–SP50) (2012) (1)
[SILICONE BREAST IMPLANTS - HISTORICAL MEDICAL ERROR]. (2020) (1)
[Clinical aspects of the antiphospholipid antibody syndrome]. (1991) (1)
[A new reality--epidemiology of terror]. (2001) (1)
Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment (2021) (1)
[Harnessing nature for treating infectious and autoimmune diseases: good and bad bacteria]. (2013) (1)
Chapter 71 – Sweat studies in patients with palmar and plantar hyperhidrosis (1977) (1)
1.P.86 Accelerated early atherogenesis in C57BL/6J mice immunized with mycobacterium tuberculosis (1997) (1)
Prolactin and the Mosaic of Autoimmunity (2019) (1)
[Primary subclavian vein thrombosis after intensive physical exertion]. (1997) (1)
Leprosy and Autoimmunity (2015) (1)
Eighth international workshop on autoantibodies and autoimmunity Berlin, Germany, 10-13 September, 2003. (2004) (1)
Spontaneous remission of erythroleukemia following interstitial pneumonia. (1981) (1)
Anti-Glomerular Basement Membrane Antibody Diagnostics in a Large Cohort Tertiary Center: Should We Trust Serological Findings? (2017) (1)
Anti-MDA5 Positive Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease and Correlation between Serum Ferritin Level and Treatment Response (2020) (1)
[Coffee drinking and myocardial infarction]. (1977) (1)
Corrigendum to "Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in naïve mice" [J. Autoimmun. 54C (2014) 118-126]. (2016) (1)
Anti-serum amyloid component P (SAP) antibodies in SLE patients correlate with disease activity Category-Extended report (2005) (1)
Japanese-type apical hypertrophic cardiomyopathy. (2009) (1)
[Consensus: diagnostic criteria for Sjogren's syndrome]. (1994) (1)
Legionella-induced Sudden Hearing Loss: a Rare Complication (2009) (1)
[Mass casualty events during night shifts in the internal medicine departments]. (2001) (1)
Tests for syphilis in patients with sle. (1977) (1)
Systemic Lupus Erythematosus and the Environment (2016) (1)
Autoantibodies--antigen driven or idiotypically induced. (1998) (1)
Idiopathic mixed cryoglobulinemia in two sisters. (1981) (1)
Anti-Inflammatory Effects of Intravenous Immunoglobulin (1999) (1)
[Smoking, sex hormones and rheumatoid arthritis: update and developments]. (2000) (1)
Rheumatology in Israel. (1996) (1)
[IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS (ICPI) AND IMMUNE RELATED ADVERSE EVENTS (IRAE'S)]. (2020) (1)
The Production of Monoclonal Antibodies by Human—Human Hybridomas (1985) (1)
[Q fever endocarditis and bicuspid aortic valve]. (1997) (1)
416 Big data in systemic lupus erythematosus: phenotypic disease expression of 171,000 adult patients (2017) (1)
Infl uenza vaccination and Guillain-Barré syndrome (2014) (1)
prospective study of 1,000 patients syndrome during a 5-year period: a multicenter Morbidity and mortality in the antiphospholipid (2009) (1)
15th International Congress on Antiphospholipid Antibodies Task Force on Catastrophic Antiphospholipid Syndrome Report (2017) (1)
[ETIOLOGIES OF EXTREME HYPERFERRITINEMIA - ANALYSIS OF A LARGE DATABASE]. (2021) (1)
[The antiphospholipid syndrome and myocardial infarction in young people]. (1993) (1)
Idiotypes of Anti-Ro and Anti-La (1997) (1)
ASIA Induced by Adjuvant Associated with a Metal Implant in the Mouth: A Response. (2021) (1)
Autoantibodies linked to autoimmune diseases associate with COVID-19 outcomes (2022) (1)
Pregnancy and antiphospholipid syndrome. A report and relevant abstracts from the 4th International Conference on Systemic Lupus Erythematosis, Jerusalem, March 1995. (1996) (1)
[Autoimmune disease of the eye]. (1988) (1)
Autoantibodies to brain lipids among patients with schizophrenia: A lasting puzzle (1991) (1)
The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti-β2GPI antibodies induced by common bacteria (2003) (1)
The mosaic of autoimmunity. (2001) (1)
[Anti-endothelial cell antibodies--clinical significance]. (1997) (1)
Corrigendum to "Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects" [J. Autoimmun. 47C (2013) 1-16]. (2016) (1)
The Protective Role of Helminths in Autoimmunity (2015) (1)
SARS-CoV-2 infection induces the production of autoantibodies in severe COVID-19 patients in an age-dependent manner (2022) (1)
Morphea Sculpted in Silica: A Case Report of Limited Cutaneous Systemic Sclerosis in a Woman with Long-Time Exposure to Silica Dust. (2017) (1)
[Internal medicine 2007--where do we stand? To expand or to reduce?]. (2007) (1)
Contemporary challenges in autoimmunity (2009) (1)
[Internal medicine in the third millennium--where is it going? I accuse!]. (2000) (1)
Bacillus Calmette-Guerin (BCG) as a Protective Factor for COVID-19? (2020) (1)
PSS (Scleroderma) and Cancer (2000) (1)
Autoinflammation and autoimmunity: pathogenic, clinical, diagnostic and therapeutic aspects. (2014) (1)
[Placebo use in clinical studies]. (2010) (1)
[Hypophosphatemia as a prognostic measure of evaluation]. (2006) (1)
Atherogenic role of protein-modified oxidized low-density lipoproteins and related autoantibodies (2004) (1)
[Antinuclear autoantibodies in pregnancy]. (1988) (0)
[Tumors of the urinary bladder and the immunological system]. (1978) (0)
[Should one perform renal biopsy in the elderly in nephrotic syndrome?]. (1998) (0)
[Disturbances in the immunological mechanism and development of malignancy]. (1976) (0)
Uric acid levels in primary antiphospholipid syndrome (2021) (0)
Identification of autoimmune markers in pulmonary tuberculosis (2023) (0)
Neutropenia of Negroes. (2009) (0)
[Parasites and autoimmunity]. (1991) (0)
Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases (2013) (0)
Melanoma Bridge 2013: Poster and Oral Presentations (2014) (0)
Oxidized Autoantigens in Atherosclerosis (2001) (0)
[Captopril--new additional applications]. (1990) (0)
[Harefuah peer review]. (2001) (0)
[Drug induced lupus erythematosus]. (1983) (0)
Classic Pityriasis Rosea. (2022) (0)
SAT0300 High proportions of dementia among sle patients: a big data analysis (2017) (0)
[Early detection of bone marrow micrometastases]. (1994) (0)
[Severe fatal shock after syncope in an old man]. (1996) (0)
[Raynaud's phenomenon: can we predict systemic disease?]. (1991) (0)
Helminthes and autoimmune diseases: Phosphorylcholin-tuftsin (TPC) conjugates attenuate clinical score and inflammation in three autoimmune mouse models (2015) (0)
[Antiphospholipid syndrome and vasculitis--just a coincidence?]. (1998) (0)
The hepatitis B vaccine and autoimmune/inflammatory syndrome induced by adjuvants: Relationship with Saccharomyces cerevisiae (2014) (0)
THE ANTIPHOSPHOLIPID SYNDROME. II: AUTOIMMUNE (2003) (0)
THU0342 Utilizing “real life” data in order to evaluate the association between giant cell arteritis and autoimmune thyroid disease (2017) (0)
Cytokines in the Antiphospholipid Syndrome (2018) (0)
[Is the lupus band test specific for systemic lupus erythematosus?]. (1987) (0)
[Anti-RA33 antibodies in various autoimmune diseases]. (2000) (0)
Autoimmune and Connective Tissue Disorders (2017) (0)
Origin of Antiphospholipid Antibodies (2017) (0)
T-cell-helper factors in autoimmunity. (1988) (0)
SARS-CoV-2 infection provoking autoimmunity (2023) (0)
The Influence of Tissue-Specific Glucocorticoid System on the Inflammatory Microenviroment: A Mini-Review (2015) (0)
[Errors in blood pressure recording]. (1982) (0)
1 Role of Adjuvants in Infection and Autoimmunity (2015) (0)
A new technique for the purification of Fc-gamma receptors II and III (1994) (0)
Erratum to: A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist’s office (2016) (0)
Contents, Vol. Ill, 1996 (1996) (0)
Soluble vascular biomarkers in rheumatoid arthritis and ankylosing spondylitis: effects of one-year anti-TNF-α therapy (2020) (0)
Vasculitides—Miscellaneous Vasculitides (2004) (0)
Tuftsin phosphorylcholine—a novel compound harnessing helminths to fight autoimmunity (2018) (0)
[Prostacyclin--its function and indications for therapeutic use]. (2000) (0)
THU0181 SOLUBLE VASCULAR BIOMARKERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: EFFECTS OF ONE-YEAR ANTI-TNF-Α THERAPY (2020) (0)
Idiotypes of Platelet Associated Antibodies (Autoimmune Thrombocytopenia) (1997) (0)
Comprar Contemporary Challenges in Autoimmunity | Harold Ellis | 9781573317627 | Wiley (2009) (0)
Ceramide pathway and Apoptosis in Autoimmunity and Atherosclerosis (2001) (0)
[Clinical significance of antihistone antibodies]. (1989) (0)
ASSESSMENT OF SMELL FUNCTION IN SCHIZOPHRENIA DURING ACUTE PSYCHOTIC EPISODE AND CORRELATION WITH CLINICAL SYMPTOMATOLOGY (2010) (0)
[Nucleosome as an autoantigen in systemic lupus erythematosus]. (1997) (0)
1 INCREASED INCIDENCE OF AUTOANTIBODIES IN CELIAC DISEASE: CELIAC ANTI DNA ANTIBODY INDUCES SYSTEMIC LUPUS ERYTHEMATOSUS LIKE DISEASE IN NAIVE MICE (1995) (0)
[Antinuclear antibodies in IgA nephropathy, as well as mesangiocapillary and membranous glomerulonephritis]. (1991) (0)
Leptin, Anti-HSP60, Anti-HSP65 and Anti- oxLDL in Autoimmune Rheumatic Diseases (2004) (0)
Thesera ofpatients withKlebsiella infections contain a commonanti-DNA idiotype (16/6) Idandanti-polynucleot ide activity (1987) (0)
I latin american congress of autoimmunity galapagos--September 15-18. (2003) (0)
[Homeopathy--permit or forbid?]. (1992) (0)
Israel–Gaza conflict (2014) (0)
Autoimmunity, COVID-19 Omicron Variant, and Olfactory Dysfunction: A Literature Review (2023) (0)
Circulating Regulatory T Cell Subsets in Patients with Sarcoidosis (2023) (0)
International Congress on Autoimmunity, Jerusalem, Israel, March 7–12, 1999 (1998) (0)
[Hypothermia secondary to endocrine dysfunction]. (1976) (0)
Contents, Vol. 109, 1996 (1996) (0)
Pathogenesis of the Antiphospholipid Syndrome (2018) (0)
Autoimmunity, part D: Autoimmune disease (Annals of the New York Academy of Sciences (2007) 1108, (505-514)) (2008) (0)
Comprar Diagnostic Criteria of Autoimmune Disease | Gershwin, M. Eric | 9781603274272 | Springer (2008) (0)
[Superantigens and autoimmunity]. (1994) (0)
FRI0185 HYDROXYCHLOROQUINE FOR THE PREVENTION OF RELAPSES IN A SERIES OF 812 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: THE HIBISCUS RETROSPECTIVE STUDY (2019) (0)
Stress in Post-traumatic Stress Disorder as an Incremental Mediator of Autoimmunity. (2023) (0)
Lessons from Monoclonal Antiphospholipid Antibodies (2002) (0)
[Conflict of interests in medicine, research and pubilcation]. (2018) (0)
Endothelial Biomedicine: Systemic Vasculitis Autoantibodies Targeting Endothelial Cells (2007) (0)
Chapter 7 – Predictive Autoantibodies (2014) (0)
FRI0065 Helminthes based novel compound, tuftsin-phosphorylcholine (TPC) ameliorates established murine arthritis (2017) (0)
THU0403 Scd163 in Adult Onset Still's Disease: A Biomarker for Macrophage Activation Related to Hyperferritinemia (2014) (0)
[Eaton Lambert syndrome--an autoimmune disease]. (1986) (0)
Susac's syndrome: Clinical characteristics, clinical classification and long term prognosis (2016) (0)
[Computerized grading for academic promotions at the faculty of medicine]. (2008) (0)
[Medical research in Israel in 2013]. (2013) (0)
[Sensitization to ampicillin in infectious mononucleosis]. (1984) (0)
Peptide mimetics of anti-dsDNA idiotypes as a tool for lupus-specific IVIG preparation: specificity and efficacy in the treatment of experimental systemic lupus erythematosus (2005) (0)
AB0511 INTERNATIONAL CONSENSUS ON ANCA TESTING AND INTERPRETATION BEYOND SYSTEMIC VASCULITIS (2020) (0)
[Vitamin D and the immunological system]. (1990) (0)
Editorial Heat-Shock Proteins in Autoimmunity (2013) (0)
2nd International Congress on Autoimmunity, March 7–12, 1999, Tel Aviv, Israel (2004) (0)
Diagnostic significance of carcinoembryonic antigen (CEA) concentrations: --a study of 61 patients with malignancies--. (1977) (0)
Vaccines, Infections, and Alopecia Areata (2015) (0)
Vitamin D, Pregnancy, and Autoimmunity (2019) (0)
Novel Treatments of Autoimmune Conditions (2020) (0)
[Accidental hypothermia in healthy adults]. (1976) (0)
Influence of silicone mammoplasty on the immunoendocrine status of female recipients (2020) (0)
Immunosuppressive acidic protein serum levels in breast cancer patients, in reference to CA 15-3 levels (1993) (0)
[Residents' restricted hours of duty--who will benefit from it: patients, society or the physicians?]. (2006) (0)
A comparative analysis of anti-CCP2 and anti-CEP-1 autoantibodies in various chronic arthritides (2015) (0)
Viral myocarditis: are we dealing with an autoimmune phenomenon? (1995) (0)
IgA and Cancer (2000) (0)
chronic inflammatory d emyelinating Polyradiculoneuropathy: r evisiting the r ole of intravenous immmunoglobulins (2013) (0)
Von Willebrand Factor and Myeloperoxidase as Laboratory Predictive Markers of In-Hospital Survival in Severe COVID-19 Patients (2022) (0)
Task Force Report on Non-criteria Manifestations: Skin (2012) (0)
[A piece of my mind. Road accident]. (1993) (0)
What Is Known ? Genes and the Environment in Antiphospholipid Syndrome (2017) (0)
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features (2017) (0)
Vaccinationofmiceforresearchpurpose: alumisaseffectiveasandsaferthan completeFreundadjuvant (2012) (0)
Autoimmunity Diseases of the Skin (2013) (0)
[Distinct subsets in systemic lupus erythematosus]. (1989) (0)
[Apoptosis (programmed cell death) in autoimmunity--autoimmunological aspect]. (1995) (0)
Editorial Biologicals Jozélio (2012) (0)
[Physicians and the battle against road accidents]. (1997) (0)
Clinical practice today (1989) (0)
The Novel Aspects on the Mosaic of Autoimmunity (2019) (0)
[The production of human-hybridomas and its contribution to the autoimmune diseases]. (1984) (0)
IX Eular Workshop for Rheumatology Research (1989) (0)
Autoimmune aspects of accelerated atherosclerosis in rheumatology (2004) (0)
Session 4 : Autoimmunity Wednesday 25 April 2001 , Moderator : Professor (0)
Central retinal vein thrombosis in a patient with primary pulmonary hypertension. (1980) (0)
Importance of intestinal microenvironment in development of arthritis. A systematic review (2014) (0)
Analyses of the Idiotypes and Ligand Binding Characteristics of Human Monoclonal Autoantibodies to Dna: Do We Better Understand Systemic Lupus Erythematosus? (2020) (0)
Erratum to: Infectious Aspects and the Etiopathogenesis of Rheumatoid Arthritis (2014) (0)
Detection of cellular Activity in Atherosclerosis by the Novel Cellscan System (2001) (0)
[Fungi and autoimmune conditions]. (1996) (0)
Infections as a Cause of Guillain–Barré Syndrome (2015) (0)
The Israeli fitness strategy: A complete program of diet and exercise based on the training system of the Israel Defense Forces (1980) (0)
Parotitis as the Presenting s ymptom of w egener's granulomatosis: c ase r eport and m eta-analysis (2013) (0)
Severe Blastocystis homini$ in an Elderly Man (1996) (0)
5-Fluoracil Cream Topical Treatment for Squamous Cell Carcinoma of the Skin: Before and After. (2022) (0)
Quality and best practice in medical laboratories: specific requests for autoimmunity testing (2020) (0)
[Can we predict autoimmune disease of the gastrointestinal tract and the liver by autoantibodies]. (2007) (0)
Poster SessionsPO17 PROTEINASES AND PLAQUE REMODELLINGANNEXIN A5 INHIBITS LYSOPHOSPHATIDYLCHOLINE INDUCED MMP-9 PRODUCTION; IMPLICATIONS FOR SLE AND CARDIOVASCULAR DISEASE (2008) (0)
[Crohn's disease and the immunological system]. (1978) (0)
[Tuberculosis in a general hospital 1987]. (1989) (0)
Anti-phospholipid syndrome from a systemic disease toward the infectious etiology. (2004) (0)
[Activity scores in systemic lupus erythematosus]. (1991) (0)
Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future (2014) (0)
The Etiology of the Antiphospholipid Syndrome (2020) (0)
SJÖGREN'S SYNDROME ASSOCIATED WITH CELIAC DISEASE: A SYSTEMATIC REVIEW (2021) (0)
[Chronic fatigue syndrome]. (2006) (0)
A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist’s office (2016) (0)
Foreword (2005) (0)
[Early detection of autoimmune diabetes mellitus]. (1994) (0)
Anti-tumor antibody profile analysis to harness the potentials of B cells in melanomas and the natural humoral immune response (2013) (0)
I: Immunomodulation of Experimental -Glycoprotein2 b Oral Tolerance to Low Dose (1998) (0)
Accelerated early atherogenesis in western-diet fed C57BL/6J mice immunized with Mycobacterium tuberculosis (1997) (0)
Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis (2013) (0)
PATIENTS AND METHODS (1980) (0)
Melanoma and immunotherapy bridge 2015 (2016) (0)
[Q fever endocarditis]. (1986) (0)
[The immunophysiological and immunopathological aspects of scleroderma systematica: fundamental and clinical aspects]. (2007) (0)
[The thymic hormones: their function and therapeutic potential]. (1984) (0)
Lancets unethical behavior. (2014) (0)
[What to wear--the physician's attire]. (2010) (0)
Prevalence of gastrointestinal associated autoantibodies in autoimmune diseases as compare to controls (2012) (0)
[Harnessing vitiligo for melanoma treatment]. (2008) (0)
Annals of the New York Academy of Sciences: Foreword (2007) (0)
[Renal crisis in scleroderma with normal blood pressure]. (1990) (0)
Efﬁcacy of IVIG afﬁnity-puriﬁed anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus (0)
Autoimmunity and the endocrine system: Thyroid, hypophysis and pregnancy. (2019) (0)
New aspects in the treatment of immunomediated diseases. (1991) (0)
Successful surgical treatment of polycystic liver disease. (1989) (0)
COVID-19 and ABO blood groups. (2021) (0)
Session 3B: Cytokines and Lupus (1992) (0)
Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice (2016) (0)
Melanoma Bridge 2013: Poster and Oral (2014) (0)
[Wine and its positive effect on human health]. (2012) (0)
Fever and chloramphenicol in leukemic patients. (1980) (0)
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome? (2023) (0)
The utility of PET/CT in diagnosing fever of unknown origin: The experience of a large tertiary medical center (2020) (0)
Future directions in anti-DNA antibody idiotype research. (1990) (0)
[Is SLE an autoimmune disease? Role of pathogenic anti-DNA idiotypes?]. (1989) (0)
erythematosus-related atherosclerosis: a novel target for treatment? The role of inflammatory cytokines in the pathogenesis of systemic lupus (2017) (0)
Use of intravenous immunoglobulin intended for the preparation of a pharmaceutical composition for the treatment of cancer (1996) (0)
[The revolution in medicine in the third millennium--from a lecture to medical students on their first exposure to clinical medicine]. (2000) (0)
[Hereditary ovalocytosis]. (1977) (0)
Acceleration of apoptotic cells clearance by macrophages upon exposure to serum amyloid P component and its synthetic derivates (2005) (0)
Coffee and Autoimmunity (2019) (0)
Editorial introductions. (2016) (0)
[The Wonderful World of Medicine]. (2021) (0)
ABC of rheumatology (2001) (0)
[Vaccine for AIDS--obstacles and approaches to solutions]. (1987) (0)
Adjuvants- and vaccines-induced autoimmunity: animal models (2016) (0)
Rheumatic Disease in Geriatrics: Diagnosis and Management (2020) (0)
Autoimmune Small Fiber Neuropathy: Is There a Place for the Confocal Microscopy? (2022) (0)
Monoclonal anti-endothelial cell antibodies (AECA), characterization and binding properties (1996) (0)
[Cytomegalovirus and atherosclerosis]. (1998) (0)
[Tumor metastases: mechanisms and dissemination pathways]. (1997) (0)
[Acclimatization to heat]. (1980) (0)
[Will I be a good doctor?]. (2012) (0)
[Diagnostic parameters in S.B.E]. (1978) (0)
Foreword (2007) (0)
[The search for medical information: the Israel Medical Association publishes update journals]. (2011) (0)
New autoimmune conditions. (1990) (0)
[The crisis in internal medicine: the combination of research with active clinical practice--one way to solve the problem]. (1986) (0)
Chapter 29 SARS-CoV-2, fertility-related autoantibodies and reproductive injury (2023) (0)
Editorial Neurologic Manifestations of Autoimmune Diseases (2012) (0)
Session 5: Autoimmunity (2004) (0)
Immunoglobulin G4-related Disease and Pancreatic Malignancy: An Association or Two Independent Processes? (2021) (0)
Chapter 5 - Atherosclerosis and Autoimmunity (2017) (0)
8 - PREDICTIVE AUTOANTIBODIES (2007) (0)
Detection of Anti-Vimentin Antibodies in Patients with Sarcoidosis (2022) (0)
Autoimmune/Inflammatory Syndrome Induced by Adjuvant Associated with a Metal Implant in the Mouth; Explantation Was Followed by Recovery. (2020) (0)
Other novel immunotherapeutic agents in the pipeline and future directions (2012) (0)
[Osteogenesis imperfecta]. (1972) (0)
[Cold injuries, Part II: Accidental hypothermia]. (1976) (0)
Another encounter with an old foe: outbreak of poliomyelitis in Israel--1988. (1989) (0)
[Patients' families abuse the medical and nursing staff]. (2005) (0)
Physical Activity and the Mosaic of Autoimmunity. Get Moving to Manage the Disease (2019) (0)
Adoptive Transfer of &bgr;2-Glycoprotein I–Reactive Lymphocytes Enhances Early Atherosclerosis in LDL Receptor–Deficient Mice (2000) (0)
Olfaction - a w indow to the mind (2009) (0)
[Testicular lymphoma]. (1979) (0)
Adoptive transfer of b2-glycoprotein I (b2GPI)-reactive lymphocyte enhances atherosclerosis in LDL receptor deficient mice (2000) (0)
Endothelial Dysfunction and Atherosclerosis in Rheumatoid Arthritis: AMultiparametric Analysis Using Imaging Techniques and Laboratory Markers of Inflammation and Autoimmunity (2008) (0)
[The need for a fifth faculty of medicine and where to locate it]. (2007) (0)
Autoimmune Concept Of Schizophrenia: HIistorical Roots and Current Facets (2020) (0)
Adjuvants and lymphoma risk as part of the ASIA spectrum (2015) (0)
Corrigendum to “Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis” [J Neuroimmunol. 2019 Dec 15;337:577070. doi: 10.1016/j.jneuroim.2019.577070. Epub 2019 Oct 24] (2019) (0)
Sjögren’s Syndrome Associated with Celiac Disease (2020) (0)
Chapter 34 – Antiphospholipid Syndrome (2014) (0)
Genetics and autoantibodies (2013) (0)
The Sixth International Lupus Conference, Barcelona 24–28 March 2001 (2001) (0)
[Autoimmune disease in mice]. (1981) (0)
Experimental Induction of Vascular Disease (2001) (0)
Conservative treatment of Budd-Chiari syndrome in polycythemia vera. (1981) (0)
Car accident : a personal angle (1993) (0)
Central Nervous System Vasculitis (2008) (0)
Silicone Breast Implant Debate. (2019) (0)
67 Dilated Cardiomyopathy (2008) (0)
Comprar Autoimmunity, Part A | M. Eric Gershwin | 9781573316637 | Blackwell Publishing (2007) (0)
Human Monoclonal Antibodies Directed Against Viral Antigens (1988) (0)
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction (2018) (0)
[The Fourth Annual Israeli- Italian conference for autoimmune diseases. Sienna, Italy, 27-28 September 2015]. (2016) (0)
[Habitual spontaneous abortions and the antiphospholipid autoantibody syndrome]. (1990) (0)
Darier's disease. (2006) (0)
Pathogenicity of anti-basement membrane (NC1) antibodies: an experimental Goodpasture's syndrome. (1996) (0)
Introduction: Organ Specific Immunopathology (2004) (0)
[ERYTHROCYTE SEDIMENTATION RATE - PURPOSEFUL REVIEW FOR CLINICAL APPLICATION]. (2022) (0)
[The leukemogenetic action of cytotoxic drugs]. (1981) (0)
[Harmful effects of smoking]. (1989) (0)
Leptin , Anti-HSP 60 , Anti-HSP 65 and Anti-oxLDL in Autoimmune Rheumatic Diseases (2004) (0)
Pharmacological Treatment of Injuries Caused by Silicone or Injected Oils: Therapeutic Algorithm (2019) (0)
Prognostic significance of CA 15-3 in breast cancer patients (1993) (0)
[The importance of the Cochrane Collaboration]. (2003) (0)
Letter to the Editor (2021) (0)
Idiotypes of Natural Autoantibodies and Monoclonal Gammopathies (1997) (0)
Vitamin D and thyroid autoimmune diseases: the known and the obscure (2014) (0)
Second International Congress on Autoimmunity (2004) (0)
[Autoantibodies in malignant disorders]. (1988) (0)
Primary antiphospholipid syndrome as a cause of impaired left ventricular diastolic function: experience from a Serbian cohort. (2022) (0)
Subject Index Vol. 16, 1998 (2000) (0)
[Penicillamine--friend or enemy?]. (1994) (0)
Autoimmunity, part C: The mosaic of autoimmunity (Annals of the New York Academy of Sciences 1107, (308-318)) (2008) (0)
Chapter 11 Antiphospholipid Antibodies, Infections, and Drugs (2009) (0)
Comprar Autoimmunity, Part C | Yehuda Shoenfeld | 9781573316620 | Blackwell Publishing (2007) (0)
Second International Congress on Autoimmunity, March 7–12, 1999, Jerusalem, Israel (2004) (0)
[Dopamine and the kidney--renal sparing effect: fact or fiction?]. (1996) (0)
[Academic requests from an MD and Phd theses--a suggestion]. (2009) (0)
THU0304 Vasculitis patients admitted to intensive care unit: implications from a single-center retrospective study (2017) (0)
Comprar Handbook of Autoimmune Disease | Shoenfeld, Yehuda | 9781603272841 | Springer (2008) (0)
[Viagra--utility and risk]. (1998) (0)
The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value (2014) (0)
Comprar Autoimmunity, Part D | Yehuda Shoenfeld | 9781573317085 | Blackwell Publishing (2007) (0)
[Medicine in the twentieth-one century: how it has changed in the last 30 years]. (2005) (0)
[Hereditary benign neutropenias]. (1977) (0)
The Dual Relationship Between Thymectomy and Autoimmunity (1999) (0)
Comment on: Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study. (2019) (0)
Preface: Pearls in autoimmunity. (2018) (0)
[The Whole World of Joy… Mixed with Sadness Cheerful Stories about Doctors and Medicine]. (2018) (0)
[Induction of experimental SLE and antiphospholipid syndrome models in naive mice]. (1992) (0)
[Indications--intravenous immunoglobulins--IVIG]. (2005) (0)
Arthralgia associated with hypercarotenemia. (1988) (0)
[Recent advances and developments in medicine]. (1990) (0)
Intensive lipid-lowering therapy: obvious benefits, possible risks. (2006) (0)
Chapter 9 In silico study of molecular mimicry between SARS-CoV-2 and neutrophil extracellular traps composition in granulocyte-rich supernatants of patients with systemic lupus erythematosus and lupus nephritis (2023) (0)
Thymoma and Autoimmune Diseases (2000) (0)
Intravenous immune globulins (IVIg) treatment for organizing pneumonia in a selective IgG immune deficiency state (2014) (0)
Impact of Antithyroperoxidase Antibodies (Anti-TPO) on Ovarian Reserve and Early Embryo Development in Assisted Reproductive Technology Cycles (2023) (0)
Bilateral Diaphragmatic Paralysis: A Rare but not to be Neglected Cause of Dyspnea. (2019) (0)
Plasma cell dyscrasias. Part I: Fluorescein angiography findings. (1981) (0)
Simultaneous nasopharyngeal and testicular involvement as a presenting sign of malignant histiocytic lymphoma. (1978) (0)
417 Worldwide picture of renal involvement in systemic lupus erythematosus using a big data analytical approach (2017) (0)
[The Israeli Medical Encyclopedia]. (2003) (0)
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through Synergy. (2019) (0)
Hyperprolactinemia and Antipsychotic Therapy in Schizophrenic Patients with Hashimoto's Thyroiditis. (2021) (0)
[Open access medical journals]. (2013) (0)
INTERNATIONAL LETTER RHEUMATOLOGY IN ISRAEL (1996) (0)
Predictive value of anti-citrullinated peptide antibodies: a real life experience (2014) (0)
PEDIATRIC CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME PATIENT EVOLVING TO SYSTEMIC LUPUS ERYTHEMATOSUS: FIRST DESCRIPTION (2021) (0)
[Tumor metastases--new experimental anti-metastatic therapies]. (1997) (0)
A medical nutriment supports dacarbazine treatment in stage III melanoma * (2005) (0)
[Mechanical trauma as a cause of cancer--a continuing dispute]. (1995) (0)
Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure (2016) (0)
[Albinism as an autoimmune disease]. (1992) (0)
Preliminary Pages / Contents (2000) (0)
Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis (2014) (0)
[Withdrawing of IVIG compound from the market]. (2010) (0)
Chapter 17 Autoantibodies in Gastrointestinal Autoimmune Diseases (2008) (0)
415 The association between world development indicators per country and gender ratio in patients with systemic lupus erythematosus: a big data approach analysis (2017) (0)
14 - HIV and Autoimmunity (2005) (0)
The effect of cyclosporine A on experimental SLE (1992) (0)
Citrullination and Autoimmunity (2019) (0)
A requisite role for IL-4 in the acceleration of fatty-streaks induced by heat shock protein 65 or mycobacterium tuberculosis (2000) (0)
Anti-idiotype regulation of experimental anti-phospholipid syndrome via reversal effect on Th1/Th2 expression (1997) (0)
Chapter 13 – Vaccination and Autoimmunity (2015) (0)
transient " lupus-type " autoantibodies following silicone implant rejection . An unusually complicated case of primary Sjögren ' s syndrome : development of (2008) (0)
[APITHERAPY - THE GOOD AND THE MYTH]. (2021) (0)
Subject Index Vol. 108, 1995 (1995) (0)
9 – AUTOANTIBODY SUBCLASSES (2007) (0)
[Hemorrhagic diathesis]. (1997) (0)
[Atherosclerosis as an autoimmune condition]. (2001) (0)
Chapter 26 The Immunoendocrine Role of Vitamin D in Autoimmunity (2008) (0)
[Immunological abnormalities in autoimmune liver diseases]. (1990) (0)
Chapter 3 Gender Bias in Murine Lupus (2008) (0)
Adjuvants and Autoimmunity: Why Do We Develop Autoantibodies, Autoimmune Diseases and Lymphomas. (2017) (0)
Book Review: Pregnancy, Autoimmunology, and Connective Tissue Disorders (1991) (0)
Early detection of recurrent mono-metastases of breast cancer to endocrine tissues by following CEA levels. (1997) (0)
[The future of medicine in Israel]. (2011) (0)
Chapter 6 – Pathogenic Mechanisms and Clinical Relevance of Autoantibodies (2014) (0)
A multidimensional autoantibody analysis specifying SLE patients with neuropsychiatric symptomatology (1991) (0)
SJÖGREN SYNDROME ASSOCIATED WITH CHIKUNGUNYA INFECTION (2021) (0)
The Etiopathogenesis of Autoimmunity (2019) (0)
Chapter 18 Neuropsychiatric side of the COVID-19 (2023) (0)
Anti-PTX3 antibody: a new antibody in lupus. (2008) (0)
Chapter 14 What is common to MDA5 and COVID-19? (2023) (0)
Second International Congress on Autoimmunity, Jerusalem, Israel, March 7–12, 1999 (2004) (0)
[Mixed connective tissue disease -- thirty three years of uncertainty]. (1996) (0)
The link between schizophrenia and hypothyroidism: a population-based study (2018) (0)
Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey (2020) (0)
New-Onset Immune Mediated Disease after Heart Transplantation: Characterization and Outcomes (2021) (0)
From autoantibody research to standardized diagnostic assays in the management of humen diseases : Report on the 12th Dresden Symposium on Autoantibodies September 23–26, 2015 (2015) (0)
Subject Index Vol. 109, 1996 (1996) (0)
[Cavitary lung lesion and chronic renal failure in a 76-year-old man]. (1995) (0)
Donato Alarcón-Segovia: a life dedicated to the study of autoimmunity. (2005) (0)
The predictive potential of autoimmune-inflammatory syndrome induced by adjuvants (ASIA) criteria to assess the risk of adverse events and efficacy of immune checkpoint inhibitor therapy (2022) (0)
A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies (2014) (0)
Hippocratic Oath and Heart Failure Journey: An Update on Therapies. (2020) (0)
Arthritis Rats Arthritis Manifestations in Adjuvant Citrullinated Autoantigens Attenuates Multiepitope Peptide Derived from Immune Tolerance Induction with Amital (2015) (0)
[Leukocytosis during labor and delivery]. (1983) (0)
PREVENTIVE TUFTSIN-PHOSPHORYLCHOLINE ACTION ON THE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN THE MICE DEVELOPMENT IN MICE C57BL/6 (2018) (0)
[Splenectomy in myeloproliferative diseases]. (1980) (0)
Letters to the editor (0)
Reply Letter - Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality? (2022) (0)
Smoke and Autoimmunity (2019) (0)
Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome (2016) (0)
Combined hyperlipidemic hyperglycemic model of atherosclerosis in apoE deficient mice (1999) (0)
[Response to stress and the immunological system]. (1991) (0)
influenza v accine and autoimmunity (2009) (0)
An idiopathic thrombocytopenic purpura with polyneuropathy (2016) (0)
Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana’s healthy population (2020) (0)
Insights from the 11th International Congress on Autoimmunity, Lisbon, Portugal, 2018. (2019) (0)
[Achievements and progress in medicine--1987]. (1988) (0)
Methode pour obtenir des anticorps anti-idiotype (2003) (0)
Hormonal therapy in a patient with ovarian agenesis and possible SLE: a choice to be made (2013) (0)
Nutritional Aspects of the Mosaic of Rheumatic Autoimmune Diseases a Recipe for Therapy? (2019) (0)
January – December 2018: Reviewer List - 2018 (2018) (0)
[Interleukin-12--polyfunctional cytokine]. (1996) (0)
The idiotypic network—animal models and clinical implications (1997) (0)
Herpes simplex virus and SLE: Though uncommon yet with significant implications (2023) (0)
Comment on the article by Cairns et al: Human hybridoma-derived autoantibodies. (1987) (0)
[Cellular immune responses in rheumatic fever]. (1996) (0)
Central Nervous System involvement in systemic lupus erythematosus: association with antibodies against a gliotypic antigen (2000) (0)
[Low cholesterol, depression and unexplained deaths--the link and the mystery]. (1999) (0)
the Sera of Patients with Lymphoma (1992) (0)
Novel Perspectives in the Treatment of the Antiphospholipid Syndrome —From Anticoagulation to Immunomodulation (2002) (0)
[Advances in immunopathology and treatment of Behçet's disease]. (1997) (0)
Narcolepsy and H1N1 vaccine (2015) (0)
Narcolepsy, Infections, and Autoimmunity (2015) (0)
Cytokines, interleukin-3 and autoimmunity. (1993) (0)
Narcolepsy, Infections, and Autoimmunity (2015) (0)
Primary Ovarian Insufficiency Incidence Rate and ETIOLOGY AMONG ISRAELI ADOLESCENTS between the Years 2000-2016 - A Multi-Center Study (2018) (0)
Acquired Adult Pure Red Cell Aplasia (2008) (0)
Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity (2023) (0)
The Human Anti-DNA Idiotype (16/6 Idiotype) (2020) (0)
[Clinical significance of anti-DNA antibodies]. (1983) (0)
[Central nervous system involvement in lymphoma patients]. (1982) (0)
Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature (2014) (0)
Anti-phospholipid antibodies To anticoagulate or not to anticoagulate ? (2014) (0)
Immunogenetic studies of allergic israeli patients (1992) (0)
Recognizing Specific Respiratory Patterns Preceding In-Hospital Clinical Deterioration: A Multi Center Study (2010) (0)
Idiotypes of Αnti-Phospholipid Antibodies (1997) (0)
Detection of Anti‐DNA and Antiphospholipid Antibodies and Their Idiotypes in Mothers With SLE and APLS and Their Offspring (1992) (0)
Prolactin and autoimmunity Autorev (2012) (0)
[Doctors as naive (innocent) drug advertisers]. (2008) (0)
SLE and other connective tissue diseases (animal models) (PP-017) (2010) (0)
Chapter 14 Autoantibodies and Infertility in Autoimmune Diseases (2008) (0)
Blockage of macrophage function with silica particles delays the onset of SLE-like syndrome in Mrl/lpr-lpr mice (1996) (0)
Delay of nephritis in NZB/NZWF1 mice injected with pentraxin 3 (2010) (0)
The Lancet against Israel--again. Response to the authors of the open letter to the people in Gaza. (2014) (0)
Euro-Phospholipid Project Comparison between antiphospholipid syndrome associated to SLE and primary APS in a cohort of 1,000 patients (2001) (0)
Vitamin D and Autoimmune Rheumatic Diseases (2023) (0)
[Aspirin for primary prevention of cardiovascular diseases--lessons from recent studies]. (2010) (0)
The Downside of Beauty: ASIA Syndrome Associated with Local Silicone Injections: A Literature Review (2021) (0)
Lack of cryoglobulin in primary antiphospholipid syndrome. (2022) (0)
["And nevertheless...autoimmunity"--celiac disease and the antibodies to tissue transglutaminase]. (2000) (0)
Antiphospholipid Syndrome—Pathophysiology (2014) (0)
Transient mixed cryoglobulinemia associated with chronic myelocytic leukemia. (1978) (0)
Comprar Autoimmune Diseases and Treatment: Organ-Specific and Systemic Disorders | Yehuda Shoenfeld | 9781573316132 | Wiley (2008) (0)
AB0215 Experimental neuropsychiatric lupus induced by 16/6 idiotype antibodies (2013) (0)
Subject Index, Vol. 111 1996 (1996) (0)
Possible Association Between Anti-Trisulfated-Heparin-Disaccharide (TS-HDS) Immunoglobulin M Autoantibody and Fibromyalgia Syndrome. (2023) (0)
Contents Vol. 138, 2005 (2005) (0)
[Selective inhibitors of cyclooxygenase-2 in upgrade in nonsteroidal anti-inflammatory drugs]. (1997) (0)
ImmuneNetwork and Autoimmunity (2007) (0)
[How to write a medical book]. (2012) (0)
Contents, Vol. 108, 1995 (1995) (0)
Hepatitis C Virus and Autoimmunity (1999) (0)
Novel Aspects of Diagnostic Test: Multiple Autoantigens, New Algorithms and Revolutionary Techniques (2006) (0)
[Complement component deficiency and autoimmune diseases]. (1988) (0)
[Why did the entity of effort syndrome disappear]. (1997) (0)
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the “Catastrophic antiphospholipid syndrome registry” (2022) (0)
Immunotherapeutic Agents for SLE (2012) (0)
2nd International Congress on Autoimmunity (2004) (0)
[Association between periodontitis, gingivitis and atherosclerosis; are they connected?]. (2001) (0)
HYPERPROLACTINEMIA AND ANTIPSYCHOTIC THERAPY IN SCHIZOPHRENIC PATIEN THYROIDITIS (2022) (0)
[Pancreatic carcinoma, sex hormones receptors and treatment with tamoxifen]. (1991) (0)
[Severe asthmatic attack induced by artofen]. (1987) (0)
Corrigendum to "Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience" [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981]. (2022) (0)
IgG4-Related Disease and Eosinophilic Granulomatosis with Polyangiitis: Similarity or Coexistence? (2019) (0)
[Physicians-researchers will vanish?]. (1992) (0)
Comment on the article by Cairns et a1 (1987) (0)
[Insulin resistance--possible connection between hypertension and coronary heart disease]. (1991) (0)
Tracing environmental markers of autoimmunity: introducing the infectome (2013) (0)
Systemic Sclerosis Anti-Endothelial Cell Antibodies in (2013) (0)
The ASIA Syndrome Registry (2015) (0)
The Biologic Feasibility of Autoimmunity as an Adverse Event (2015) (0)
The 20th anniversary of IMAJ. (2019) (0)
Contents, Vol. 101, 1993 (1993) (0)
[Anti-cytokine therapy in inflammatory joint diseases]. (1999) (0)
The ASIA Syndrome Registry (2015) (0)
[COVID-19 AND AUTOIMMUNE DISEASES]. (2021) (0)
[Peer Review]. (2012) (0)
Second International Congress on Autoimmunity. March 7–12, 1999. Jerusalem, Israel (2004) (0)
[Antiperinuclear factor: a specific marker for rheumatoid arthritis]. (1993) (0)
Intravenous Immunoglobulin Therapy in Systemic Lupus Erythematosus (2007) (0)
[A STRATEGY FOR PEACE BUILDING THROUGH MEDICINE: THE ISRAELI-PALESTINIAN CASE]. (2021) (0)
Foreword (2007) (0)
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases (2014) (0)
AB0082 Effects of Anti-Tnf Therapy on Circulating Oxldl-Beta2Gpi Complex Levels in Arthritis (2015) (0)
List of Contributors (2020) (0)
Contents, Vol. 100, 1993 (1993) (0)
List of Contributors (2019) (0)
[Is it worthwhile to be a reviewer for a medical-scientific journal?]. (2009) (0)
Comment on published article in Lupus: Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil; IVIG in myelofibrosis in SLE (2017) (0)
[The Lancet crosses all boundaries]. (2014) (0)
[AUTHORSHIP - A GREAT HONOR OR AN ONEROUS RESPONSIBILITY?] (2017) (0)
Vitamin D and autoimmune thyroid diseases: facts and unresolved questions (2014) (0)
[Pathogenesis of hemolytic uremic syndrome and thrombotic thrombocytopenia purpura]. (1997) (0)
Contents, Vol. 100, 1993 (1993) (0)
[Calcium blockers and cancer--is there any link between them?]. (1997) (0)
[Ways and means of determining academic rank of physicians: a proposal]. (1986) (0)
Comprar Autoimmunity: Concepts and Diagnosis at the Cutting Edge, Volume 1050 | M. Eric Gershwin | 9781573315173 | Wiley (2008) (0)
Silicone Breast Implants and Autoimmune/Inflammatory Syndrome induced by Adjuvants (ASIA): A Literature Search (2015) (0)
Silicone breast implants and Lupus (2022) (0)
Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I (2015) (0)
[The effect of hypophosphatemia on the peripheral blood cells]. (1981) (0)
Chronic Fatigue: Definition and Overlap with Fibromyalgia (2021) (0)
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil (2016) (0)
Helminthes and Autoimmunity, a Love Story (2019) (0)
[Blunt trauma causing emboli from friable atherosclerotic plaques]. (1997) (0)
Foreword (2007) (0)
Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry (2016) (0)
Low Folate Levels are Associated with Strokes and Less Venous Thromboses in Primary Antiphospholipid Syndrome (2022) (0)
[Viral and autoimmune etiology of idiopathic dilated cardiomyopathy]. (1992) (0)
OP0231 The effect of “triple therapy” with anticoagulation plus corticosteroids plus plasma exchange and/or intravenous immunoglobulins on the mortality of catastrophic antiphospholipid syndrome (CAPS) patients (2017) (0)
Introduction to the special issue on the 9th International Congress on Autoimmunity (2014) (0)
Abstracts of 2nd international congress on autoimmunity, March 7-11, 1999, Tel Aviv, Israel (1999) (0)
[Peer review--is there a better system?]. (2006) (0)
Epidermal ridge disarrangement and Hamman-Rich syndrome. (1980) (0)
Gangrene and Livedo Reticularis in Antiphospholipid Syndrome. (2021) (0)
Immune Thrombocytopenic Purpura: Between Infections and Vaccinations (2015) (0)
[Indication for use and mechanisms of action of intravenous immune globulin in autoimmune diseases]. (1995) (0)
Brief report Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination (2008) (0)
[Th1/Th2 cells and autoimmunity]. (1996) (0)
Comment on: 'Mast cell biology in the context of dysautonomia and neuropathy' by Dr. Nevio Cimolai. (2020) (0)
Composition for the prevention and treatment of atherosclerosis. (1999) (0)
[Publications in "Harefuah"]. (1987) (0)
Subject Index Vol. 138, 2005 (2005) (0)
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures (2017) (0)
[The "pneumonia-urinary tract infection" syndrome: loss of diagnostic ability in medicine]. (1993) (0)
[Chronic eosinophilic pneumonia]. (1978) (0)
[Zinc, the immune system and autoimmune diseases]. (1985) (0)
Antiphospholipid Syndrome — Experimental Models: Insight into Etiology, Pathogenesis, and Treatments (2006) (0)
Small fiber neuropathy definition, diagnosis and treatment (review) (2019) (0)
Sjögren’s Syndrome in Israel: A Scientific Point of View (2011) (0)
β2-Glycoprotein 1 (apolipoprotein-h) as an influencial determinant in atherosclerosis (1999) (0)
Does a glycosylation defect of IgG reduce their binding to the corresponding receptors? (1994) (0)
The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade (2012) (0)
The Link Between Sauna Bathing and Mortality May Be Noncausal. (2015) (0)
Can IVIG Inhibit Formation of Tumor by Inseminated Cells in an Eye Model (2007) (0)
The opposite effect of HLA-genotypes in sarcoidosis and tuberculosis (literature review) (2019) (0)
Foreword (2007) (0)
Rubella and autoimmunity. (2012) (0)
Composition destinee a la prevention et/ou au traitement de l'atherosclerose (1999) (0)
Author and Subject Index (2000) (0)
[Clinical significance of antibodies to SM and RNP]. (1988) (0)
[Bibliography--the achilles heel of medical articles]. (1991) (0)
[Goodpasture's syndrome as an autoimmune disease--identification of the autoantigen]. (1995) (0)
Environment, Immune Dysfunction, and Systemic Lupus Erythematosus (2012) (0)
the r ole of v itamin d in r egulating immune r esponses (2010) (0)
Cutting Edge Issues in Autoimmunity (2008) (0)
HPV and systemic lupus erythematosus: a mosaic of potential crossreactions (2017) (0)
Microbiota and Autoimmunity (2015) (0)
[Therapy of colon and rectal carcinoma: quality of life vs. prolongation of life]. (1995) (0)
Environment, Immune Dysfunction, and Systemic Lupus Erythematosus (2012) (0)
[What is new about benign familial leukopenia]. (1988) (0)
The olfactory function is impaired in patients with idiopathic inflammatory myopathies (2014) (0)
This information is current as 2-Glycoprotein I β TLR 2 Is One of the Endothelial Receptors for Shoenfeld (2010) (0)
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients (2023) (0)
Molecular mimicry in autoimmunity and vaccinations (2013) (0)
HLA-DRB1 the notorious gene in the mosaic of autoimmunity (2016) (0)
[Immunological aspects of endocarditis]. (1997) (0)
Comprar Autoimmunity, Part D: Autoimmune Disease, Annus Mirabilis | Yehuda Shoenfeld | 9781573317085 | Wiley (2008) (0)
The mosaic of autoimmunity: Why we develop autoimmune diseases: (2018) (0)
The idiotypic network implications animal models and clinical (1997) (0)
Modèles animaux de syndrome antiphospholipides (1998) (0)
Leukemoid reaction in a patient with pulmonary edema. (1992) (0)
The Sputnik V Vaccine against COVID-19: A Promising Platform for Mass Vaccination. (2022) (0)
[RED CENT]. (2021) (0)
Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites (2022) (0)
Oral tolerance induced by low dose β2-glycoprotein-I in experimental anti-phospholipid syndrome (1997) (0)
[Clinical significance of antineutrophil cytoplasmic antibody]. (1991) (0)
The impact of gender on the mosaic of autoimmunity (2006) (0)
[The hantaviruses--clinical syndromes]. (1995) (0)
2nd International Congress on Autoimmunity, Tel Aviv, Israel, March 7–12, 1999 (2004) (0)
Manipulation of Autoantibody Idiotypes in Autoimmune Diseases (1997) (0)
Breastfeeding and Autoimmunity (2019) (0)
Autoimmunity, T cells and immune regulation (1991) (0)
Autoantibodies in Gastrointestinal Autoimmune Diseases (2017) (0)
400 ATHEROGENIC IN VIVO LDL OXIDATION, THROMBOXANE-MEDIATED PLATELET ACTIVATION AND SIMULTANEOUS OCCURRENCE OF NATURAL IMMUNITY IN ATHEROSCLEROSIS-PRONE (LDLR−/− AND APOE−/−) MICE (2011) (0)
Immunolocalization of (cid:98) 2 -Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques Potential Implications for Lesion Progression Brief Rapid Communication (1999) (0)
Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study. (2017) (0)
[Pulmonary adenocarcinoma in myasthenia gravis--autoimmunity and late development of malignancy]. (2000) (0)
Bacillus Calmette-Guerin (BCG) as a Protective Factor for COVID-19? (2020) (0)
[Anti-idiotypic antibodies vaccines]. (1988) (0)
Autoantibodies in Females Exposed to Indoor Air Dampness Microbiota and Complaining of Electromagnetic Hypersensitivity- The Case Control Report (2022) (0)
Y Shoenfeld antiphospholipid syndrome Coincidence of granulomatosis and polyangiitis with atypical clinical manifestation and (2013) (0)
[Erdheim-Chester disease]. (2014) (0)
[Serological indicators in systemic lupus of the central nervous system]. (1988) (0)
sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia (2014) (0)
Autoimmune disease, annus mirabilis (2007) (0)
Session 6C: Animal Models (1992) (0)
96 Adult Pure Red Cell Aplasia (2008) (0)
[Are research physicians an endangered species in Irael?]. (2000) (0)
[Who is afraid of medical malpractice?] (2020) (0)
Vaccines - the good, the bad, and the unkown (2017) (0)
[The X-ANCA antibodies--importance and clinical significance]. (1999) (0)
Hypothesis for the development of immune-related adverse events in immune checkpoint inhibitors therapy. (2022) (0)
[Environmental factors and scleroderma]. (1998) (0)
Why are autoimmune diseases so diversified? Pathogenic idiotypes--an additional etiological factor. (1989) (0)
Chapter 8 Molecular mimicry and SARS-CoV-2 (2023) (0)
Autoimmune disorders caused by intravesical bacillus Calmette-Guerine treatment: A systemic review. (2023) (0)
Sarcoidosis: Progression to the chronic stage and pathogenic based treatment (narrative review) (2022) (0)
Haemophagocytic lymphohistiocytosis: from diagnostic challenges to predictive possibilities (2015) (0)
Antiperinuclear factor – clinical, serological and genetic correlates in Israeli patients with rheumatoid arthritis (1997) (0)
Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications (2014) (0)
[Is the drinking of cow milk in infancy a predisposing factor for insulin-dependent diabetes mellitus?]. (1998) (0)
[Ischemic heart disease and benign familial leukopenia in Yemenite Jews]. (1987) (0)
[IMAJ--the reflection of medical research in Israel 2012-2013]. (2013) (0)
ΟxLDL induces ceramide and apoptosis in macrophages but not in aortas of apoΕ-deficient mice (1999) (0)
[A family with hereditary ovalocytosis]. (1977) (0)
FRI0029 Clinical significance of 14–3–3eta protein levels in patients with rheumatoid arthritis (2018) (0)
Foreword (2005) (0)
[Systemic lupus erythematosus in Israel]. (1997) (0)
Dendritic Cells (2019) (0)
[Passive smoking]. (1981) (0)
Impaired Behavior in Young Female Mice Following Administration of Aluminum Adjuvants and the Human Papillomavirus ( HPV ) Vaccine Gardasil (2016) (0)
[Viagra--the first oral treatment for impotence that is not lacking in fatal effects]. (1998) (0)
Hepatitis C Virus, Autoimmunity and Cancer (2000) (0)
Autoimmunity: Concepts and diagnosis at the cutting edge: Foreword (2005) (0)
Lim Por Yen Lecture Theatre Autoantibody testing by the numbers: practical approaches to interpreting results - Symposium Sponsored by Bio-Rad Plenary Session 1: Novel aspect of therapeutics of autoimmune diseases (2013) (0)
Ronald A. Asherson—“In Memoriam” (2009) (0)
Seasonality and Autoimmune Diseases (2019) (0)
[Treatment of Raynaud's phenomenon]. (1993) (0)
The Lancet strikes again. (2014) (0)
Iloprost treatment of finger gangrene in a patient with Raynaud's syndrome. (2000) (0)
[Orthostatism in healthy people and in spinal patients]. (1977) (0)
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases. (2022) (0)
Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation. (2020) (0)
Chapter 5. The Role of Bisphenol A in Development of Autoimmunity (2022) (0)
( Auto-inflammatory ) Syndrome induced by Adjuvants ' ( ASIA ) : analysis of 93 cases Autoimmunity following Hepatitis B vaccine as part of the spectrum of ' Autoimmune (2012) (0)
The Journal of Rheumatology Volume 33 , no . 6 thrombosis ? Nonthrombotic manifestations of the antiphospholipid syndrome : away from (2006) (0)
Helminthes Derivative for Treating Acute and Chronic Colitis in Mice Models (2017) (0)
Inflamación y aterosclerosis acelerada: mecanismos básicos (2005) (0)
Assessment of Hearing and Vestibular Functions in a Post-COVID-19 Patient: A Clinical Case Study (2022) (0)
Interacciones neuroendocrinas-inmunes en el lupus eritematoso sistémico: una base para comprender la patogenia y la complejidad de la enfermedad (2005) (0)
1129P Comparison of predictive value of ASIA criteria and PD-L1 expression in patients taking checkpoint inhibitors in real clinical practice (2021) (0)
Lupus and leprosy: beyond the coincidence (2014) (0)
Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle (2013) (0)
Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I (2014) (0)
New diagnostic index for prediction of severe irAEs in patients with metastatic melanoma taking checkpoint inhibitors. (2022) (0)
RESILIENCE IN PREGNANCY: MUSIC AS AN AGENT IN DOPAMINE, OXYTOCIN AND GROWTH HORMONE PRODUCTION (0)
The Novel Diagnostic Index Based on HLA-DRB1 Genotype and PD-L1 Expression can Predict Severe irAEs in Patients with Metastatic Melanoma Taking Immune Checkpoint Inhibitors. The Results of the Pilot Study. (2022) (0)
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I (2014) (0)
[When assumptions are insufficient]. (1994) (0)
PReS13-SPK-1577: 'Asia' - autoimmune (auto-inflammatory) syndromes induced by adjuvants (2013) (0)
Transient monoclonal gammopathy in hydralazine induced lupus erythematosus. (1983) (0)
Loss of Orexine Neurons in the Hypothalamus and Narcolepsy-Like Behavior Induced by Autoantibodies in Mice (S19.003) (2013) (0)
410 AUTOANTIBODIES-ANTIGEN DRIVEN OR IDIOTYPICALLY INDUCED (1998) (0)
Harnessing the absence (helminthes) to treat the epidemic (autoimmunity) (2014) (0)
Autoantibodies as a clinical diagnostic tool. Introduction. (1998) (0)
[Autoimmune syndromes in malignant disorders]. (1988) (0)
[Vasculitis: classification, mechanisms, animal, models and treatment]. (1997) (0)
A between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis (2002) (0)
Imbalance in B cell and T Follicular Helper Cell Subsets in Pulmonary Sarcoidosis (2020) (0)
Is the physician like the pilot?: Lessons learned from two professions demanding great responsibility. (2000) (0)
Carbohydrate-Deficient Transferrin and False-Positive Results for Alcohol Abuse in Primary Biliary Cirrhosis: Differential Diagnosis by Detection of Mitochondrial Autoanti bodies (2004) (0)
[Microchimera--the secret path that leads to autoimmunity?]. (1999) (0)
[The lymphocyte, the plasmocyte and the immune response]. (1975) (0)
Autoimmunity Diseases of the Skin [Editorial] (2013) (0)
[Thromboembolic events in heparin-induced thrombocytopenia]. (1994) (0)
The effect of purified IgG antibodies from vitiligo patients on melanoma-bearing mice: 294 (1993) (0)
[Lymphatic leukemic infiltration and peptic ulcer mimicking gastric carcinoma (author's transl)]. (1978) (0)
[The athletic heart]. (1976) (0)
POS1203 INCREASED PROTEASE-ACTIVATED RECEPTOR 1 AUTOANTIBODIES ARE ASSOCIATED WITH SEVERE COVID-19 (2022) (0)
[Catalytic antibody-structure and possible applications]. (1995) (0)
[Methods in investigating physical fitness]. (1975) (0)

This paper list is powered by the following services:

Other Resources About Yehuda Shoenfeld

What Schools Are Affiliated With Yehuda Shoenfeld?

Yehuda Shoenfeld is affiliated with the following schools:

Yehuda Shoenfeld's Academic­Influence.com Rankings

Yehuda Shoenfeld's Degrees

Why Is Yehuda Shoenfeld Influential?

Yehuda Shoenfeld's Published Works

Published Works

Other Resources About Yehuda Shoenfeld

What Schools Are Affiliated With Yehuda Shoenfeld?

Image Attributions

Yehuda Shoenfeld's AcademicInfluence.com Rankings